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CHAPTER ONE 
 
INTRODUCTION 
 
 Infections caused by the intracellular pathogen Mycobacterium. avium subsp. 
paratuberculosis (MAP) have a devastating impact on the dairy industry.  Dairy cows 
generally are infected as neonates through the ingestion of water or feed contaminated with 
the bacteria.  Animals will remain in the subclinical, or asymptomatic state, of the disease 
until a period of extreme stress, such as parturition.  The clinical stage of the disease is 
characterized by severe weight loss, intermittent diarrhea, and fecal shedding of the bacteria.  
Currently, limited data exist on the effect of periparturient immunosuppression on the 
progression of Johne’s disease (JD) to the clinical stages.  Furthermore, a better 
understanding of the host immune response during this critical time period is essential for 
management of this and other diseases.  The experiments described in the subsequent 
sections of this dissertation are guided by the hypothesis that the host immune response to 
MAP infection is altered during the periparturient period. 
 
DISSERTATION ORGANIZATION 
 
 The objective of Experiment 1, described in Chapter 2, was to characterize cytokine 
gene expression and secretion in dairy cows naturally infected with MAP during the 
periparturient period as compared with healthy control cows. The progression of the disease 
is dependent upon the cytokine microenvironment.  The T helper 1 (Th1), or cell-mediated, 
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cytokines include interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-1α, and 
IL-12.  These cytokines normally are upregulated in subclinical animals.  In contrast, as the 
disease progresses to the clinical stage, the cytokine profile transitions from a Th1 to a Th2, 
or humoral, immune response.  Characteristic Th2 cytokines that are upregulated in clinical 
animals include IL-4 and IL-10.  A third subset, Th3 cells, secrete transforming growth factor 
(TGF)-β. 
 The objective of Experiment 2, described in Chapter 3, was to determine the 
percentages of CD4+, CD8+, and γδ T-cells, B-cells, and monocytes in the peripheral blood of 
dairy cows naturally infected with MAP during the periparturient period as compared with 
healthy control cows.  In addition, cell populations were delineated further by staining for 
CD5, a marker for T- and B-cell activation.  Parturition has a major impact on the number of 
T- and B-cells, both components of the adaptive immune system, and the number of 
monocyte/macrophages, effectors of the innate immune system in the peripheral blood of 
healthy dairy cows.  This shift in Th1 to Th2 immunity is characterized by a decreased 
percentage of peripheral blood T-cells and an increase in the percentage of B-cells for 
clinically infected cows. 
 The objective of Experiment 3, described in Chapter 4, was to evaluate osteopontin 
(Opn) gene and protein expression in dairy cows naturally infected with MAP during the 
periparturient period as compared with healthy controls.  In addition, Th1 and Th2 cytokines 
were evaluated for expression and secretion and correlated with that of Opn.  Investigation of 
the role of Opn in JD is of interest based upon its ability to influence cytokine expression and 
to improve host defense against mycobacterial infections.  Osteopontin is capable of 
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enhancing Th1 cytokine expression by augmenting IL-12 and subsequently inducing CD4+ 
T-cell differentiation into Th1-like cells.   
 The objective of Experiment 4, described in Chapter 5, was to identify Opn in the 
ileum and ileocecal (IC) lymph node of dairy cows naturally infected with MAP and to 
compare the frequency and intensity of staining between the different infection groups.  The 
formation of granulomas at the site of MAP infection is critical for the control of new and 
existing infections.  Studies evaluating granuloma formation in other mycobacterial 
infections supported an upregulation of Opn in the inflamed tissues.   Furthermore, Opn has 
been shown to enhance the production of IFN-γ and TNF-α, two cytokines important for the 
formation of granulomas. 
 
LITERATURE REVIEW 
 
Johne’s Disease 
 
 
Johne’s disease, caused by Mycobacterium avium subsp. paratuberculosis (MAP), is 
estimated to infect more than 22% of US dairy herds and cost the US dairy industry $250 
million annually (Ott et al., 1999).  It was first described in 1895 by Johne and Frothingham 
(Collins and Manning, 2007).  Both noted that the tissue samples from a deceased dairy cow 
consisted of a thickened intestinal mucosa and enlarged mesenteric lymph nodes.  It is a 
devastating disease that is an issue of both economics and animal welfare. Although domestic 
and wild ruminants primarily are infected, MAP also has been isolated from monogastric 
animals, such as fox, rat, badger, and crow (Beard et al., 2001).  M. paratuberculosis is a 
weakly gram-positive, facultative, acid-fast bacillus.  Advantages of this intracellular 
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bacterium include its ability to avoid antibodies, utilize complement, and utilize host 
nutrients.  Once infected, cows generally remain in the subclinical, or asymptomatic, stage of 
the disease for the first few years of life and then the disease progresses to the clinical stage.  
The clinical stage of the disease is characterized by severe weight loss, intermittent diarrhea, 
and fecal shedding of MAP and may ultimately lead to death of the animal.  This literature 
review focuses on the host immune response of periparturient dairy cows to MAP infection. 
 
Pathogenesis of Johne’s Disease 
 
Transmission of Mycobacterium avium subsp. paratuberculosis 
The transmission of MAP generally occurs by the interaction of the cow with her calf.  
Calves are most likely to be infected with MAP during the first six months of life (Sweeney, 
1996).  Compared with older adult cows, calves are more susceptible to MAP infection.  
When one-month-old calves were challenged with MAP, after 150 days, the calves had a 
greater number of MAP organisms and lesions in their tissues compared with adult cattle 
ranging in age from 5 to 11 years (Larsen et al., 1975).  The majority of infections are caused 
by fecal shedding of the bacteria by clinical adult cows.  Subclinically infected animals shed 
few, if any, bacteria in their feces.  Amazingly, at 15°C, MAP can survive in cattle manure 
slurry for up to 98 days (Jorgensen, 1977) and transmission does not seem to be a seasonal 
problem.  The bacteria have been reported to survive in cattle manure slurry for 21 days at 
35°C (Olsen et al., 1985).  In addition to fecal shedding, in clinical cows there have been 
reports of in utero transmission during gestation (Sweeney et al., 1992).  MAP also has been 
isolated from the colostrum and milk of clinically infected cows (Streeter et al., 1995).  In 
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these three scenarios, the source of MAP infection was consistently from clinically infected 
cows.  Infected cows do not begin to shed the bacteria until an extreme period of stress, such 
as parturition.  This shedding generally is between 2 and 3 years of age.  However, more 
recently, Van Roermund et al., (2007) provided data to support horizontal transmission of 
MAP between calves suggesting that calves can shed sufficient quantities of MAP to infect 
other animals.  
 
Peyer’s Patches and M cells 
 In order to establish infection, the bacteria must be able to breach the host by 
establishing a route of entry into the body.  Gut-associated lymphoid tissue (GALT) in the 
intestines is a site of host vulnerability.  This area is advantageous for MAP in that it 
provides a source of entry.  In ruminant animals, the GALT consists of aggregates of 
lymphoid follicles called Peyer’s patches (PP).  The PP extend into the intestinal lumen as 
dome-shaped structures consisting primarily of lymphocytes, macrophages, and dendritic 
cells (DCs).  Although these patches are located throughout the jejunum and ileum, the ileum 
accounts for 80-90% of the total mass of PP tissues.  Unlike other sites of the intestinal 
epithelium, PP do not contain mucous secreting goblet cells.  This feature provides the 
invading bacteria with ever greater accessibility to the host.    
 Within the PP, the bacteria gain entry by utilizing specialized cells known as M cells.  
M cells are important because they are capable of sampling antigen from the lumen of the 
small intestine and delivering it to the cells of the immune system.  MAP is translocated 
across the epithelium by these cells.  M cells differ from other intestinal epithelial cells in 
that they express integrins on their luminal surface.  MAP binds to M cells by forming a 
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fibronectin bridge between the integrins on the M cells and the fibronectin attachment 
proteins on MAP (Secott et al., 2004).  Compared with the enterocytes of the rest of the 
intestine, M cells are shorter and do not have closely packed microvilli (Owen, 1999).  Ileal 
PP are one of the largest producers of B lymphocytes in ruminant animals. Lymphocytes do 
not enter M cells but are able to pass between them (Owen, 1999).  Another unique feature of 
M cells is that they do not contain lysosomes that will degrade the invading bacteria (Owen 
et al., 1986).  This feature insures that the bacteria will be intact during transcytosis until it is 
released from the cell.    
 The ability of MAP to gain entry into the intestines via the PP and M cells is key for 
its initial attempts to establish infection in the host. 
 
Immunology of Johne’s Disease 
 
Innate Immune Response 
 The purpose of the innate immune response is to provide an initial line of defense 
against invading pathogens.  Once MAP has transcytosed the M cell, it will encounter 
subepithelial and intraepithelial macrophages (Momotani et al., 1988).  There are key 
features of mycobacteria that provide an advantage in evading the host immune response.  
Mycobacteria have a rich peptidoglycan layer that contains a thick lipoarabinomannan 
(LAM) component.  The LAM is very hydrophobic, and this trait is advantageous to the 
mycobacteria because it delays the formation of the phagolysosomes (Fratti et al., 2003).  
Under normal conditions, the macrophage can phagocytize a pathogen by opsonic (CR1 and 
CR2) or non-opsonic (mannose and scavenger receptors) uptake.  Typically, large particles 
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are taken up into the phagosome.  A macrophage in early activation will have Rab5 and 
EEA1 molecules on the phagosomal membranes and an internal pH of 6.5.  Activation of the 
macrophage includes recruitment of vesicular ATPases to supply the protons needed to 
acidify the vacuole (Singh et al., 2006).  A phagosome in late stage will express Rab7 and 
will have an internal pH of 5.5.  Finally, when fusion of the phagosome and lysosome has 
occurred, Rab9, LAMP-1, and cathepsin D are upregulated and expressed.  MAP is also 
capable of halting phagosome fusion by blocking the release of calcium.  The pH in this 
environment is 4.5.   
 Mycobacteria have a unique ability to halt the activation of the phagosome during the 
early stages.  The bacteria utilize the macrophages as intracellular niches to survive and 
replicate, essentially evading the host.  In a 7-day period, MAP is able to multiply by 200-
250% within monocyte-derived macrophages and monocytes (Zurbrick and Czuprynski, 
1987).  The ability of MAP to avoid digestion is also evident by the finding of intact bacteria 
in macrophages four weeks post-infection (Bendixen et al., 1981).  Using the mouse 
macrophage cell line J774A.1, Hostetter et al. (2003) showed that in phagosomes containing 
live MAP there is increased expression of the early activating marker, transferrin receptor, 
and decreased expression of LAMP-1 compared with macrophages containing dead MAP.  
There is down-regulated expression of vesicular proton-adenosine triphosphatase, a necessity 
for proper phagosomal acidification, in MAP-infected macrophages (Sturgill-Koszycki et al., 
1994).  The ability to prevent the maturation of the phagosome is not unique to MAP.  Other 
mycobacteria exhibit this similar characteristic.  For example, macrophages that have been 
infected by M. avium fail to acidify below pH 6.3 (Sturgill-Koszyzki et al., 1994). 
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 IFN-γ is produced by T cells and provides the major stimulatory signal for 
macrophage activation.  Mycobacteria downregulate surface expression of the IFN-γ receptor 
(Singhal et al., 2007).  When MAP infected J774A.1 macrophages are treated with IFN-γ and 
LPS, there is a greater ability of the phagosomal compartment to acidify and mature into 
functional phagolysosomes compared with the control (Hostetter et al., 2002).  Activated 
macrophages secrete nitric oxide, reactive oxygen intermediates (H2O2 and OH-) and T 
helper 1 (Th1) cytokines.  These cytokines will be reviewed in a later section, but include IL-
1, IL-12, IL-8, and TNF-α.  In addition to secreting cytokines, mycobacteria block iNOS 
recruitment to phagosomes and subsequently reduce the secretion of nitric oxide by the 
macrophage (Miller et al., 2004).  Receptors on macrophages important for MAP entry 
include CR1, CR3, CR4, FcR, mannose-receptor, LPS-binding receptor, CD14, transferring 
receptor, and scavenger receptors surfactant protein A receptor. 
 
Formation of Granulomas 
 The formation of granulomas at the site of MAP infection is critical for the control of 
new infections.  A hallmark characteristic of Johne’s disease is the formation of these 
granulomas.  Granulomas are inflammatory lesions that are primarily located in the GALT, 
lamina propria, and submucosa and are in close proximity to the lymphoid tissue of the PP.  
They are important for the containment of the bacteria but may also result in the destruction 
of tissue via the inflammatory response.  Activated T lymphocytes secrete IFN-γ, which acts 
to recruit and activate additional macrophages to the site of infection.  In addition to IFN-γ, 
TNF-α is also critical for the development of protective granulomas (Roach et al., 2002).  
 9
 In sheep, the early subclinical stage of the disease is characterized by the formation of 
tuberculoid-type lesions.  These lesions are not typically found in MAP-infected cows.  
These lesions are present in the ileal lamina propria and subcapsular sinus and are composed 
primarily of lymphocytes, plasma cells, and macrophages.  In situ hybridization of the ileum 
from subclinical dairy cows revealed IL-18 (proinflammatory) mRNA present in the 
macrophages in the lamina propria, submucosa, and lymphoid follicles of PP (Tanaka et al., 
2005).  The presence of CD4+ T-cells is important in the acceleration of granuloma 
formation.  This presence directly results in the increase of TNF-α and IFN-γ production 
(Hansch et al., 1996).  When weaned Merino lambs were infected orally with 107 M. avium 
subsp. paratuberculosis, there were increased numbers of CD4+ T-cells in the ileal and 
jejunal PP and mesenteric lymph nodes compared with the control lambs four months after 
initial infection (Reddacliff et al., 2004).  However, significant histological lesions were not 
detected in the ileal tissue of infected lambs.  Furthermore, the number of resident 
macrophages in the ileum of MAP-infected cows is three times that of noninfected cows (Lee 
et al., 2001).  The increase in macrophages is expected based upon the upregulation of IL-12 
secretion by CD4+ T-cells in the tissue.  Intracellular adhesion molecule-1 (ICAM), a 
transmembrane glycoprotein, is important for the recruitment of macrophages to the site of 
infection.  Challenging ICAM knock-out mice with M. tuberculosis resulted in extensive 
cellular infiltration, failure to organize granulomas to contain the bacteria, and eventual death 
(Saunders et al., 1999).   
 As the disease progresses in sheep, there is a switch in the type of lesion from 
tuberculoid to lepromatous.  Again, these types of lesions are not typically observed in the 
bovine.  These lesions are found in the lamina propria, submucosa, and the lymphoid follicles 
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of PP in the ileum.  Langerhans cells infiltrate the tissue at the site of the lesion.  These cells 
are large cells formed by the fusion of macrophages.  During the clinical stage, there is a high 
bacterial load in the granulomas (Hostetter et al., 2005).  The lepromatous lesions consist 
primarily of macrophages containing large numbers of MAP and can be characterized by a 
Th2 cytokine response.  Compared with a tuberculoid-type granuloma, there is greater 
expression of IL-4 and IL-10 in the lepromatous group.  The end result to the host in the 
advanced stage of JD is a corrugated and thickened instestinal mucosa (Clark, 1997).  The 
sloughing of the mucosa during this stage results in increased shedding of MAP in the feces.  
The terminal stage of disease also is characterized by severe diarrhea.  Inflammation and 
thickening of the intestinal mucosa results in reduced protein absorption, and fluid is not 
sufficiently absorbed.  This directly results in an increase of water in the feces. 
 
Lymphocytes and Johne’s Disease 
 
 There are two distinct lineages of T-cells based upon the T-cell receptor, αβ and γδ, 
with commitment to a lineage occurring early in T-cell development (MacDonald et al., 
2001).  T-cells committing to the αβ lineage will develop further into either a CD4+ or CD8+ 
phenotype.  Both the duration and strength of the T-cell receptor signaling control the CD4-
CD8 lineage.  A longer duration of signal results in the propagation of CD4+ T cells, and a 
repression of CD8+ T cells is required for CD4+ lineage commitment (Liu and Bosselut, 
2004).  Likewise, an increase in signal strength results in the CD4+ lineage (Watanabe et al., 
2000).        
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CD4+ T Lymphocytes 
CD4+ T-cells, also known as T helper cells, play an active role in initiating both the 
humoral and cell-mediated immune responses.  Naïve CD4+ cells are uncommitted and may 
proliferate into a Th0 immature effector T-cell.  The immature cell can differentiate into Th1, 
Th2, Th3, or Treg cells.  Which lineage is chosen is based on the cytokine microenvironment 
surrounding the infectious agent.  Cytokines, such as IFN-γ and IL-12, will drive Th0 cells to 
a cell-mediated, or Th1, immune response.  Production of IL-12 from macrophages and 
dendritic cells (DC) acts on naïve CD4+ T-cells to direct development towards a Th1 
response (Macatonia et al., 1995).  In contrast, the presence of IL-4 will drive a humoral, or 
Th2, immune response.  The differentiation of the Th0 cell is critical in controlling the 
outcome of intracellular infection.  
 The percentage of CD4+ T-cells in PBMCs from healthy adult dairy cattle is 
approximately 25-35%.  In mycobacterial infections, CD4+ T-cells are recognized as the 
primary producers of IFN-γ (Stuehr and Marletta, 1987; Flynn et al., 1993).  The effects of 
MAP on the percentages of CD4+ T-cells are unclear.  One study did not observe differences 
in the percentage of CD4+ T-cells in fresh PBMCs isolated from MAP-infected periparturient 
cows (Harp et al., 2004).  However, another study found that the ileum and peripheral blood 
of clinically infected cows have fewer CD4+ cells than subclinically infected cows (Koets et 
al., 2002).    
 
CD8+ T Lymphocytes 
CD8+ or cytotoxic T-cells are important for their ability to recognize viral and 
bacterial antigens and target dendritic cells displaying these antigens for apoptosis (Kagi et 
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al., 1994).  These cells release granules that contain perforin and granzymes.  CD8+ cells also 
express a Fas ligand, which, upon binding, can activate apoptosis.  This T cell subset 
recognizes the MHC class I molecule.  MHC class I molecules present peptides generated in 
the cytosol to CD8+ T-cells.  The importance of a functional MHC class I was highlighted by 
Flynn et al. (1992) who developed a mouse with a disruption in the β2-microglobulin.  These 
mice did not have a functional MHC class I.  Infection with M. tuberculosis resulted in the 
death of 70% of the knockout mice after 6 weeks compared with 20 weeks for the controls.  
The knockouts also had a greater number of tubercle bacilli present in lung tissue.  The 
importance of MHC I in controlling mycobacterial infections was highlighted further in a 
study that reported mice deficient in transporter associated with antigen processing (TAP) 1 
were more susceptible to intravenous infection with M. tuberculosis (Behar et al., 1999).  
TAP1 is located in the endoplasmic reticulum (ER) and mediates the active transport of 
peptides from the cytosol into the lumen of the ER.  These TAP1 KO mice had 10-100 fold 
increase in the number of bacteria isolated from their lungs and had a reduced survival rate.  
Studies using Fas and perforin knockout mice have shown that mice challenged with 
mycobacteria do not rely on Fas or perforin-mediated effects for the early control of infection 
(Cooper et al., 1997a; Laochumroonvorapong et al., 1997).  The secretion of cytokines is 
likely very important for the contribution of CD8+ cells to the host immune response against 
MAP. 
Cytokine secretion by the CD8+ cells contributes to the host immune response to 
invading mycobacteria.  Similar to CD4+ T-cells, CD8+ cells also secrete the 
proinflammatory cytokines, IFN-γ and TNF-α, making them equally important in controlling 
infection (Fong and Mosmann, 1990; Berg et al., 2002).  CD8+ T-cells also have the capacity 
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to produce Th2 cytokines.  Stimulation of rat spleen with PMA and ionomycin resulted in an 
upregulation of IL-4, IL-5, IL-10, and IFN-γ (Noble et al., 1995).  CD8+ cells also secrete 
TGF-β and IL-4 (Weiner et al., 1994).   
Studies depleting mice of their CD8+ T-cell populations by using anti-CD8 antibodies 
have demonstrated a protective role for CD8+ cells in M. tuberculosis infection (Muller et al., 
1987).  Activation of CD8+ in response to live M. bovis has been reported in human PBMCs 
(Turner et al., 1996).  Studies in healthy dairy cows support a decline in CD8+ cells at 
parturition (Kimura et al., 1999; VanKampen et al., 1999).  This decline is in contrast to two 
studies reported by Harp et al. (1991 and 2004) that suggested CD8+ T-cells in peripheral 
blood were not influenced by parturition.  MAP infection does not seem to affect the 
percentage of CD8+ cells (Koets et al., 2002). 
 
γδ T-Lymphocytes 
The γδ T-cell population is a distinctly different subset of T-cells that are not 
characterized by the αβ TCR chain.  γδ T-cells seem to initiate immune responses and may 
regulate host inflammatory response to infection (King et al., 1999; Tagawa et al., 2004).  
However, their specific roles in host immunity are still relatively undefined.  These cells are 
unique in that they do not utilize MHC complexes to recognize antigens.  The percentage of 
γδ T-cells in blood is greatest in the calf (40%) and gradually declines to approximately 5% 
of adult PBMCs (Hein and MacKay, 1991).  In ruminant animals, a subset of the γδ T-cell 
population expresses WC1+ on their surface.  Observations for periparturient dairy cows 
suggest that percentages of γδ T-cells either decline (VanKampen and Mallard, 1997; Kimura 
et al., 1999) or remain unchanged (Park et al., 1992; Harp et al., 2004; Meglia et al., 2005).  
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WC1.1+ cells are the primary source for IFN-γ derived from γδ T-cells (Rogers et al., 2005).  
In addition to IFN-γ, γδ T-cells also secrete IL-2 and TNF-α (Christmas et al., 1990).   
 A role exists for this subpopulation of T-cells in the early stages of intracellular 
infections.  These cells play a regulatory role by influencing the movement and function of 
the inflammatory effectors, neutrophils (Fu et al., 1994) and macrophages (Tagawa et al., 
2004), to the site of infection.  This is an important point since the formation of granulomas 
at the site of infection is a hallmark of Johne’s disease.  Mice infected with live M. bovis 
BCG had a large accumulation of γδ T-cells at the site of infection (Griffin et al., 1991).  
Koets et al. (2002) reported that the population of γδ T-cells in freshly isolated PBMCs was 
much greater in control cows compared with MAP-infected clinical cows.  The early stages 
of  infection with M. tuberculosis resulted in increased numbers of activated γδ T-cells that 
were capable of producing IFN-γ (Tsukagucki et al., 1995).  The secretion of IFN-γ by the γδ 
T-cells contributes to the early protection needed before the initiation of the αβ T-cell 
response.  The exact role of γδ T-cells in MAP-infection remains unclear. However, studies 
suggest that γδ T-cells plays an initial role in the host immune response to the invading MAP 
bacteria. 
 
B Lymphocytes 
 As Johne’s disease progresses, there is a transition from the cell-mediated to humoral 
immune response.  B-cells are responsible for the induction of the humoral response.  Upon 
activation, B cells differentiate into antibody-secreting plasma cells.  The presence of helper 
T cells and antigen are needed to support this activation that occurs by the binding of the 
antigen to the B-cell receptor.  Secreted antibodies can neutralize or opsonize the pathogen or 
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activate complement.  Isotype switching of the secreted antibody results in IgG, IgA, IgM, 
IgD, or IgE.  Cytokines are capable of inducing isotype switching.  IFN-γ is essential for the 
class-switching to IgG2a and IgG3 (Snapper and Paul, 1987), whereas, the Th2 cytokine IL-4 
induces the expression of IgG1 and IgE (Abbas et al., 1996).  The antibodies IgG and IgM are 
expressed in high concentrations in serum of cattle naturally infected with MAP (Abbas and 
Riemann, 1988).  In addition to serum, IgG and IgM also were found in greater quantity in 
the ileum of MAP-infected cows compared with noninfected animals (Momotani et al., 
1986).  Both of these classes of immunoglobulins promote neutralization of bacteria and 
activate the complement system.   
 In the advanced stages of JD, antibody production by B-cells does little to protect the 
host from the progressive MAP-infection. B-cells from clinical, but not subclinical JD cows, 
fail to proliferate in response to antigen stimulation (Waters et al., 1999).  Furthermore, the 
percentages of B-cells in peripheral blood are similar between subclinical and control cows 
but greater in clinical cows (Waters et al., 1999).   Coussens et al. (2002) reported a 
repression of the Lyn B protein tyrosine kinase in clinical cows compared with that in  
subclinical and control cows.  The Lyn B gene is involved in B-cell signaling through the B-
cell antigen receptor.   The periparturient period does not have an effect on B-cell 
proliferation (Nagahata et al., 1992).  However, decreased IgM secretion immediately before 
calving has been reported (Lacetera et al., 2005).    Decreased MAP-specific serum antibody 
was observed after calving in dairy cows with JD (Stabel and Goff, 2004). 
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Cytokine Regulation of Johne’s Disease 
 
 The development and progression of Johne’s disease is influenced greatly by the 
cytokine microenvironment.  Cytokines are small proteins or peptides released from cells that 
have a specific effect on the behavior of cells.  Although CD8+ and γδ T-cells secrete 
cytokines, the CD4+ subset plays the primary role in controlling MAP infection through 
cytokine production.  In 1989, Mosmann et al. (1986) described the formation of two distinct 
populations of mouse CD4+ T-cells that could be distinguished on the basis of their patterns 
of cytokine production.  These populations are called Th1 and Th2, and the interaction of the 
two results in a polarization of the cytokine response.  Naïve CD4+ T-cells have the potential 
to develop into a Th1, Th2, Th3, or Treg cell.  This section of the literature review presents 
data that support a role for the Th1 cytokines in subclinically infected dairy cows.  As 
paratuberculosis progresses to the clinical stage, there is a transition from a Th1 to a Th2 
cytokine response.  A summary of the Th1/Th2 paradigm is provided in figure 1.1. 
 
T-helper 1, Proinflammatory Cytokines 
 An effective Th1 response to MAP infection is critical for controlling the initial 
stages of the disease.  The secretion of Th1 cytokines is primarily responsible for the 
induction of a cell-mediated immune response.  Classical Th1 cytokines include IL-1α, IL-
1β, IL-8, IL-12, IL-18, IFN-γ, and TNF-α (Fig. 1.1).  Of the classical cytokines, IFN-γ is 
among the first to be activated in subclinically infected cows (Sweeney et al., 1998). 
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Figure 1.1 The Th1/Th2 Paradigm.
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Interferon-γ is a Type II interferon and is secreted by CD4+ Th1 cells, CD8+ T-cells, 
γδ T-cells, and activated natural killer cells.  Biologically active IFN-γ is a noncovalent 
linked homodimer (Ealick et al., 1991).  Interferon-γ has two receptors that are members of 
the class II cytokine receptor family.  The first chain, IFNGR1, is the binding chain, and the 
second chain, IFNGR2, is responsible for signal transduction (Aguet et al., 1988).  However, 
the IFNGR1 chain is produced in surplus (Bernabei et al., 2001) and has binding motifs for 
Janus tyrosine kinase (Jak)1 and signal transducer and activator of transcription (Stat)1.  
Interferon-γ binds to IFNGR1, and then this complex associates with IFNGR2.   Ligand 
binding phosphorylates Jak1, which, in turn, phosphorylates Stat1.  The Stat1 homodimer 
translocates to the nucleus where it binds to promoter elements to influence gene expression.  
The importance of functional IFN-γ receptor recognition is evident when mice lacking the 
IFN-γ receptor are infected with the BCG strain of M. bovis.  Infection is lethal for deficient 
mice but not for the wild-type mice with a functional receptor (Kamijo et al., 1993).  
Micewith disrupted IFN-γ gene do not survive when exposed to sublethal doses of M. bovis 
(Dalton et al., 1993).     
  Tumor necrosis factor-α was first described in 1985 by Lloyd Old.  Tumor necrosis 
factor-α is predominantly involved in local and systemic inflammation and is a major 
mediator of endotoxic shock.  It is produced by macrophages, T cells, mast cells, and natural 
killer cells.  There are two receptors for TNF-α, TNF-R1 and TNF-R2. TNF-R1 is 
constitutively expressed by all mammalian cells, but TNF-R2 is only expressed by immune 
cells (Tartaglia et al., 1991).  However, the majority of information on the TNF-α receptors 
is for the TNF-R1. Upon engagement of TNF-α and its receptors, a trimer is formed and 
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conformational changes in the receptor occur.  These changes cause the disassociation of 
silencer of death domains (SODD) (Takada et al., 2003) and the subsequent binding of 
TNFRSF1A-associated via death domain (TRADD) to the death domain.  After TRADD 
binds, there are three potential pathways that can be activated.  These are the activation of 
NF-κB, activation of MAPK pathways, or the induction of death signaling via caspase 3.  
These three distinct pathways ultimately will result in cellular proliferation, inflammation, or 
apoptotic cell death. 
 Peritoneal mast cells constitutively contain large amount of TNF-α in their granules 
(Gordon and Galli, 1990).  In addition to causing inflammation, TNF-α enhances the growth 
and maturation of B cells (Jelinek and Lipsky, 1987) and causes upregulation of MHC class I 
on endothelial cells.  It is interesting to note that TNF-α induces its own mRNA in 
inflammatory peritoneal macrophages (Kindler et al., 1989).  Tumor necrosis factor-α is 
involved in the early stages of MAP infection by controlling bacterial proliferation 
(Appelberg, 1994).  This cytokine is of critical importance in the formation of granulomas in 
response to MAP infection.  Treatment with anti-TNF-α antibodies prevents the development 
of granulomas.  Particles that are left undigested within macrophages lead to an increased 
and sustained release of TNF-α (Stein and Gordon, 1991).  Partial digestion is consistent with 
the behavior of phagocytized MAP.  Isolated PBMCs from subclinical cows produced more 
TNF-α when stimulated with a whole-cell sonicate of MAP compared with PBMCs from 
control and clinical cows (Stabel, 2000).  Stimulating PBMCs from MAP-infected castrated 
male Holstein calves with live MAP resulted in significantly higher TNF-α gene expression 
(Buza et al., 2003).  These studies highlight the importance of TNF-α secretion in the 
immune response to MAP infection. 
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Interleukin-12 is secreted by activated macrophages, natural killer cells, and T cells.  
It plays an active role in inducing CD4+ T cells to differentiate to Th1-like cells and secrete 
IFN-γ (Kaplan et al., 1996).  Interleukin-12 has a heterodimeric structure that is composed of 
two subunits, p35 and p40, linked by a disulfide bond.  Each subunit is unique in that it is 
expressed by its own gene and is on a different chromosome (Brombacher et al., 2003).  
However, coexpression of both subunits is required for the secretion of biologically active 
IL-12 (Gubler et al., 1991).  Interleukin-12 receptors are primarily expressed on activated T 
cells and natural killer cells (Desai et al., 1992).  The two type I transmembrane glycoprotein 
receptors, IL-12Rβ1 and IL-12Rβ2, form dimers, and their coexpression is required for high-
affinity IL-12 binding (Presky et al., 1996).  Interleukin-12 is able to induce tyrosine-
phosphorylation of Stat4, which induces naïve T-cells towards a Th1 phenotype.  The 
importance of Stat4 to the IL-12-mediated immune responses was highlighted in a study 
utilizing stat4-/- mice.  Stimulating the spleen cells of Stat4 knock-out mice with IL-12 
resulted in no detectable production of IFN-γ (Thierfelder et al., 1996).  In the absence of 
Stat4, IL-12 induced proliferation of lymphocytes is halted and there is an increase in Th2 
lymphocytes (Kaplan et al., 1996). 
 The major role of IL-12 is to regulate the balance of Th1 and Th2 cells.  It does this 
by promoting the differentiation of naïve T cells to Th1 cells.  IL-12 induces the secretion of 
IFN-γ from activated T cells and NK cells (Puddu et al., 1997).  When mice are treated with 
IL-12, an enhancement of IgG2a and suppression of IgG1 production is observed (Buchanan 
et al., 1995).  Both IL-12 and IFN-γ support the differentiation of CD8+ T-cells into active 
cytotoxic cells (Abbas et al., 1996).   
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The ability of IL-12 to induce the expression and secretion of IFN-γ, makes this 
cytokine of interest in MAP-infection.  Neutralizing IL-12 in female BALB/c mice 
intravenously infected with 106 CFU of M. avium resulted in increased expression of both IL-
4 and IL-10 mRNA and reduced expression of IFN-γ compared with the controls (Castro et 
al., 1995).  Incubating monocytes isolated from adult healthy cattle for 4 hours with live 
MAP (10 bacilli/monocyte) reduced the expression of IL-12 (Souza et al., 2006).   
Overall, the Th1 cytokines, representing the proinflammatory cytokines, predominate 
in the subclinical stage of Johne’s disease.  These cytokines are responsible for not only 
activating the innate immune response but also in influencing the differentiation of naïve 
CD4+ T-cells to a Th1 response.  
 
T-helper 2, Anti-inflammatory Cytokines 
 
 The transition from the subclinical to clinical state coincides with the differentiation 
of naïve CD4+ T-cells to a Th2 immune response.  The production of Th2 cytokines supports 
a humoral immune response by stimulating the proliferation of B lymphocytes and inhibiting 
Th1 cytokines.  Classical Th2 cytokines include IL-4, IL-5, and IL-10.   
Interleukin-10 was originally described in 1989 as a cytokine synthesis inhibitory 
factor that was secreted from Th2 T-cells, but not Th1 cells (Fiorentino et al., 1989).  
Interleukin-10 is produced by T cells, macrophages, and B cells (O’Garra et al., 1990) and 
functions to suppress the Th1 response.  The receptors for IL-10 are IL-10R1 and IL-10R2.  
Both receptors are similar in structure and are members of the class II cytokine receptor 
family (Kotenko, 2002).  Together the receptors make up four transmembrane polypeptides.  
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Two of the chains are for the IL-10R1 receptor and are responsible for ligand binding.  The 
two other chains are for the IL-10R2 and initiate signal transduction.  Upon binding of IL-10 
to its receptors, Jak1 and Tyk2 are activated (Finbloom and Winestock, 1995).  Jak1 is 
constitutively bound to IL-10R1.  Macrophages from Jak1 knockout mice do not respond to 
IL-10 (Rodig et al., 1998).  The activation of Jak1 and Tyk2 results in the phosphorylation of 
Stat3, Stat1, and Stat5.  The Stat proteins form homodimers and heterodimers (Wehinger et 
al., 1996), translocate to the nucleus, and activate Stat3 responsive genes.  Two of these 
activated genes are suppressor of cytokine signaling (SOC) 1 and 2.  The activation of 
SOCS1 inhibits IFN-γ production by T-cells (Ding et al., 2003). 
In human monocytes, IL-10 inhibits the production of the Th1 cytokines, IL-1α, IL-
1β, IL-6, IL-8, TNF-α, GM-CSF, and G-CSF (de Waal Malefyt et al., 1991).  Interleukin-10 
functions to inhibit the expression of IFN-γ.  Neutralizing IL-10 in MAP-infected PBMCs 
isolated from 40-month-old castrated male Holstein cattle resulted in a 9-fold increase in 
IFN-γ production (Buza et al., 2004).  Interleukin-10 suppresses macrophage activation and 
downregulates the expression of the costimulatory molecules, CD80 and CD86, and MHC II 
(Willems et al., 1994). 
Data suggest that IL-10 and TGF-β are upregulated in clinical MAP-infected dairy 
cows (Khalifeh and Stabel, 2004a).  Treatment of PBMCs with exogenous IL-10 and TGF-β 
resulted in the downregulation of IFN-γ production (Khalifeh and Stabel, 2004a).  PBMCs 
isolated from dairy cows naturally infected with MAP, had increased GATA 3 expression 
compared with control cows (Coussens et al., 2005).  The transcription factor GATA 3 
polarizes cells to a Th2-like phenotype.  Infection of monocyte-derived bovine monocytes 
with MAP resulted in upregulation of IL-10 (Weiss et al., 2005).  Furthermore, neutralizing 
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IL-10 caused a 57% increase in the ability of macrophages to kill MAP within 96 hours, an 
increase in the acidification of phagosomes, and an increase in the expression of IL-12 and 
TNF-α (Weiss et al., 2005).  These experiments provide support for the anti-inflammatory, 
suppressive role of IL-10 in the progression of JD. 
 Interleukin 4 is produced by T cells, mast cells, and natural killer cells.  The primary 
mode of initiating a response is by the engagement of IL-4 with its Type 1 cytokine receptor.  
The IL-4 receptor is composed of a common gamma chain (γc) and an alpha chain (α) 
(Nelms et al., 1999).  The IL-4Rα chain has a high affinity for IL-4 (Galizzi et al., 1990) and 
IL-4 will bind with this chain first.  It is also a component of the IL-13 receptor (Obiri et al., 
1997).  Upon binding, the complex dimerizes with IL-4Rγ chain (Mueller et al., 2002).  The 
initial signaling steps occur with the phosphorylation of Jaks (Hershey, 2003).  Additional 
phosphorylation of the tyrosine residues in IL-4Rα is required for the activation of Stat6 
(Ryan et al., 1996).  The complex then is translocated into the nucleus where it can affect 
gene expression.  Interleukin-4 induced T cell differentiation occurs via Stat6 (Zhu et al., 
2001).  Mice deficient in Stat6 have impaired macrophage development and function, a 
decline in MHC class II expression, and a decline in nitric oxide production (Takeda et al., 
1996).   
 The main function of IL-4 is to promote B-cell activation and to suppress the Th1 
response.  Interleukin-4 promotes the isotype switching of murine plasma B-cells to IgE 
(Abbas et al., 1996; Del Prete et al., 1988).  In Stat6 knock-out mice challenged with 
Nippostrongylus brasiliensis, there was a 16-fold lower production of IgG1 compared with 
the wild-type mice and undetectable production of IgE.  In addition to the effect on isotype 
switching, there was also a decrease in the production of Th2 cytokines and B-cell 
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proliferation (Shimoda et al., 1996; Takeda et al., 1996).  Secretion of IL-4 upregulates MHC 
class II production.  Coussens et al. (2004) reported decreased IL-4 expression from PBMCs 
isolated from subclinical JD cows compared with clinical and control cows.  Both IL-4 and 
IL-10 are expressed significantly more in the ileal lymph nodes of lepromatous lesions 
compared with tuberculoid lesions in dairy cows infected with MAP (Tanaka et al., 2005).  
Similarly, peripheral blood mononuclear cells isolated from patients with advanced disease 
caused by M. tuberculosis had increased IL-4 production compared with patients with mild 
TB.  The IFN-γ/IL-4 ratio of the patients with mild TB were significantly higher than the 
patients with advanced TB (Dlugovitzky et al., 1999).  Increased expression of IL-4 during 
the later stages of mycobacterial infections may have implications for the role of IL-4 in 
disease progression.  Additional research is required to further characterize this potential role 
in MAP-infected dairy cows. 
  
T-helper 3 Cytokines 
A third type of naïve CD4+ T-cell differentiation results in Th3 cells.  These cells are 
responsible for the induction of TGF-β.  In the mammalian species, there are three isoforms 
of TGF-β: TGF-β1, TGF-β2, and TGF-β3.  However, isoforms 2 and 3 play insignificant 
roles in the immune system (Govinden and Bhoola, 2003).  Mature TGF-β is a 24-kDa 
homodimer and is associated with a latency-associated peptide (LAP).  This association is 
essential to insure proper secretion and correct folding of TGF-β.  Once disassociation of 
TGF-β and LAP has occurred, TGF-β is free to bind to its receptor through two 
transmembrane serine/threonine receptor kinases (Rubtsov and Rudensky, 2007).  It initially 
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binds to the type II receptor, which then recruits and phosphorylates the type I receptor.   
Receptor regulated Smad is subsequently phosphorylated and forms a heteromeric complex 
with Smad4 (Govinden and Bhoola, 2003).  This complex translocates into the nucleus and is 
able to influence gene expression.   
The immune functions of TGF-β are diverse.  In 1986, it was first reported that TGF-
β is produced by activated T-cells and has an autocrine function to inhibit the proliferation of 
these T-cells (Kehrl et al., 1986).  Peripheral blood monocytes also have been shown to 
secrete TGF-β.  Deletion of the TGF-β receptor II in mice, resulted in development of a 
lethal inflammation related to T-cell activation (Li et al., 2006).  TGF-β and Th2 cytokines 
work synergistically to inhibit the secretion of IFN-γ and the activation of macrophages.  
Secretion of TGF-β1 is required to sustain the CD4+ regulatory T-cell subset that expresses 
the transcription factor forkhead box P3 (Chen et al., 2003; Marie et al., 2005).  T regulatory-
1 cells are important for the production of IL-10 (Maynard et al., 2007).  When human 
PBMCs are treated with PPD and recombinant TGF-β, there was a 70-fold increase in the 
production of IL-10 from monocytes compared with PPD treatment alone (Othieno et al., 
1999).  The effects of TGF-β on monocytes/macrophages include increasing chemotaxis but 
decreasing phagocytosis and antigen presentation (Rubtsov and Rudensky, 2007).  TGF-β 
affects B cells by causing an increase in IgA class switching and by decreasing the activation, 
proliferation, and survival of the cells (Ohtsuka and Sanderson, 2000; Rubtsov and 
Rudensky, 2007). 
Understanding the role of TGF-β in mycobacterial infections is important based on its 
interaction with a diverse array of immune cells.  TGF-β is upregulated in clinical Johne’s 
 26
cows (Khalifeh and Stabel, 2004a) and was found to be expressed 3.4-fold higher in PBMCs 
from infected cows compared with control (Coussen et al., 2005).  When PBMCs were 
isolated from naturally infected cows and incubated with MAP, there was an increase in 
TGF-β expression in infected macrophages compared with nonactivated cells (Weiss et al., 
2004).  Importantly, the Th2 and Th3 cyokines have been shown to work synergistically.  
TGF-β and IL-10 act in concert to repress macrophage activation (Mullins et al., 2001).  
Interleukin-10 interacts with IL-4 and TGF-β to inhibit the production of nitric oxide from 
IFN-γ-activated macrophages (Oswald et al., 1992).  The ability of MAP to modulate the Th2 
and Th3 cytokines is critical in the pathogenesis of JD. 
 
Cytokines and Mycobacterial Infections 
 
 During mycobacterial infection, the host is challenged with the initial need to control 
the invading organism.  CD4+ T-cells, of the Th1 phenotype, play a protective role in 
controlling mycobacterial infections.  As previously stated, the acute phase of the disease is 
characterized by a Th1 response which gives way to a Th2 response during the chronic 
phase.  Wangoo et al. (20001), in an effort to characterize the contribution of Th1 and Th2 
cells to mycobacterial infection, used a murine model where splenocytes had a Th0 profile.  
The profile could be altered by in vitro culture conditions to polarize toward a Th1 or Th2 
phenotype.  Murine cells cultured with 10 U/mL IL-12 and 10 µg/mL anti-IL-4 Ab-generated 
cells with a Th1 profile and had a 70-fold increase in IFN-γ production.  Cells cultured with 
IL-4 expressed a 20-fold increase in IL-4 expression.  Furthermore, the bacterial load in the 
lungs of mice infected with M. tuberculosis in the presence of Th2 cells was 10-fold higher 
than in the presence of Th1 cells. 
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 The importance of the Th1 response is highlighted in studies utilizing Th1 cytokine 
knock-out mice.  When IFN-γ knock-out mice were infected intravenously with 105 M. 
tuberculosis, the mice lost their ability to control the bacteria (Cooper et al., 1993).  The KO 
mice developed the fatal disseminated form of tuberculosis, and bacterial infection was 
present in the kidney and bone marrow.  IL-12p40-/- knock out mice are unable to control 
bacterial growth when infected with 105 M. tuberculosis.  All of the IL-12 KO mice had 
decreased secretion of IFN-γ and succumbed to the disease between 40 and 45 days post-
infection (Cooper et al., 1997b).  
 It is well documented in M. tuberculosis-infected mice that the initial phase of 
infection is highlighted by a Th1 response.  CD4+ T-cells expressing a Th2 phenotype 
predominate during the chronic phase of the disease.  When healthy mice were injected with 
105 M. tuberculosis, the host acquired response was characterized by an early Th1 response 
(Orme et al., 1993).  Secretion of IFN-γ was high for the first 30 days of infection, but then 
declined.  As IFN-γ declined, there was an increase in production of the Th2 cytokine, IL-4 
(Orme et al., 1993).  A similar study examined the transition from a Th1 to Th2 response in 
mycobacterial infections by injecting mice with 106 M. tuberculosis.  The authors reported 
that, as the disease progressed, there was a transition from an acute to chronic phase which 
was characterized by a decline in IFN-γ expression and an increase in IL-4 (Hernandez-
Pando et al., 1996).   
 The magnitude of the Th2 response has been correlated with the extent of disease 
progression.   In human patients infected with M. tuberculosis, expression of IL-4 mRNA 
was correlated with clinical measures of disease severity, with advanced disease resulting in 
increased IL-4 expression (Seah et al., 2000).  The authors of this study concluded that Th2 
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cytokines are related to unfavorable disease outcomes.  There is also a positive correlation 
between Th2 cytokine response and tissue necrosis in patients with pulmonary tuberculosis.  
As the disease progresses, there is a decline in the IFN- γ/IL-4 ratio (van Creval et al., 2000). 
 These studies provide evidence in support of a transition from a Th1 to a Th2 
phenotype that can be correlated with progression of mycobacterial disease. 
 
 
The Periparturient Period 
 
Negative Energy Balance  
 The periparturient period, defined as three weeks prepartum through three weeks 
postpartum, represents a time of physiological stress for the dairy cow (Grummer, 1995).  
Although it is anecdotal information, field observations suggest that dairy cows transition 
from the subclinical to clinical stage of MAP infection during this stressful time.  During the 
first week of lactation, the dairy cow does not maintain sufficient intake to support nutrient 
requirements for milk production (Bell, 1995).  The recommended energy density in diets fed 
to periparturient dairy cows is 1.62 Mcal NEL/kg DM (NRC, 2001).  In the immediate post-
partum time period, the dairy cow experiences a decline in dry matter intake (DMI), which 
coincides with an increased energy need to support the onset of lactation.  Although a 30% 
reduction in DMI is typical during the last four weeks of gestation (Grummer, 1995), a 
decline up to 47% has been reported (Douglas et al., 2006).  Reduction in DMI also occurs 
within the first few days after calving and may be depressed as low as 40% during the 
immediate postpartum period (Vazquez-Anon et al., 1994).  Negative energy balance, 
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independent of parturition, may occur in subclinical MAP-infected dairy cows (Johnson-
Ifearulundu et al., 2000).  Although this suggestion is reasonable based on the reduction in 
intestinal function reported in subclinical cows further investigation is required.   
 The end result of the negative energy balance is the mobilization of body fat stores as 
non-esterified fatty acids (NEFAs).   Serum NEFA concentrations are often elevated above 
1000 μeq/L during the initial postpartum period (Karcher et al., 2007; Vazquez-Anon et al., 
1994).  One study examined the effects of feeding periparturient dairy cows naturally 
infected with MAP a diet at 2% of their body weight and then manually stuffing the orts into 
the rumen.  Results showed that stuffed cows had a reduction in both serum NEFA and β-
hydroxybutyrate concentrations (Stabel et al., 2003), suggesting that additional energy 
reduced the need to breakdown fat.  Serum NEFAs also have been reported to play a role in 
the immune regulation by inhibiting the secretion of both IgM and IFN-γ at concentrations 
ranging from 0.25 – 2.0 mmol/L (Lacetera et al., 2004).   
 
Nutritional and Immunological Challenges 
 In addition to the nutritional challenges the periparturient dairy cow faces there are 
also challenges to the immune system.  Increases in both metabolic and infectious diseases 
are observed during this critical time period (Goff and Horst, 1997).  The major incidences of 
metabolic disease occur during the first two weeks of lactation (Goff and Horst, 1997). 
Examples of metabolic diseases afflicting periparturient dairy cows include fatty liver, 
mastitis, hypocalcemia, and displaced abomasum.  Both the innate and adaptive immune 
responses are lowest during the periparturient period (Mallard et al., 1998).   Neutrophil 
function is compromised at parturition (Kehrli et al., 1989a), and the killing capacity of 
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neutrophils is diminished (Cai et al., 1994; Detilleux et al., 1995).  Lymphocyte function is 
also diminished at parturition (Kehrli et al., 1989b).  Studies with dairy cows have supported 
an increase (Van Kampen et al., 1999), decrease (Kimura et al., 1999), or no change (Harp et 
al., 2004) in the percentage of CD4+ T-cells at parturition.  Similar studies with healthy cows 
have reported a decline in CD8+ T-cell percentages at parturition (Kimura et al., 1999; 
VanKampen et al., 1999).  This change is in contrast to two studies reported by Harp et al. 
(1991 and 2004) that suggest that CD8+ T-cells in peripheral blood are not influenced by 
parturition.  Typical observations for dairy cows during the periparturient period include 
either declining numbers of γδ T-cells (Van Kampen and Mallard, 1997; Kimura et al., 1999) 
or no change in the percentage of γδ T-cells (Park et al., 1992; Harp et al., 2004; Meglia et 
al., 2005).  Kimura et al. (1999) reported a decline in γδ T-cells from 7.3% on day -13 to 
5.4% on day +5 relative to calving.  There are also conflicting reports in the literature 
regarding B-cells.  Some studies indicate that the percentage of B-cells in peripheral blood 
throughout the periparturient period remains constant at 25% (Park et al., 1992; Harp et al., 
2004) whereas others indicate increasing (Meglia et al., 2005) and decreasing (Van Kampen 
and Mallard, 1997) percentages during the postpartum period.  Detilleux et al. (1995) 
reported a depression of IgG1, but an increase in IgG2 at calving.   
 The transition to lactation is a complicated time for even healthy dairy cows.  Further 
understanding of the immune response at this time is required and how immunosuppression 
during this time may result in the progression of JD.   
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Cytokine Expression and the Periparturient Period 
 In order to appreciate the effects of parturition on the progression of JD, it is 
important to understand the cytokine expression profile in healthy periparturient cows.  
Throughout mid to late lactation, cytokine profiles mirror a Th1 immune response.  The 
expression (Shafer-Weaver et al., 1999) and secretion (Ishikawa et al., 1994) of IFN-γ begins 
to decline as parturition approaches.  Contrary to IFN-γ, isolated mononuclear cells from 
periparturient dairy cows produce greater amounts of TNF-α than do mid to late lactating 
dairy cows (Sordillo et al., 1995).  This finding contradicts the Th1/Th2 paradigm typically 
expressed by dairy cows at parturition.  As the transition to lactation occurs, there is a shift in 
the CD4+ T-cell population supporting a Th2 response (Shafer-Weaver et al., 1999).  In 
healthy periparturient dairy cows, IL-10 expression is greater in cell cultures isolated 
immediately postpartum compared with mid to late lacatation (Shafer-Weaver et al., 1999). 
IL-4 is upregulated during the immediate postpartum period, and production is lowest in mid 
to late lactation cows (Shafer-Weaver and Sordillo, 1997; Shafer-Weaver et al., 1999). The 
Th2 response in humans has also been characterized during pregnancy.  Increased expression 
of IL-10 and IL-10R1 has been observed in humans in the early stages of pregnancy (Vigano 
et al., 2002).   Taken together, these studies suggest the immediate postpartum period favors 
a Th2 response in cattle. 
 
Periparturient Hormonal Regulation of Cytokines 
 Hormonal fluctuations during the periparturient period contribute to the typical 
immunosuppression observed at parturition.  The polarization of a specific Th response may 
be influenced by the hormonal status of the animals.  Progesterone and estradiol are both key 
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pregnancy hormones that have been shown to affect the differentiation of CD4+ T-cells.  In 
periparturient dairy cows, progesterone concentrations decline at parturition and remain low 
during the initial weeks of lactation (Radcliffe et al., 2003).  High circulating concentrations 
of progesterone and 17β-estradiol near the onset of parturition can suppress lymphocyte 
function (Medina and Kincade, 1994; McMurray et al., 2001).  Progesterone is capable of up-
regulating the Th2 response and contributes to the natural suppression of cell-mediated 
immunity.  When naïve murine T cells were exposed to progesterone, there was an induction 
of IL-10- and IL-4-producing Th2 cells (Miyaura and Iwata, 2002).  Interleukin-5 mRNA 
expression also was increased in progesterone-treated T-cells (Wang et al., 1993).   
Progesterone inhibited nitric oxide production and decreased inducible nitric oxide synthase 
(iNOS) gene promoter activity in IFN-γ (10 U/mL)- stimulated murine macrophages (Miller 
et al., 1996).  In contrast, estradiol enhances Th1 development (Maret et al., 2003).  In vitro 
estrogen treatment enhanced the anti-Mycobacterium avium complex (MAC) killing activity 
of macrophages isolated from mice injected intratracheally with MAC (50 μl bacterial 
suspension containing 2 x 105 CFU) (Tsuyugucki et al., 2001).  Stimulating human PBMCs 
with 0.5 – 30 ng/mL of 17β-estradiol enhanced pokeweed mitogen-induced generation of 
antibody-secreting cells (Sthoeger et al., 1988).  Furthermore, estrogen enhances 
phagocytosis by macrophages isolated from gonadectomized Balb/c mice (Baranao et al., 
1991).  
 In periparturient dairy cows, insulin-like growth factor (IGF)-1 concentration in the 
blood and liver begins to gradually decline at day -14 relative to calving and then rapidly 
declined at parturition (Kobayashi et al., 1999).  The expression of IGF-1 decreases in tissues 
when fasting occurs.  Macrophages and B-cells secrete IGF-1 (Merimee et al., 1989), and 
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physiological concentrations of IGF-1 are capable of increasing IFN-γ (Arkins et al., 1993) 
and TNF-α (Renier et al., 1996) production by macrophages.  IGF-1 skews cytokine 
production to the Th1 response and supports a proinflammatory role. 
 Finally, the steroid hormone cortisol is a member of the immunosuppressive 
glucocorticoid family.  Cortisol is secreted from the adrenal cortex.  Blood serum 
concentrations of cortisol dramatically increase at parturition and then decline during the 
postpartum period (Mallard et al., 1997).  Cortisol influences the differentiation of naïve 
CD4+ T-cells by promoting the secretion of Th2 cytokines.  Glucocorticoid analog 
dexamethasone (DEX)-stimulated rat CD4+ T-cells to express more IL-4, IL-10, and IL-13 
and less IFN-γ and TNF-α compared with nonstimulated controls (Ramirez et al., 1996).  
Interleukin-12 production is suppressed by DEX treatment (Visser et al., 1998).  Parturition 
affects the expression of the glucocorticoid receptor (GR) in neutrophils.  Preisler et al. 
(2000) noted a 49% reduction in GR expression at calving compared with expression 2 to 4 
weeks before calving.  In addition to expression of GR, Fas expression decreases between 
calving and 12 hours postpartum (Chang et al., 2004) and downregulates apoptosis in 
circulating cells.  When M.tuberculosis-infected human PBMCs were stimulated with 
physiological concentrations of cortisol, there was a decline in the mycobacterial antigen-
driven proliferation of the cells (Mahuad et al., 2004).  Furthermore, it seems that the growth 
of M. tuberculosis is not inhibited by the presence of glucocorticoids and that glucocorticoids 
can overcome the inhibition of growth observed by stimulation with recombinant IFN-γ 
(Rook et al., 1987). 
 
 
 34
Osteopontin 
 
Osteopontin (Opn), also identified as early T cell activator-1 (Eta-1), is a highly 
acidic glycoprotein that is produced by both immune and non-immune cells.  It was first 
isolated in 1985 from the mineralized matrix of bovine bone (Franzen & Heinegard, 1985).   
Non-immune sources of Opn include osteoclasts, osteoblasts, smooth muscle cells, epithelial 
cells, and endothelial cells.  Osteopontin also can be isolated from physiological fluids-- 
urine, milk, and seminal plasma (Cancel et al., 1997)-- and can be detected in the human 
glandular epithelial cells that line the stomach, small intestine, appendix, and bowels (Brown 
et al., 1992).  Isolation of Opn from bovine milk revealed concentrations of 8 mg/L (Bayless 
et al., 1997).  This is significantly higher than the 3 to 10 μg/mL reported in human milk 
(Senger et al., 1989).  In healthy gut tissue, Opn is expressed by a subset of lamina propria 
mononuclear cells (Gassler et al., 2002).  Osteopontin is most abundant in bovine bone cells 
and is barely detectable in bovine liver tissue (Kerr et al., 1991).   Among its many functions, 
the ability of Opn to modulate the immune system to a Th1 response has earned it 
recognition as an important cytokine in controlling intracellular infection. 
 
Structure and Function 
Bovine Opn is a 278 amino acid protein and has a predicted molecular mass of 40 
kDa (Kerr et al., 1991).  The molecular mass of Opn from bovine milk is 66 kDa (Sorensen 
and Petersen, 1994).  All mammalian species express Opn, and the cDNA and deduced 
protein sequences have been determined for the rat, mouse, pig, and human.  Bovine Opn is 
most closely related to the pig with 71% identity and 83% similarity (Kerr et al., 1991).  The 
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reported molecular mass of the protein will vary depending on the species and the tissue 
source.  Evaluation of murine Opn revealed a molecular mass of 32 kDa and 297 amino acids 
(Young et al., 1990).  Despite conservation among mammalian species, bovine Opn differs 
from others by a 22 amino acid deletion (Kerr et al., 1991).  Osteopontin from all mammalian 
species has an arginine-glycine-aspartate (RGD) component at bp 517-525.  The RGD site 
functions in cell attachment and exerts its effects by interacting with the αvβ3 integrin on 
macrophages.  There are also hydroxyapatite (Oldberg et al., 1986) and calcium-binding 
domains (Patarca et al., 1993).  Osteopontin lacks a membrane-anchoring domain and 
contains two heparin-binding domains (Patarca et al., 1993). 
 Osteopontin is secreted in both phosphorylated and nonphosphorylated forms.  The 
various functions of Opn are made possible by extensive posttranslational modifications. 
These are primarily phosphorylation and glycosylation.  Bovine Opn has 60 potential 
phosphorylation sites (Kerr et al., 1991), and it is phosphorylation that regulates the 
biological activity of the secreted cytokine.  Evaluation of bovine milk Opn revealed 27 
phosphoserines and one phosphothreonine (Sorensen et al., 1995).  The most recognized 
biological activity of Opn lies within the N-terminal thrombin cleaved fragment.  Thrombin 
cleavage regulates cell-receptor interactions with the RGD motif of Opn (O’Regan et al., 
1999). 
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Figure 1.2. Bovine osteopontin protein with potential posttranslational modifications.  
Adapted from Sorensen et al., 1995.  P- phosphorylation sites at serine; □ – transglutaminase 
reactive glutamines;  hexagon – threonines. 
 
 
 
 
As previously stated, the molecular mass of the secreted Opn varies depending upon 
the tissue and mammalian species.  In general, Opn is between 44 and 75 kDa.  Differences 
in molecular mass can be explained by extensive phosphorylation and N-linked glycosylation 
(Singh et al., 1990).  The posttranslational modifications of Opn are dependent on the tissue 
in which it resides, and it is these modifications that allow for the multiple functions of the 
protein.  Osteopontin has been identified in the Holstein bull reproductive tract and seminal 
plasma as three proteins at 55, 45, and 14 kDa (Cancel et al., 1997; Cancel et al., 1999).  To 
date, there is a very small pool of literature evaluating Opn expression in bovine tissues and 
immune cells. 
 
Innate Immune Response 
Osteopontin plays an early role in initiating the innate immune response by promoting 
cellular adhesion and recruitment, increasing the activation of macrophages, and eliciting a 
Th1 cytokine response.  Monocytes do not secrete Opn, but Opn is upregulated when 
monocytes differentiate into activated macrophages (Atkins et al., 1998).  In healthy normal 
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tissue, the majority of Opn is expressed in bone and epithelial tissue (Brown et al., 1992).  
Although Opn is expressed constitutively, it is upregulated in inflamed tissues such as 
granulomas (Nau et al., 1997).   
The importance of macrophages in the innate immune response has been discussed in 
previous sections.  Osteopontin and macrophages interact through two receptors: αvβ3 
integrin and CD44.  The CD44 receptor mediates chemotactic migration.  In 1990, it was 
reported that Opn binds to murine macrophages through a RGD-containing domain (Sing et 
al., 1990).  Several years later, it was discovered that there was a receptor-ligand interaction 
between CD44 and Opn (Weber et al., 1996).  Research by the same group later showed that 
the C terminal domain of Opn interacted with CD44 and that this engagement induced 
chemotaxis and chemoattractant activity (Weber et al, 2002).  The N-terminal domain 
contains the αvβ3 integrin, which induces haptotaxis, adhesion, and spreading (Weber et al., 
2002).  When rats were injected intradermally with 300 ng of recombinant Opn, there was a 
225% increase in the number of macrophages present at the injection site compared with the 
control (Giachelli et al., 1998).  The Opn promoter region contains a vitamin D3 response 
element and when macrophages were stimulated with vitamin D, upregulation of Opn 
transcription and protein secretion occured (Denhardt and Guo, 1993). 
Stimulation of murine macrophages with osteosarcoma-derived Opn caused an 
increase in the production of the inflammatory cytokines, IL-12 and TNF-α (Weber et al., 
2002), but not IL-10 or IL-6.  This phenomenon is a result of the engagement of the αvβ3 
NH2-terminal fragment (Ashkar et al., 2000) and occurs in a phosphorylation-dependent 
manner.  Stimulation of human PBMCs with 1 μg/mL of Opn resulted in a 5-fold increase in 
the production of IL-12 compared with stimulation of anti-CD3 alone (O’Regan et al., 2000).  
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Production of IL-12 as a result of Opn stimulation results in activation of additional 
macrophages and subsequent secretion of Opn.  The presence of IFN-γ is required for the 
Opn-regulated production of IL-12 (O’Regan et al., 2000).   There was a 15-fold increase in 
Opn promoter activity when a human monocyte/macrophage cell line was treated with 
exogenous IFN-γ (Li et al., 2003).  These studies highlighting the importance of IFN-γ in 
Opn stimulation are further examples of an elegant feedback loop.  Osteopontin knock-out 
mice have a 95% and 90% decrease in IL-12 and IFN-γ secretion, respectively, compared 
with the wild-type controls (Ashkar et al., 2000).  In addition to IFN-γ, stimulating 
macrophages with TNF-α resulted in an upregulation of Opn mRNA and protein (Denhardt 
and Gou, 1993). 
The ability to inhibit Th2 cytokines further establishes the role of Opn as a Th1 
cytokine.  Inhibition of IL-10 expression by Opn occurs by the phosphorylation-independent 
engagement of CD44 (Ashkar et al., 2000).  Interestingly, Opn-deficient mice have increased 
IL-10 production and decreased macrophage function (Ashkar et al., 2000).  Osteopontin 
stimulation also increases macrophage infiltration.  Osteopontin inhibits gene transcription 
and protein expression of iNOS by the degradation of STAT1 in murine macrophages (Gao 
et al., 2007).  This directly downregulates nitric oxide synthesis by murine macrophages 
(Guo et al., 2001) 
In addition to macrophages, DCs play a major role in the innate immune response.  
Treatment of human DCs with 0.5 μg/mL Opn, induces DC differentiation, the upregulation 
of HLA-DR, CD40, CD80, CD86, CD44, and CD54 and promotes the emigration of 
Langerhans cells from the epidermis (Renkl et al., 2005).   Furthermore, incubating human 
derived-DCs with 0.5 μg/mL of Opn stimulated secretion of TNF-α and IL-12; however, IL-
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10 secretion was not affected (Renkl et al., 2005).   Immature DCs secrete Opn, which, in 
turn, enhances the differentiation and maturation of DCs (Kawamura et al., 2005).  This 
mechanism is similar to the one seen with the regulation of Opn and macrophages. In fact, 
murine Langerhans cells migrate to sites of high Opn expression in peripheral tissues (Weiss 
et al., 2001).  Dendritic cells interact with Opn through the CD44 and αvβ3 receptors (Weiss 
et al., 2001). The ability of Opn to stimulate the activation of DCs and alter the cytokine 
microenvironment is key to a successful innate immune response. 
 Neutrophils are also key players in the innate immune response.  However, compared 
with macrophages, neutrophils express much lower levels of Opn cDNA and Opn does not 
seem to be associated with the CD44 receptor (Koh et al., 2007).  Deletion of Opn in the 
Opn-/- murine model reduced the recruitment of neutrophils by 2-fold (Koh et al., 2007).  
Experiments evaluating the relationship between Opn and neutrophil recruitment in women 
suffering from alcoholic liver disease revealed that Opn upregulated the CD11b neutrophil 
adhesion molecule (Banerjee et al., 2006).  Despite its apparent role in increasing chemotaxis 
of neutrophils, it does not seem that neutrophil function was affected by the absence of the 
cytokine.  Neutrophils isolated from osteopontin-null mice did not have any impairment of 
phagocytosis, cytokine production, or generation of reactive oxygen species (Koh et al., 
2007). 
 Overall, Opn is a critical Th1 cytokine that plays a fundamental role in activating and 
recruiting the various components of the innate immune system.   
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Adaptive Immune Response 
Osteopontin plays an integral role in the cell-mediated immune response.  It is well 
established that activated T cells secrete Opn (Singh et al., 1990; Ashkar et al., 2000).   
Murine macrophages express approximately 104 Opn receptors/cell (Singh et al., 1990).  
Osteopontin induces T cell chemotaxis and costimulates T cell proliferation (O’Regan et al. 
1999).  When human T cells were stimulated for 24 h with anti-CD3 mAb and 1 μg/mL of 
Opn, there was an IL-12-dependent 4-fold increase in the production of IFN-γ than with anti-
CD3 mAb alone (O’Regan et al., 2000).  Upregulation of IFN-γ by activated CD4+ T-cells is 
important because IFN-γ is needed to further activate macrophages. This same study 
evaluated the effects of Opn stimulation on CD40 ligand expression and confirmed that Opn 
costimulation of CD3-positive T cells upregulated CD40L expression (O’Regan et al., 2000).  
The upregulation of CD40L is crucial in the adaptive immune response because it increases 
the potential for the interaction with an antigen presenting cell.  There was a dose-dependent 
increase in the production of IFN-γ, TNF-α, and IL-10 when human gut-derived T-cells were 
stimulated with milk-derived purified bovine Opn (0.01 – 10.0 μg/mL) and CD3 (0.1-0.5 
μg/mL) antibody (Agnholt et al., 2007).  Osteopontin also may promote the survival of 
activated T cells.  When 5 μg of carrier-free mouse recombinant Opn was added to cultures 
of stimulated murine T-cells, there was an increase in the transcription factor NF-κB (Hur et 
al., 2007).  Inhibition of forkhead box 03A and the proapoptotic proteins Bim, Bak, and Bax 
also was observed (Hur et al., 2007).   
 In addition to its effects on T-cells, Opn has an effect on B cells.  Using a murine 
model, 5 μg/mL of recombinant Opn stimulated IgM and IgG production from a B 
cell/macrophage mixture (Lampe et al., 1991).  It is not known if Opn interacts directly with 
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the B cell or if this is an indirect effect through macrophage cytokine production.  Sato et al. 
(2005) showed that the primary producers of Opn in human inflamed intestinal tissue were 
primarily IgG+ plasma cells. The majority of these Opn-producing IgG+ plasma cells were 
IgG1+ and IgG2+.   
  
Osteopontin and Intracellular Bacterial Infections 
Based on its ability to upregulate and promote pro-inflammatory cytokines, the role 
of Opn in the host immune response to intracellular bacterial infections has been studied.  To 
date, there are no studies evaluating the role of Opn in infections caused by MAP.  However, 
there are an extensive number of human and murine studies documenting interactions 
between mycobacterial infection and Opn. 
 As previously discussed, during the subclinical stages of JD, there is formation of 
granulomas.  Osteopontin is associated with CD3+ T-cells in sarcoid granulomas, and Opn 
plasma concentrations are elevated in human patients with sarcoidosis compared with healthy 
controls (O’Regan et al., 1999).  Staining of tuberculous lung sections from human patients 
infected with M. tuberculosis with anti-Opn detected Opn in the inflammatory border 
surrounding necrotic tissue and an overall increase in expression compared with normal lung 
sections (Nau et al., 1997).  Osteopontin promotes chemotaxis and cellular adhesion of 
murine monocytes and macrophages (Weber et al., 2002).  These effects, combined with its 
ability to anchor cells, link Opn to the initial stages of granuloma formation.   
 Crohn’s disease (CD) is characterized by severe inflammation of ileal tissue and 
formation of granulomas.  Plasma Opn is increased significantly in patients with active CD 
(Agnholt et al., 2007; Sato et al., 2005).  Patients with active CD also exhibit upregulation of 
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Opn in the intestinal mucosa and immunohistochemical analysis of the mucosa detected Opn 
in areas surrounding granulomas (Sato et al., 2005).  There is an inverse correlation between 
the concentration of Opn in tissues and disease severity in patients with mycobacterial 
infection (Nau et al., 2000).  Patients suffering from nontuberculous mycobacterial infections 
with high Opn expression in infected lymph nodes recovered faster from the disease than did 
those patients with decreased Opn concentrations and disseminated infection (Nau et al., 
2000).  The relationship between inflammatory disease and Opn is important because of the 
ability of Opn to influence cytokine production towards a Th1 immune response.   
 Infections caused by M.  tuberculosis are of particular concern because of its impact 
on world economics and health.  M. tuberculosis infections are characterized by granuloma 
formation.  A sufficient Th1 response it thought to be needed in the development of 
protective immunity against intracellular infections.  Upregulation of Opn during infection 
offers the host protection during the initial stages.  In fact, when human alveolar 
macrophages were infected with M. tuberculosis (bacteria:macrophage ratio of 10:1), Opn 
gene expression increased (Nau et al., 1997). To better understand the role of Opn in 
mycobacterial infections, Nau et al. (1999) utilized a murine Opn-KO mouse model.  The 
mutant mice were challenged intraperitoneally with 107 CFU of Mycobacterium bovis 
bacillus Calmette-Guerin (BCG).  Compared with the controls, the mutant mice had more 
severe infection, heavier bacterial loads, and greater granuloma burdens.  The macrophages 
from these mice were defective in killing BCG as evidenced by the delayed clearance of the 
bacteria.  The results of this study support the hypothesis that Opn is a key player in the host 
response to intracellular bacteria.  When granulocyte-macrophage colony-stimulating factor 
(GM-CSF)-induced human macrophages were cultured with BCG (10 mg/mL) for three 
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hours, there was an upregulation of Opn (Khajoee et al., 2005).  Furthermore, stimulation of 
the GM-CSF-induced human macrophages with Opn (2.5 μg/mL) resulted in an increase in 
the production of superoxide by the macrophages (Khajoee et al., 2005). 
 
Summary 
 Johne’s disease has a devastating impact on the dairy industry and is an issue of both 
economics and animal welfare.  The studies presented in this dissertation focus on this 
destructive disease and the periparturient period.  Despite on farm observations of 
progressing JD during the early post-parturient time period, there is a lack of research in the 
literature focusing on the host immune response to MAP at this time.  In addition to 
characterizing cytokines and lymphocyte subsets during periparturient period, we also 
evaluated the potential role of Opn in regulating disease progression in MAP-infected 
periparturient cows.  As reviewed in this chapter, Opn can enhance the Th1, cell-mediated, 
immune response and improve host defense against mycobacterial infections.  To the best of 
our knowledge, this is the first known data investigating Opn gene and protein expression in 
MAP-infected cows.  The experiments described in the subsequent chapters of this 
dissertation are guided by the hypothesis that the host immune response to MAP infection is 
altered during the periparturient period. 
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Figure 1.3. Role of osteopontin in regulating the Th1/Th2 balance in mycobacterial infection. 
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ABSTRACT 
 
Johne’s disease (JD) caused by Mycobacterium avium subsp. paratuberculosis (MAP), is 
estimated to infect more than 22% of US dairy herds. Periods of immunosuppression may 
contribute to the transition from the subclinical to clinical stage of infection. Understanding 
the effects of stressors such as parturition on the escalation of disease may provide 
information that will help manage JD. The objective of this study was to characterize 
cytokine gene expression and secretion in periparturient dairy cows naturally infected with 
MAP.  Blood was collected from the jugular vein of healthy noninfected, and subclinically 
and clinically infected dairy cows for 3 wk pre- to 4 wk post-calving. Real-time PCR was 
performed to evaluate the expression of the following cytokine genes by peripheral blood 
mononuclear cells: IFN-γ, TNF-α, IL-12p35, IL-10, TGF-β, and IL-4.  To assess the effects 
of parturient immunosuppression on cytokine gene expression, RT-PCR data were analyzed 
by using 2-ddCt values calibrated to dCt value at +1 d relative to calving for each animal.  
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Overall, cytokine gene expression was not influenced by infection status of the cows in this 
study. However, significant effects in cytokine gene expression were noted across sampling 
days within the periparturient period.  Expression of IFN-γ, TNF-α, IL-4, and IL-10 declined 
at calving compared with prepartum values in both control and infected cows.  PBMC 
isolated from infected cows secreted higher concentrations of IFN-γ, IL-10, and TGF-β in the 
postpartum period as compared to control cows.  Clinically infected cows secreted higher 
levels of nitric oxide throughout the periparturient period when compared to control or 
subclinically infected cows. These data suggest that parturition is a very dynamic time period 
for host immunity, with potential for altered immunity to hinder the ability of dairy cows to 
thwart infectious diseases. 
Key Words: periparturient, cytokine, Mycobacterium avium subsp. paratuberculosis 
 
1. INTRODUCTION 
 
Johne’s disease (JD), caused by Mycobacterium avium subsp. paratuberculosis 
(MAP), is estimated to infect more than 22% of US dairy herds and cost the US dairy 
industry $250 million annually (Ott et al., 1999).  Dairy cows generally become infected as 
neonates through the fecal-oral route.  Infected animals may remain in the subclinical, or 
asymptomatic, stage of the disease for several years following initial exposure of the bacteria 
(Larsen et al., 1975).  During this stage, the majority of animals shed a negligible amount of 
bacteria, and granulomas begin to form in the small intestine.  Stressors, such as parturition, 
may induce the transition from the subclinical to a more clinical stage of disease 
characterized by consistent fecal shedding of the bacteria, intermittent but persistent diarrhea, 
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progressive weight loss, and eventual death.  Many questions still exist as to what triggers the 
progression of the disease. 
Although it is anecdotal information, cows with paratuberculosis may advance to the 
clinical stage of the disease during the weeks following parturition.   Research on what 
prompts the progression of disease during this time period is lacking.  The transition period, 
defined as three weeks prior to and the three weeks following parturition, represents a time of 
physiological stress for the dairy cow (Goff and Horst, 1997).  The immunosuppression 
experienced by the healthy periparturient cow has been well characterized.  The week 
immediately following calving is marked by a decrease in lymphocyte proliferation (Kehrli et 
al., 1989b; Meglia et al., 2005) and the ability of neutrophils to migrate and phagocytize 
(Kehrli et al, 1989a; Lee and Kehrli, 1998).  At calving, there is an increase in the activity of 
CD8+ lymphocytes compared with those from mid to late lactation animals (Shafer-Weaver 
and Sordillo, 1997). Endocrine and metabolic changes (Goff and Horst, 1997), in 
combination with immune suppression, contribute to the susceptibility of the cow to both 
metabolic and infectious diseases.  The dramatic changes in estrogen and progesterone in the 
periparturient period potentially play a key role in immune suppression.  In periparturient 
dairy cows, progesterone concentrations decline rapidly at parturition and remain low during 
the initial weeks of lactation (Radcliff et al., 2003).   Progesterone has the ability to up-
regulate Th2 cell activity and contributes to natural suppression of cell-mediated immunity 
(Miyaura and Iwata, 2002).  Plasma estrogen concentrations increase dramatically two weeks 
prior to calving and then decline rapidly at calving (Radcliff et al., 2003).  Previous work has 
shown that estradiol enhances Th1 development in vivo (Maret et al., 2003).  The decline in 
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progesterone and estradiol followed by decreased immune function may contribute to the 
progression of JD from subclinical to clinical state after calving. 
The transition from the subclinical to the clinical stage of infection is characterized by 
a shift from cell-mediated (Th1) immunity to a Th2 response. Classical proinflammatory Th1 
cytokines include IFN-γ, IL-12, and TNF-α (Mosmann et al., 1986; Roach et al., 2002).  
Expression of IL-12 promotes Th1 lymphocytes by inducing the secretion of IFN-γ (Bontkes 
et al., 2005) and subsequently enhancing the formation of granulomas (Smith et al., 1997).  
Th2 cytokines are predominantly considered to be suppressive and anti-inflammatory.  
Interleukin-4, IL-10, and TGF-β are capable of inhibiting Th1 cytokines, suppressing Th1 
cell functions, and deactivating macrophages (Ho et al., 1992; Mullins et al., 2001). 
A recent study demonstrated that nonstimulated PBMCs isolated from dairy cows 
with subclinical MAP infection had higher IFN-γ expression than did PBMCs from clinically 
infected cows or noninfected healthy controls (Coussens et al., 2004).  Interestingly, in the 
same study, expression of IL-12 for infected animals was decreased compared to the 
controls.  Recent data also demonstrated an increase in IFN- γ expression in subclinically 
infected cows (Khalifeh and Stabel, 2004b) and an upregulation of TGF-β and IL-10 in 
clinical cows naturally infected with MAP (Khalifeh and Stabel, 2004a).  These studies 
provide further support for the paradigm of a Th1 response in early stages of JD with a 
switch to Th2-mediated responses as disease progresses. 
To date, limited research is available characterizing host immunity in periparturient 
dairy cows infected with MAP or the potential impact of periparturient immunosuppression.  
Therefore, the objective of this study was to characterize cytokine gene expression and 
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secretion in dairy cows naturally infected with MAP during the periparturient period as 
compared with healthy control cows. 
 
 2. MATERIALS AND METHODS 
 
2.1 Animals  
 Twenty-one multiparous Holstein cows and 2 primiparous Holstein cows were 
grouped according to infection status.  These 3 groups consisted of 5 noninfected healthy 
cows, 14 cows naturally infected with MAP, but asymptomatic, and 4 naturally infected cows 
with clinical Johne’s disease.  The 2 primiparous cows were both in the subclinically infected 
group.  The stage of infection was determined by fecal shedding of MAP, IFN-γ secretion, 
and specific antibody response to MAP.  Infection was monitored by bacteriologic culture for 
the fecal shedding of MAP by standard methods (Stabel, 1997).  By definition, clinical 
animals were shedding more than 100 CFU/tube (BBL™ Herrold’s Egg Yolk Agar Slants 
with mycobactin J, amphotericin, nalidixic acid, and vancomycin; Becton, Dickinson and 
Co., Sparks, MD) and presented with weight loss and intermittent diarrhea. Subclinically 
infected cows were shedding less than 10 CFU/tube and were asymptomatic. The noninfected 
control cows were characterized by repeated negative fecal cultures performed quarterly over 
a 3- to 5-yr period and had been purchased from herds with no recent history of Johne’s 
disease. In addition, these animals were negative on any serologic assays (i.e., production of 
antibody specific for MAP and IFN- ) performed during that period. All procedures 
performed on the animals were approved by the Institutional Animal Care and Use 
Committee (National Animal Disease Center [NADC], Ames, IA. 
 
 71
2.2 Blood Collection, Culture Conditions, and Sample Collection 
 Blood was collected from the jugular vein in 2x acid-citrate-dextrose (ACD; 1:10).  
For each animal, blood was collected at -21, -14, -7, +1, +7, +14, +21, and +28 days relative 
to calving.  Peripheral blood mononuclear cells were isolated from the buffy coat fractions of 
peripheral blood.  PBMCs were resuspended in RPMI-1640 (Gibco, Grand Island, NY) with 
10% fetal calf serum (Atlanta Biologics, Atlanta, GA), 100 U of penicillin G sodium per ml, 
100 μg of streptomycin sulfate per ml, 0.25 μg of amphotericin B per mL, and 2 mM L-
glutamine (Gibco, Grand Island, NY).   
     Cells were cultured at 1.4 x 106/mL in 48-well flat-bottomed plates (Corning, Corning, 
NY) with either medium alone (nonstimulated, NS), with ConA (10 μg/mL) or with MAP 
whole cell sonicate (MPS; 10 μg/mL) added to designated wells.  Plates were incubated for 
24 h at 39°C in 5% CO2 in a humidified atmosphere.  After 24 h plates were removed and 
centrifuged at 400 x g for 5 min.  Supernatants were removed without disturbing the cells in 
culture, and stored at -20°C prior to cytokine measurement. 
Additional blood samples were collected at each time point into vacutainer tubes 
(Becton Dickinson, Rutherford, NJ), and serum was harvested and stored at -20°C.  Serum 
progesterone and 17β-estradiol were quantified by using double antibody radioimmunoassay 
kits with the human standards supplied (ImmuChem™ Double Antibody, MP Biomedicals, 
Costa Mesa, CA).  Serum insulin-like growth factor I (IGF-I) was quantified by using a non-
extraction two-site immunoradiometric assay (DSL-2800; Diagnostic Systems Laboratories, 
Inc., Webster, TX).  The minimal sample concentration of IGF-1 that could be detected by 
the kit was 9 ng/mL.  The intra-assay coefficient of variation for progesterone was 4.14% and 
the interassay variation was 12.8%.  For 17β-estradiol, the intra-assay coefficient of variation 
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was 4.10%, and the interassay variation was 10.00%.  The intra-assay coefficient of variation 
for IGF-1 was 5.08%, and the interassay variation was 4.48%.   
 
2.3 Bacteria   
 
M. avium subsp. paratuberculosis strain K-10 (NADC) was grown in Middlebrook 
7H9 broth (pH 6.0) supplemented with mycobactin J (2 mg/liter; Allied Monitor, Fayette, 
MO) and oleic acid-albumin-dextrose complex (Becton Dickinson Microbiology, San Jose, 
CA).  The bacteria were harvested, washed 3 times with PBS (137 mM sodium chloride, 10 
mM phosphate, 2.7 mM potassium chloride; pH 7.4), and sonicated on ice for 10 min.  After 
incubating at RT for 10 min, the bacteria was sonicated for an additional 10 min and then 
centrifuged at 2500 x g for 20 min.  Supernantant was removed and absorbance was read at 
540 nm.  Bacterial stocks (109/mL) were frozen in PBS at -80°C until used in the 
experiments.   
 
2.4 RNA Extraction and RT-PCR 
Peripheral blood mononuclear cells from each of the sampling time points were 
resuspended in RPMI 1640 (Gibco, Grand Island, NY) containing 10% fetal calf serum.  
PBMCs from each cow at each sampling time point were split into two aliquots: one aliquot 
that was cultured with medium alone (NS) and one that was stimulated with ConA (10 
μg/mL).  Cells were cultured in 75-cm2 flasks at a concentration of 1 x 107 PBMCs per flask 
at 39°C in 5% CO2 in a humidified atmosphere for 24 h.  RNA was extracted from NS and 
ConA-stimulated PBMCs by using the standard protocol for Trizol Reagent (Invitrogen Life 
Technologies Corp., Carlsbad, CA).  All RNA samples were purified by using the RNeasy® 
Mini Kit Protocol for RNA Cleanup (Qiagen, Valencia, CA).  Samples were treated with 
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TURBO DNA-free (Ambion, Austin, TX).  The quantity of total RNA was determined by 
UV spectrophotometry.  RNA samples were frozen at -80°C until converted to cDNA. 
Real time RT-PCR was performed by using an Applied Biosystems 7500 DNA 
sequence detection system (Perkin-Elmer Corp., Foster City, CA).  Total RNA extracted 
from both NS and ConA-stimulated cells was converted to first strand cDNA.  Briefly, 2 µg 
of total RNA was added to 12-µl reaction mixture consisting of 10 mM oligo(dT)12-18 primer 
(Invitrogen, Carlsbad, CA) and RNAse-free water.  The reaction mixture was incubated at 
70°C for 5 min and then quickly chilled on ice to 20°C.  To the reaction mixture, 4 µl of 5x 
First Strand Buffer (Invitrogen, Carlsbad, CA), 2 µL of 10 mM dNTP Mix (Invitrogen, 
Carlsbad, CA), 1 µL of 0.1 M dithiothreitol (Invitrogen, Carlsbad CA), and 2 U 
SuperScript™ RNase H-Reverse Transcriptase (Invitrogen, Carlsbad CA), were added for a 
total volume of 20 µL.  The reaction mixture was incubated at 42°C for 1 h, heated to 70°C 
for 15 min, and then cooled to 37°C.  Two units of DNase-free RNase H (Invitrogen, 
Carlsbad, CA) was added to the mixture that then was incubated at 37°C for 20 min to 
remove the original RNA template.  The RNase H was inactivated by heating the reaction 
mixture at 70°C for 10 min.  All cDNA samples were stored at -80°C until RT-PCR analyses 
were performed. 
For RT-PCR analysis, SYBR Green PCR master mixture (Perkin-Elmer Corp., Foster 
City, CA), template cDNA, and gene-specific primers for IFN-γ, TNF-α, IL-12p35, IL-4, IL-
10, TGF-β, and β-actin were combined in a 20 µL reaction mixture.  Primer sequences are 
listed in Table 1.  All reactions were performed in triplicate.  The β-actin gene was used as 
the control for calculation of dCt.  RT-PCR data were analyzed by using the 2−(dd )Ct  method 
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as described previously (Livak and Schmittgen, 2001). The mean +1 DRTC dCt value within 
treatment was used as the reference expression point. 
 
2.5 Measurement of IFN-γ, IL-10, TGF-β, and Nitric Oxide Production in Cell Culture 
Supernatants by ELISA  
Bovine IFN-γ was measured by using the Bovigam test kit (Biocor Animal Health, 
Omaha, NE) as described by the manufacturer.  The minimal sample concentration of IFN-γ 
that could be detected by using the kit was 0.39 ng/mL.  Bovine IL-10 was quantified by 
coating MaxiSorp microtiter plates (Nunc, Rochester, N.Y.) with mouse anti-bovine IL-10 in 
coating buffer (15 mM sodium carbonate, 34 mM sodium bicarbonate, pH 9.6) (100 µL per 
well at 2 µg/mL) (MCA2110, Serotec, Raleigh, NC) overnight at RT.  Plates were washed 5 
times with PBS containing 1% Tween 80 (washing buffer).  The samples and serial 2-fold 
dilutions of bovine IL-10 standard (0.3125-20 ng/mL) (generous gift from Dr. Jayne Hope, 
Compton, UK) were added to duplicate wells and incubated at RT for 1 h.  Plates were then 
washed 5 times with washing buffer before incubating with the detection antibody, mouse 
anti-bovine IL-10:biotin (MCA2111B, Serotec, Raleigh, NC).  Plates were washed 5 times 
with washing buffer, 100 µL of avidin-HRP conjugate (diluted 1:800) (PharMingen, San 
Diego, CA) was added to each well, and the plates were incubated for 45 min at RT.  After 
another wash cycle, plates were incubated with substrate solution (40 mM ABTS [2, 2’-
azino-di-ethylbenzthiozoline-6-sulfonic acid] in citrate buffer (50 mM, pH 4.0) and H2O2 
(30% solution as 1:30 dilution).  Color development was quantified after 30 min by 
measuring absorbance at 405 nm with a Wallac Victor 1420 multilabel counter ELISA plate 
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reader (Perkin-Elmer, Gaithersburg, MD).  The minimal sample concentration of IL-10 that 
could be detected by using the kit was 0.3125 units. 
Bovine TGF-β was quantified using the Quantikine® Human TGF-β1 Immunoassay 
kit as described by the manufacturer and by using standards supplied (R&D Systems, Inc, 
Minneapolis, MN).  Previous studies have utilized anti-bovine TGF-β1 antibodies to detect 
bovine TGF-β activity (Ginjala and Pakkanen, 1998; Khalifeh and Stabel, 2004a).   
Significant concentrations of latent TGF-β1 are found in bovine cell culture supernatants.  
Latent TGF-β was activated by the addition of 1 N HCl followed by 10 min of incubation.  
The samples were neutralized by the addition of 1.2 N NaOH/0.5 M HEPES.   The 
concentration determined by the standard curve was multiplied by the dilution factor 1.4 to 
account for the activation procedure.  Because of the high cost of the kit and large number of 
samples in this study, only NS and MPS-stimulated cell culture supernatants were evaluated 
at -14, -7, +1, +7,+14, and +21 days for this assay.  The minimal sample concentration of 
TGF-β that could be detected by using the kit was 31.2 pg/mL. 
To determine the amount of nitric oxide produced (NO), the stable oxidation product, 
nitrite, was quantitated. For this analysis, 24 h cell culture supernatants from NS, ConA, and 
MPS-stimulated PBMCs were evaluated at -21, -14, -7, +1, +7, +14, +21, and +28 days.  The 
samples and serial two-fold dilutions of sodium nitrate standard (0.028-18 μM) were added 
in duplicate to a 96 well- round bottom plate (Corning, Corning, NY).  The culture 
supernatant (100 μl) was mixed with 100 μl of Greiss reagent (0.5% sulfanilamide; Sigma 
Chemical Co., St. Louis, MO) in 2.5% phosphoric acid (Mallinckrodt Chemical, Inc., 
Hazelwood, MO) and 0.05% N-(1-naphthyl) ethylenediamine dihydrochloride (Sigma 
Chemical Co., St. Louis, MO).  The mixture was allowed to incubate at RT for 10 min, and 
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color development was measured at 505 nm. The concentration of nitrite in the supernatant 
was quantified by comparison with absorbance values of sodium nitrite standards within a 
linear curve fit.  The minimal sample concentration of NO that could be detected using the 
kit was 0.28 μM. 
 
2.6 Statistical Analysis   
RT-PCR data were analyzed by using the 2-(ddCt) method as previously described 
(Livak and Schmittgen, 2001).  β-actin was used as the reference gene, and the dCt value at 
+1 d for each animal was used as the reference expression point.  Outliers were determined 
by the SAS/STAT  PROC RobustReg software.  To evaluate the appropriateness of β-actin 
as a reference gene, the 2-(dCt) method was used as previously described (Schmittgen and 
Zakrajsek, 2000).  This test indicated that β-actin would serve as a suitable reference for 
healthy and MAP-infected animals. 
Several 2-factor repeated measures analyses of variance were performed (one for 
each stimulation level-gene combination) comparing fold expression of 2 treatments through 
time. Levene’s homogeneity of variance test was performed on data to determine 
transformation necessity.  All analyses were performed on transformed data where necessary, 
but raw data means are presented for ease of interpretation.  If a significant F-test value from 
the ANOVA was obtained at P ≤ 0.05, differences of least squares means were used as the 
pairwise multiple comparison test for determining day or infection group x day differences. 
Means differed if P < 0.05 and tended to differ if 0.05 ≤ P ≤ 0.15.  Analyses were performed 
using PROC MIXED in SAS
®
 PC Windows Version 9.1.3 software. 
 
 77
3. RESULTS 
 
3.1 Effect of infection status on cytokine gene expression 
In this study, +1 day was used as the reference expression point in the analyses of the 
gene expression data.  Due to sampling error, 3 of the 4 clinical cows did not have useable 
RNA samples for the +1 d time point.  Because of the nature of the periparturient study, we 
were not able to retrospectively isolate additional PBMCs from the blood of these cows at +1 
d for RNA extraction.  In the 2-ddCt analysis, it is critical to have the dCt for the reference 
expression point day. On the basis of these results, we were not able to evaluate the cytokine 
gene expression data for the clinical cows in this study. All gene expression data presented 
herein contrasts results between healthy noninfected control cows and subclinically infected 
cows. 
Regardless, there were no significant effects due to infection status on the expression 
of cytokines, IFN-γ, IL-12p35, TNF-α, IL-4, IL-10, and TGF-β during the period extending 
from 3 wk prior to calving to 4 wk post-calving (Figs. 1-2). There was also no effect of 
infection group on expression of IGF-1 from NS PBMCs (Fig.3), however, a strong trend 
was present demonstrating higher expression of IGF-1 for PBMCS isolated from 
subclinically infected cows compared with that of control cows in the prepartum period.  
 
3.2 Effect of parturition on cytokine gene expression   
 There was a significant effect of parturition on IFN-γ expression in NS (P < 0.05) and 
ConA-stimulated (P < 0.01) PBMCs (Fig. 1A).  For both groups, expression declined 
beginning on -14 d through calving.  Expression in NS PBMCs did not recover during the 
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postpartum period.  However, IFN-γ expression by ConA-stimulated PBMCs was 
significantly (P < 0.01) greater by +28 d compared with -7 d (Fig. 1B). 
In the NS PBMCs, expression of TNF-α was variable throughout the periparturient 
period, but declined for both groups of cows from -7 d to +1 d and rebounded by +7 d (P < 
0.01) (Fig. 1C).  Despite the lack of an overall effect of parturition on ConA-stimulated 
PBMCs, TNF-α expression significantly (P < 0.05) declined from +1 d to +21 d for control 
cows (Fig. 1D).   
 Similarly, there was no effect of parturition on IL-12p35 or TGF-β expression for 
either NS or ConA-stimulated PBMCs (data not shown).  Expression of both cytokines 
remained relatively stable during the 3 wk before and 4 wk after calving, regardless of 
infection group. 
 A significant (P < 0.05) effect of parturition on IL-10 expression was noted for the 
NS PBMCs (Fig. 2A).  During the prepartum period, all cows exhibited a decline in IL-10 
expression (P < 0.05) between d -21 and calving, but control cows showed an increase (P < 
0.01) in IL-10 expression during the postpartum period.  Stimulating the PBMCs with ConA 
did not result in overall effects of parturition on IL-10 mRNA expression (Fig. 2B); however, 
there was a decline in expression between -21 d and -7 d in subclinical cows (P < 0.05).  
There was no effect of parturition on IL-4 expression by NS PBMCs (Fig. 2C).  A linear 
decrease in IL-4 expression was noted for ConA-stimulated PBMCs isolated from 
subclinically infected cows between -21 d and +1 d (P < 0.05) (Fig. 2D). 
 For both control and subclinical animals, there was a significant increase in IGF-1 
expression at parturition followed by a sharp decline post-calving (P < 0.001) (Fig. 3). 
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3.3 IFN-γ, IL-10, TGF-β, and Nitric Oxide Secretion   
There was no effect of infection or parturition on secretion of IFN-γ from NS 
PBMCS.  Overall, throughout the sampling period, production of IFN-γ by ConA-stimulated 
PBMCs tended to be greater in subclinical (14.36 ng/ml ± 1.6; P < 0.06) and clinical (14.28 ± 
2.7; P < 0.12) cows than the controls (8.30 ± 2.2) (Fig. 4A).  There was an overall effect of 
parturition and an interaction of infection group and parturition (P < 0.0001), but this effect 
was most likely the result of extremely high concentration of ConA-stimulated IFN-γ noted 
on -21 d for the clinical cows.  By -14 d, this value was within the range of the average 
values noted for subclinical and control cows.  A significant (P < 0.05) increase in ConA-
stimulated IFN-γ secretion was observed for subclinically infected cows on d +21 and +28 
post-calving as compared to other groups.  When PBMCs were stimulated with MPS, there 
was a tendency (P < 0.11) for clinical cows to secrete more IFN-γ compared with the 
controls (Fig. 4B).  A significant (P < 0.001) decline in MPS-stimulated IFN-γ secretion was 
observed for clinical cows from -21 d (2.18 ng/mL ± 0.8) to +1 d (0.75 ng/mL ± 0.2.  
Concentrations for subclinical and control cows remained relatively stable throughout the 
sampling period. 
Overall, secretion of IL-10 by NS and ConA-stimulated PBMCs was not affected by 
infection group (Fig. 5).  There was a spike in IL-10 secretion in the prepartum period by NS 
PBMCs from subclinical cows with secretion increasing sharply from -21 d to -14 d and then 
rapidly declining to +1 d (P < 0.01) (Fig. 5A).  Clinical cows followed a similar pattern with 
secretion increasing sharply from -14 d to -7 d and then declining to a nadir of 0.307 U at +1 
d.  This resulted in an overall interaction of infection group and parturition (P < 0.001).  
When PBMCs were stimulated with ConA, there was no longer an effect of parturition (data 
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not shown).  For the MPS-stimulated PBMCs, the days were combined into three periods: -
21 d, -14 d, -7 d = precalving; +1 d = calving; and +7 d, +14 d, +21 d = postcalving.  Also, 
because of similar trends for both infected groups, subclinical and clinical cows were 
combined into one infected group.  Secretion of IL-10 tended (P < 0.09) to be greater for 
infected cows compared with that of control cows at calving and during the postpartum 
period (Fig. 5B).  Interestingly, stimulating the PBMCs with MPS resulted in a 7.7-, 9.7-, and 
12.0-fold increase in secretion for control, subclinical, and clinical cows, respectively, 
compared with secretion from NS PBMCs (data not shown). 
Overall, parturition did not seem to have a significant effect on TGF-β production by 
PBMC’s stimulated with medium only (NS) (Fig. 5C).  However, at +7 d, subclinical cows 
had significantly lower TGF-β secretion compared with control cows (P < 0.05; 868.5 ± 79.3 
pg/mL vs. 1187.3 ± 77.9 pg/mL) and clinical cows (P < 0.01; 868.5 ± 71.1 pg/mL vs.1305.6 
± 98.9 pg/mL) at +7 d.   In addition, an overall trend for higher TGF-β secretion by NS 
PBMC isolated from clinical cows was noted in the postpartum period.  There was no overall 
effect of cow infection status on concentrations of TGF-β when PBMCs were stimulated with 
MPS, except at +1 d when clinical cows had significantly (P < 0.05) increased TGF- β 
secretion compared with that of subclinical and control cows (Fig. 5D).  
Nitric oxide production by NS PBMCs was not affected by either infection group or 
parturition (data not shown).  In the MPS-stimulated cells, the clinical cows (0.75 μM ± 0.2) 
tended to have greater NO production compared with that of the control (0.31 μM ± 0.15; P < 
0.10) and the subclinical cows (0.42 μM ± 0.09; P < 0.15), and an overall infection group x 
parturition interaction was noted (P < 0.10) (Fig. 6B). Similar effects were observed for 
ConA-stimulated cells, but the effects were not significant (Fig. 6A). 
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3.4 Serum Progesterone, 17β-Estradiol, and IGF-1   
For all cows sampled, regardless of infection status, progesterone concentrations 
declined as parturition approached (Fig. 7A).  This decline resulted in a strong day effect (P 
< 0.001).  At -21 d, subclinical cows showed significantly (P < 0.05) elevated progesterone 
compared with control cows.  During the sampling days after calving, concentrations of 
serum progesterone declined and reached values lower than that that could be detected by 
using the kit (0.2 ng/mL).  Estradiol concentrations remained fairly constant for control and 
clinically infected cows until -7 day (Fig. 7B).  At d -7, estradiol concentrations began to 
decline and by d +7 reached a nadir of 10 pg/mL.  This decline was characteristic for all 
cows, regardless of infection status, resulting in an overall day effect (P < 0.001).  At -7 d, 
estradiol spiked for subclinically infected cows with concentrations greater than both control 
(P < 0.001) and clinical (P < 0.001) cows and declined thereafter.   
In general, for healthy control cows and infected cows, IGF-1 concentrations declined 
between -14 d and +1 d and then began to recover after parturition (Fig. 7C).  The decline in 
the weeks prior to parturition and subsequent recovery of IGF-1 serum concentrations within 
the first few weeks after parturition resulted in an overall day effect (P < 0.0001). There was 
no overall effect of MAP infection on serum IGF-1 concentrations.   
      
4. DISCUSSION 
 
 Johne’s disease has a devastating impact on the health of the dairy cow, and this 
disease has had cumulative economic impact on the dairy producer.  Most animals will 
encounter MAP during the first year of life and will remain in the subclinical, or 
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asymptomatic, stage of the disease for several years.  The transition from subclinical to 
clinical state coincides with the differentiation of naïve CD4+ T-cells from a Th1 to a Th2 
immune response.  Limited research exists that focuses on the role that parturition plays, if 
any, in the progression of JD from the subclinical to clinical state.  To the best of our 
knowledge, this study is the first to document changes in cytokine gene expression and 
secretion in dairy cows naturally infected with MAP throughout the periparturient period. 
 Even the healthy dairy cow experiences increased challenges to the immune system 
during the periparturient period. Increases in both metabolic and infectious disease are 
observed during this time (Goff and Horst, 1997).  Throughout mid to late lactation, cytokine 
profiles mirror a Th1 immune response.  However, as transition to lactation occurs, there is a 
shift in the CD4+ population supporting a Th2 response (Shafer-Weaver et al., 1999).  The 
immune system is further compromised by decreases in both neutrophil and lymphocyte 
function that is caused by parturition (Kehrli et al., 1989a; Kehrli et al., 1989b).   
 To better understand the interaction of parturition and MAP infection, we evaluated 
the ability of cytokines to modulate progression of JD during the periparturient period by first 
examining the expression of the Th1 cytokines.  In the current study, MAP infection did not 
have an effect on the gene expression of IFN-γ, TNF-α, or IL-12.  These results are in 
contrast to previous work in our laboratory that concluded that subclinical JD cows have 
greater IFN-γ expression compared with that of clinical cows (Stabel, 2000; Khalifeh and 
Stabel, 2004a; Khalifeh and Stabel, 2004b).  However, PBMCs from subclinical cows did 
tend to secrete more IFN-γ compared with clinical and control cows.  Interferon-γ is 
important for initiating the innate immune response to intracellular bacteria and it is one of 
the first cytokines to be activated in subclinical MAP-infected dairy cows (Sweeney et al., 
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1998).  Together, IFN-γ and TNF-α promote the protective formation of granulomas (Roach 
et al., 2002), a critical step in controlling MAP-infection.  Both IFN-γ and TNF-α expression 
by NS PBMCs declined as parturition approached, which is in agreement with previous 
observations suggesting a decline in Th1 cytokines at parturition (Shafer-Weaver et al., 
1999).  Interestingly, IL-12 expression was not affected by infection or parturition.  This is in 
contrast to Coussens et al. (2004) who showed that PBMCs from MAP-infected cows 
expressed 13-fold less IL-12p35 than did cells from control cows. 
 In addition to understanding the effects of parturition and MAP infection on the Th1 
cytokines, we also sought to determine the role of the classical Th2 cytokines, IL-4 and IL-
10, and the Th3 cytokine, TGF-β.  The transition from the Th1 to Th2 represents a switch 
from cell-mediated to antibody-mediated immunity.  In the current study, there was no effect 
of parturition or MAP infection on gene expression of the Th2 or Th3 cytokines.  Recent data 
from our laboratory suggested that there was an upregulation of TGF-β and IL-10 expression 
in clinical cows naturally infected with MAP (Khalifeh and Stabel, 2004a).  TGF-β has been 
shown to act synergistically with IL-10 in repressing macrophage activation (Mullins et al., 
2001).  Despite minimal differences in TGF-β expression, NS and MPS-stimulated PBMCs 
isolated from clinical cows secreted more TGF-β during the immediate postpartum period 
compared with subclinical and control cows.  MPS-stimulated PBMCs from infected cows 
secreted more IL-10 than did the control cows at calving and during the postpartum period.  
The increase in IL-10 secretion observed during the postpartum period for infected cows may 
result in the down-regulation of macrophage and natural killer cell function.  Interleukin-4 
functions to promote B-cell activation and Th1 cell suppression.  Others have reported 
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upregulation of IL-4 during the immediate postpartum period but this effect was not observed 
in the present study (Shafer-Weaver and Sordillo, 1997; Shafer-Weaver et al., 1999). 
 It is of interest to note that the cytokine profiles for the cows in our study typically 
followed the established Th1/Th2 dichotomy observed in periparturient dairy cows.  We did 
not, however, observe an effect of MAP infection on cytokine expression.  Both the innate 
and adaptive immune responses are lowest during the periparturient period (Mallard et al., 
1998).  To date, there is not a complete characterization of the consequences of this 
immunosuppression.  There exists a possibility that the immunosuppression at calving was 
severe enough to essentially override the traditional Th1/Th2 paradigm observed in MAP-
infected animals.  This may explain why we did not observe differences in cytokine 
expression between infection groups. 
 Hormonal fluctuations during the periparturient period contribute to the typical 
immunosuppression observed at calving.  The polarization of a specific Th response may be 
influenced by the hormonal status of the animal.  On the basis of their potential role during 
this critical time period, we evaluated IGF-1, progesterone, and 17β-estradiol concentrations 
in the peripheral blood.  All of the cows exhibited the typical hormonal responses observed 
around parturition (Radcliff et al., 2003).  Despite our hypothesis, MAP infection did not 
appear to affect blood hormone concentrations. 
 One major hypothesis of the current study was that subclinical cows would transition 
to the clinical stage of the disease during the 4 wk postpartum.  However, not one of the 14 
subclinical cows on the study seemed to make the transition to the clinical stage of the 
disease during the 4 wk postpartum.  This conclusion was based on diagnostic measurements 
such as fecal shedding of the bacteria, antigen-specific IFN-γ responses, and ELISA titers for 
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the entire sampling period.  Further studies are needed to determine if the cytokine profile of 
JD cows is altered later in lactation than the +28 d observed in the current study. 
 
5. CONCULSIONS 
 
Results of this study indicate that parturition modulates mRNA expression of IFN-γ, 
TNF-α, IL-10, and IGF-1 in dairy cows.  Infection with MAP did not significantly alter 
cytokine gene expression compared with that of control cows, but secretion of IFN-γ, IL-10, 
and TGF-β were up-regulated by infection in the postpartum period. The periparturient 
period did not alter the transition from subclinical to clinical infection status in cows with 
paratuberculosis, but the period of observation was relatively brief.  A more protracted period 
of study would likely yield more significant effects.  In addition, the highly dynamic nature 
of the immediate periparturient period may have precluded distinct observations between 
infection groups. 
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Table 1. Primers used for RT-PCR of bovine cytokines 
Gene             Primer1      Sequence 
β-actin            F                CGCCATGGATGATGATATTGC 
β-actin            R                AAGCCGGCCTTGCACAT 
IL-4            F                GCCACACGTGCTTGAACAAA 
IL-4                R                TGCTTGCCAAGCTGTTGAGA 
IL-10              F                GCCTTGTCGGAAATGATCCA 
IL-10              R                TCAGGCCCGTGGTTCTCA 
IL-12p35        F                CTTTCTTCAAATGCAGCATTGG 
IL-12p35        R                GGGTCTGGGTGATACAACGAA 
IFN-γ             F                 AGCCAAATTGTCTCCTCCTACTTC 
IFN-γ             R                 CTGACTTCTCTTCCGCTTTCTG 
TNF-α            F                 CAAGTAACAAGCCGGTAGCC   
TNF-α            R                 TGGAAGACTCCTCCCTGGTA 
TGF-β            F                 CTGAGCCAGAGGCGGACTAC 
TGF-β            R                 TTGCTGAGGTAGCGCCAGGAATTG 
    1F, forward; R, reverse. 
 
 90
 
Figure Legends 
 
 
Figure 1. Expression of Th1 cytokines, IFN-g and TNF-a, by peripheral blood mononuclear 
cells from healthy control cows (♦) and cows naturally infected with Mycobacterium avium 
subsp. paratuberculosis (■).  A) IFN-γ expression by nonstimulated (NS) PBMCs. 
(parturition effect, P < 0.05). B) IFN-γ expression by concanavalinA-stimulated PBMCs. 
(parturition effect, P < 0.001).  C) TNF-α expression by NS PBMCs. (parturition effect, P 
<0.01). D) TNF-α expression by concanavalinA-stimulated PBMCs. (parturition effect, P < 
0.05). Significant differences on a given day relative to day 1 are represented by asterisks (P 
< 0.05). 
 
Figure 2. Expression of Th2 cytokines, IL-10 and IL-4, by peripheral blood mononuclear 
cells from healthy control cows (♦) and cows naturally infected with Mycobacterium avium 
subsp. paratuberculosis (■). A) IL-10 expression by nonstimulated (NS) PBMCs. 
(parturition effect, P < 0.05). B) IL-10 expression by concanavalinA (ConA)-stimulated 
PBMCs. C) IL-4 expression by NS PBMCs. D) IL-4 expression by ConA-stimulated 
PBMCs. Significant differences on a given day relative to day 1 are represented by asterisks 
(P < 0.05). 
 
Figure 3.   Insulin-like growth factor-1 mRNA expression by non-stimulated peripheral 
blood mononuclear cells from healthy control cows (♦) and cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis (■). (parturition effect, P < 0.0001). 
Significant differences on a given day relative to day 1 are represented by asterisks (P < 
0.05). 
 
Figure 4. Interferon gamma secretion by peripheral blood mononuclear cells isolated from 
control (♦), subclinical (■), and clinical (▲) periparturient dairy cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis. A) ConcanavalinA-stimulated PBMCs. 
(parturition effect, P < 0.0001; infection x parturition effect, P <0.001).  B) MAP whole cell 
sonicate-stimulated PBMCS. (parturition effect, P < 0.05; infection x parturition effect, P 
<0.01). Significant differences between infection groups on a given day relative to calving 
are represented by asterisks (P < 0.05). 
 
Figure 5.  Interleukin 10 and transforming growth factor beta secretion by peripheral blood 
mononuclear cells isolated from control (♦), subclinical (■), and clinical (▲) periparturient 
dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis. A) IL-10 
secretion by nonstimulated (NS) PBMCs. (parturition effect, P <0.01; infection x parturition 
effect, P <0.001). B) IL-10 secretion by MAP whole cell sonicate (MPS)-stimulated PBMCs. 
C) TGF-β secretion by NS PBMCs. D) TGF-β secretion by MPS-stimulated PBMCs. 
Significant differences between infection groups on a given day relative to calving are 
represented by asterisks (P < 0.05). 
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Figure 6. Nitrite production by peripheral blood mononuclear cells isolated from control (♦), 
subclinical (■), and clinical (▲) periparturient dairy cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis. Nitrite is the stable product of nitric oxide.  
The amount of nitrite in the sample is proportional to the amount of nitric oxide secreted by 
the PBMCs. A) ConcanavalinA-stimulated PBMCs. (parturition effect P < 0.05). B) MAP 
whole cell sonicate-stimulated PBMCs. (parturition effect, P < 0.01).  Significant differences 
between infection groups on a given day relative to calving are represented by asterisks (P < 
0.05). 
 
Figure 7. Serum hormone concentrations obtained from peripheral blood of control (♦), 
subclinical (■), and clinical (▲) periparturient dairy cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis.  A) Progesterone concentration. (parturition 
effect, P <0.001). B) 17β-estradiol concentration. (parturition effect, P <0.0001).  C) IGF-1 
concentration. (parturition effect, P <0.0001). Significant differences between infection 
groups on a given day relative to calving are represented by asterisks (P < 0.05). 
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Figure 3.  
 
0
0.2
0.4
0.6
0.8
1
1.2
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
IG
F-
1 
M
ea
n 
R
el
at
iv
e 
Ex
pr
es
si
on
 (d
dC
t)
***
**
* *
IG
F-
1 
M
ea
n 
R
el
at
iv
e 
Ex
pr
es
si
on
 (d
dC
t)
♦ Control   ■ Subclinical 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 95
Figure 4. 
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Figure 5. 
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 CHAPTER THREE 
 
PARTURITION INVOKES CHANGES IN PERIPHERAL BLOOD 
MONONUCLEAR CELL POPULATIONS IN HOLSTEIN DAIRY COWS 
NATURALLY INFECTED WITH MYCOBACTERIUM AVIUM SUBSP. 
PARATUBERCULOSIS 
 
 
A paper submitted to Veterinary Immunology and Immunopathology 
 
E.L. Karcher1,3, D.C. Beitz1, J.R. Stabel2,4 
 
 
ABSTRACT 
Johne’s disease is characterized by a protracted period of subclinical infection. Infected cows 
may remain in the subclinical state until stressors such as parturition and lactation invoke 
more clinical signs of disease.  The objective of this study was to evaluate changes in the 
percentages of CD4+, CD8+, and γδ T-cells, B-cells, monocytes, as well as the expression of 
the activation marker, CD5, on these cell subpopulations in the peripheral blood of dairy 
cows naturally infected with Mycobacterium avium subsp. paratuberculosis (MAP) during 
the periparturient period. Peripheral blood mononuclear cells (PBMCs) were collected from 3 
wk pre- to 4 wk post-calving and sampled fresh or incubated for 7 d.  Day 7 cultures were 
further exposed to live MAP at a 10:1 MOI (bacteria to adherent monocyte-derived 
macrophages) and cultures were incubated for an additional 24 h.  Fluorescent antibody 
labeling of lymphocyte subsets and monocytes was conducted and analyzed with flow 
cytometry.  In fresh mononuclear cells, subclinical cows expressed a greater percentage of  
1Department of Animal Science, Iowa State University, Ames, IA  50010. 
2USDA-ARS, National Animal Disease Center, Ames, IA  50010. 
3Primary Researcher and author. 
4Author for correspondence. 
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CD8+ and γδ T-cells compared with clinical cows.  The percentage of CD4+ T-cells increased 
in clinical cows as parturition approached.  During the postpartum period, clinical cows had 
greater CD4:CD8 ratios compared with subclinical and control cows.  Day 8 after parturition, 
uninfected PBMCs from clinical cows had greater percentages of CD14+ cells compared with 
subclinical cows.  When stimulated with MAP, there was no effect of infection group or 
parturition on percentage of cells expressed.  In freshly isolated PBMCs, clinical cows 
expressed lower percentages of CD4+/CD5bright and CD8+/CD5bright compared with control 
cows, but greater percentages of CD5dim cells for all lymphocyte subsets.  These results 
suggest changes in the percentages of lymphocyte subsets, monocytes, and CD5 markers are 
modulated by both infection status and the periparturient period. 
Keywords: Mycobacterium avium subsp. paratuberculosis, lymphocytes, periparturient, 
peripheral blood mononuclear cells. 
 
1. INTRODUCTION 
 
Johne’s disease (JD), caused by the intracellular pathogen Mycobacterium avium 
subsp. paratuberculosis (MAP), is estimated to infect more than 22% of US dairy herds and 
cost the US dairy industry up to $250 million annually (Ott et al., 1999).  In general, dairy 
cows will become infected with MAP as neonates through fecal-oral transmission.  Once 
infected, cows may remain in the subclinical, or asymptomatic, stage of the disease for 
several years (Larsen et al., 1975).  Stressors, such as parturition, may induce the transition 
from subclinical to clinical stage of the disease.  Clinical animals are characterized by fecal 
shedding of the bacteria, intermittent but persistent diarrhea, progressive weight loss, and 
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eventual death.  The exact mechanism that triggers the progression of the disease remains 
unknown. 
Anecdotal observations suggest that dairy cows infected with MAP may demonstrate 
increased signs of clinical disease during the weeks following parturition.  Research on what 
prompts the progression of disease from the asymptomatic subclinical state to a more clinical 
state during this time period is lacking.  The transition period, defined as three weeks prior to 
and the three weeks following parturition, represents a time of physiological stress for the 
dairy cow.  Metabolic changes such as the rapid increase in non-esterified fatty acid 
concentrations (Radcliff et al., 2003; Karcher et al., 2007), accompanied by a postpartum 
decline in both blood glucose (Radcliff et al., 2003) and calcium concentrations (Kimura et 
al., 2006), present challenges to the dairy cow.  Rapid fluctuations in both serum 
progesterone and estradiol during the periparturient period contribute additional stressors 
(Weber et al., 2001; Radcliff et al., 2003).  In addition, the cow is forced to deal with 
immunosuppression characterized by decreased lymphocyte function (Kehrli et al., 1989a; 
Meglia et al., 2005) and the decreased ability of neutrophils to migrate and phagocytize 
(Kehrli et al, 1989b; Lee and Kehrli, 1998).  Parturition has a major impact on the number of 
T- and B-cells, both components of the adaptive immune system, and the number of 
monocyte/macrophages, effectors of the innate immune system in the peripheral blood of 
healthy dairy cows. Studies have noted dramatic decreases in the percentage of peripheral 
blood CD4+ T-cells and γδ T-cells at parturition (Van Kampen and Mallard, 1997; Kimura et 
al., 1999).  In contrast, increased activity of CD8+ lymphocytes has been observed in cows at 
calving compared with mid to late lactating cows (Shafer-Weaver and Sordillo, 1997).  The 
percentage of B-cells in peripheral blood was highest immediately prior to and lowest 
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immediately following parturition (Van Kampen and Mallard, 1997).  In addition, the 
number of monocytes and monocyte-derived macrophages were increased at calving (Kimura 
et al., 2002). The total number and percentages of CD4+ and CD8+ (α/β T-cells), γδ T-cells, 
and B-cells, play a significant role in the ability of the animal to respond to an infection. 
In paratuberculosis, the progression from a subclinical to a clinical stage of disease is 
characterized by a shift from cell-mediated (Th1) immunity to an antibody-mediated (Th2) 
humoral response.  This shift in Th1 to Th2 immunity is characterized by a decreased 
percentage of peripheral blood T-cells and an increase in the percentage of B-cells for 
clinically infected cows (Waters et al., 1999; Koets et al., 2002).  More specifically, the 
percentages of γδ and CD4+ T-cells in peripheral blood are remarkably decreased in clinical 
cows compared with healthy controls (Koets et al., 2002).  The CD4:CD8 ratio is also 
decreased in chronically infected animals as the number of CD8+ T-cells does not seem 
overtly affected by the transition to a clinical disease state (Koets et al, 2002).   The decline 
in CD4+ T-cells observed in clinical cows further illustrates the compromised nature of the 
immune system as these cells are key effectors of Th1-mediated immunity through the 
secretion of IFN-γ, a cytokine that is credited for controlling mycobacterial infections 
(Cooper et al., 1993; Flynn et al., 1993).      
To date, limited research is available characterizing detailed aspects of periparturient 
immunosuppression in the dairy cow.  Further, it is not clear what impact the periparturient 
period and its associated stressors may have on host immunity in cows with paratuberculosis.  
Therefore, the objective of this study was to determine the percentages of CD4+, CD8+, and 
γδ T-cells, B-cells, and monocytes in the peripheral blood of dairy cows naturally infected 
with MAP during the periparturient period as compared with healthy control cows.  In 
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addition, cell populations were further delineated by staining for CD5, a marker for T- and B-
cell activation.   
 
2. MATERIALS AND METHODS 
 
2.1 Animals 
  Twenty-one multiparous Holstein cows and two primiparous Holstein cows (age 
range from 3 to 6 yr) were grouped according to infection status.  These groups consisted of 
1) noninfected healthy control cows (n = 5), 2) cows naturally infected with MAP, but 
asymptomatic (n = 14), and 3) naturally infected cows with clinical Johne’s disease (n = 4).  
The 2 primiparous cows were both in the subclinically infected group.  The stage of infection 
was determined by fecal shedding of MAP and IFN-γ.  Infection was monitored 
bacteriologically for the fecal shedding of MAP by standard culture methods (Stabel, 1997).  
By definition, clinical animals were shedding more than 100 CFU/tube and presented with 
weight loss and intermittent diarrhea.  Subclinically infected cows were shedding less than 10 
CFU/tube. The noninfected control cows were characterized by repeated negative fecal 
cultures performed quarterly over a 3- to 5-yr period. In addition, these animals were negative 
on any serologic assays (i.e., production of antibody specific for MAP and IFN-γ) performed 
during that period. All animals were housed in American Association for Accreditation of 
Laboratory Animal Care-accredited facilities, and all procedures performed on animals were 
approved by the Institution Animal Care and Use Committee (National Animal Disease 
Center [NADC], Ames, Iowa). 
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2.2 Blood Collection and Culture Conditions 
Blood was collected from the jugular vein in 2x acid-citrate-dextrose (ACD; 1:10).  
For each animal, blood was collected at -21, -14, -7, +1, +7, +14, +21, and +28 days relative 
to calving (DRTC).  Peripheral blood mononuclear cells (PBMCs) were isolated from the 
buffy coat fractions of blood.  PBMCs were resuspended in complete media [RPMI-1640  
(Gibco, Grand Island, NY) with 10% fetal calf serum (Atlanta Biologics, Atlanta, GA), 100 
U of penicillin G sodium (Gibco, Grand Island, NY) per mL, 100 μg of streptomycin sulfate 
(Gibco, Grand Island, NY) per mL, 0.25 μg of amphotericin B (Gibco, Grand Island, NY) per 
mL, and 2 mM l-glutamine (Gibco, Grand Island, NY)]. Cells were cultured at 2.0 x 106/mL 
in 48-well flat-bottomed plates (Corning Incorporated, Corning, NY).  Briefly, plates were 
centrifuged at 400 x g for 5 min and the supernatant was decanted.  Cells were resuspended 
gently in 300 μl of PBS (137 mM sodium chloride, 10 mM phosphate, 2.7 mM potassium 
chloride; pH 7.4).   In 96-well round bottom plates (Corning Incorporated, Corning, NY), 50 
μL of the cell suspension was added to wells containing 50 μL of primary monoclonal 
antibody to CD4+, CD8+, γδ T-cells, B-cells, monocytes, and CD5 (Table 1).  All wells 
received 10 μg/mL of DAPI (4’-6-diamidino-2-phenylindole; Sigma, St. Louis, MO) to 
differentiate live from dead cells and allow gating on viable cells.  Cells then were incubated 
at 4°C for 30 min.  After incubation, plates were centrifuged at 400 x g for 2 min at 4°C and 
the supernatant decanted.  Secondary antibody cocktail (100 μL) consisting of fluorescein-
conjugated anti-mouse IgM (Southern Biotech, Birmingham, AL), R-phycoerythrin-
conjugated goat F(ab)2 anti-mouse IgG2a (Southern Biotech, Birmingham, AL), and 
peridinin-chlorophyll-protein complex (PerCP)-conjugated rat anti-mouse IgG1 (Becton 
Dickinson, San Jose, CA) diluted 1:312, 1:625, and 1:42 respectively, in PBS with 1% fetal 
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calf serum and 0.04% sodium azide was then added to designated wells.  After incubation the 
plate was centrifuged again at 400 x g for 2 min at 4°C.  The cells then were suspended in 
200 μL of BD FacsLyse (BD Biosciences, San Jose, CA) for immediate flow cytometric 
analysis. 
Additional cultures were incubated for 7 d in complete medium for flow cytometric 
analyses.  Replicate wells were set up concurrently and incubated under the same conditions 
for enumeration of monocyte-derived macrophages in the cultures. After 7 d of incubation, 
nonadherent cells were removed from the plates and the wells were washed with cold 1× 
PBS to remove the adherent cells from the plates. The adherent cells were approximately 80 
to 90% monocyte-derived macrophages as determined by staining and were quantified with a 
cell counter prior to the addition of live MAP.  M. avium subsp. paratuberculosis strain K-10 
(NADC) was added at a ratio of 10 bacteria per adherent PBMC to the experimental wells 
(Khalifeh and Stabel, 2004).  Control wells (medium alone; 8 d control PBMC) and infected 
wells (MAP infected; 8 d infected PBMC) were then incubated for an additional 24 h.  Cells 
then were prepared for flow cytometric analysis by using the same procedure as described 
above.   
 
2.3 Bacteria 
M. avium subsp. paratuberculosis strain K-10 (NADC) was prepared as previously 
described (Khalifeh and Stabel, 2004).  Bacteria were grown in Middlebrook 7H9 broth (pH 
6.0) supplemented with mycobactin J (2 mg/L; Allied Monitor, Fayette, MO) and oleic acid-
albumin-dextrose complex (Becton Dickinson Microbiology, San Jose, CA). The bacteria 
were harvested, washed 3 x with PBS (pH 7.4; 0.15 M), and resuspended in PBS to a final 
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concentration of 109/mL as determined by the absorbance at 540 nm. Bacterial stocks then 
were frozen in PBS at -80°C until used in the experiments. Prior to in vitro infection, frozen 
bacterial stocks were thawed, and clumps were dispersed by brief sonication at 25 W for 40 s 
with a Tekmar sonic disturber (Tekmar, Lorton, VA). The viable cells in the frozen bacterial 
stocks were determined by culturing on HEYM. Viable cells in stocks typically were 
decreased after thawing and sonication to approximately 108 CFU/mL. 
 
2.4 Flow Cytometric Analysis 
Samples were evaluated by analyzing 30,000 events per sample using a FACScan 
flow cytometer (Cell Quest Software; Becton Dickinson, San Jose, CA).  Analysis was 
conducted by gating on mononuclear cells based on forward and side scatter characteristics 
(FlowJo, Tree Star, Inc., Ashland, OR).  The percentage of CD4+, CD8+, γδ T-cells, B-cells, 
and monocyte/macrophage populations were determined from the gated mononuclear cell 
population.  Percentages of CD5 positive cells within these cell populations also were 
determined. 
 
2.5 Statistical Analysis 
Percentages of each cell population were analyzed by using the PROC Mixed analysis 
of SAS (PROC MIXED in SAS
®
 PC Windows Version 9.1.3 software).  For repeated 
measurements, the model included the fixed effects of infection group and DRTC, random 
effects of cow within infection group by time, the interactions of fixed effects, and the 
residual error.  The covariance structure utilized was compound symmetry in all analyzed 
parameters.  Significant differences because of treatment group were considered different if 
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P < 0.05 and considered a tendency towards significance if 0.05 ≤ P ≤ 0.15.  Values were 
reported as least square means ± standard errors of the mean unless noted otherwise.    
 
3. RESULTS 
3.1 Mononuclear cell populations in freshly isolated cells 
 An overall effect of parturition (P < 0.05) caused a significant decline in the 
percentage of total mononuclear cells from -7 to +1 DRTC for all animals regardless of 
infection status (data not shown).  Values returned to pre-calving values by +14 d.  On +7 d 
and +21 d after calving, clinical and subclinical cows had decreased (P < 0.05) numbers of 
mononuclear cells compared with the control cows.  A significant (P < 0.05) DRTC effect 
was observed throughout the periparturient period for the percentage of CD4+ cells in fresh 
PBMC cultures (Fig. 1A).  Compared with the prepartum period, the percentage of CD4+ T-
cells increased at parturition for clinically infected cows (P < 0.08), whereas healthy control 
cows showed a gradual decline in number of CD4+ T-cells from -21 d to -7 d.  A highly 
significant (P < 0.01) infection group x parturition effect was observed throughout the study.  
At +7 d and +21 d, infected cows had a greater (P < 0.01) percentage of CD4+ T-cells in total 
PBMC compared with the control cows. There was an overall effect of infection group on the 
percentage of CD8+ T-cells in the fresh PBMC cultures (Fig. 1B).  On average, the 
percentage of CD8+ T-cells was greater (P < 0.05) in subclinically infected cows (20.3% ± 
2.1) compared with clinically infected (10.3% ± 3.77) and control (10.3% ± 3.3) cows.  An 
interaction of infection group and DRTC was observed (P < 0.01) as subclinical cows had 
greater percentages of CD8+ T-cells compared with the other groups on all sampling days 
during the postpartum period.  
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 The CD4:CD8 ratio was dissimilar within the infected groups with higher (P < 0.01) 
CD4:CD8 ratios noted for clinical compared to subclinical cows (Table 2).  There was a 
significant (P < 0.05) infection group x DRTC interaction with higher CD4:CD8 ratio 
observed on d +1, +7, and +14 of the study.   
 In fresh PBMC cultures, the overall percent of γδ-TCR+ cells was lower (P < 0.01) in 
clinical cows (1.7% ± 0.9) compared with subclinical cows (4.4% ± 0.5), with a trend (P < 
0.06) to be lower than control cows (3.9% ± 0.8) (Fig. 1C). There was no significant effect at 
parturition; however, both control and subclinical cows tended to have increased (P < 0.12) 
numbers of γδ T-cells as parturition approached, with further increases noted for 
subclinically infected cows in the postpartum period.   
There was no effect of infection group or parturition on the percentage of B-cells in 
this study (Fig. 2A).  However, the percentage of B-cells from subclinical cows declined as 
parturition approached (P < 0.03).  An increase in the percentage of B-cells from clinical 
cows was noted from -14 d to +7 d (P < 0.06).  Similarly, there was no effect of infection or 
parturition on the percentage of CD14+ cells in fresh PBMCs (Fig. 2B), but a trend for an 
infection group x DRTC effect (P < 0.12) was observed.  Subclinical cows expressed a 
greater percentage of CD14+ cells on +7, +14, and +21 d compared with control and clinical 
cows.   
 
3.2 Effects of in vitro infection with M. avium subsp. paratuberculosis on mononuclear 
cell populations in 8 d cultures 
 
PBMCs from clinical cows incubated with medium alone had an overall lower (P < 
0.05) percentage of mononuclear cells (61.3% ± 3.2) compared with both control (71.2% ± 
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2.8) and subclinically infected cows (68.5% ± 1.6) (data not shown).  Statistically significant 
differences due to infection status were only observed during the prepartum period (infection 
group x DRTC effect, P < 0.01).  For control and subclinical cows, the percentage of 
mononuclear cells declined from -7 to +1 d and rapidly increased by +7 d (data not shown).  
Similar trends were observed after in vitro infection with MAP, with lower percentages of 
mononuclear cells noted for clinically infected cows during the prepartum period compared 
with control and subclinical cows (infection group x DRTC effect, P < 0.10).  A significant 
(P < 0.05) overall DRTC effect was observed for clinical cows as the number of 
mononuclear cells increased from -7 to +7 d and gradually decreased again by +28 d.  
Although not statistically significant, the control and subclinical cows had a decline in 
mononuclear cells from -14 to +1 d (Fig. 3).  There was no overall effect of infection group 
on the percentage of CD4+ T-cells from 8 d control PBMCs (Fig. 4A).  A trend for a DRTC 
effect (P < 0.09) was noted with both control and clinical cows demonstrating a decline in 
CD4+ T-cells as parturition approached.  By +21 d, the percent had returned to prepartum 
values.  Subclinical cows were unique in that they showed a 32% increase in CD4+ T-cells 
beginning at -14 d and continuing until +7 d (Fig. 4A).  By +28 d, the percentage had 
returned to -14 d prepartum values. For 8 d infected PBMC cultures, there was an infection 
group x DRTC effect (P < 0.01) (Fig. 4B). For subclinical cows, the percentage of CD4+ T-
cells increased from 21.2% ± 2.1 at -14 d to 35.6% ± 2.2 at +1 d (P < 0.01), followed by a 
decline during the postpartum period.  Interestingly, in contrast to subclinically infected 
cows, in clinically infected cows the percentage of CD4+ T-cells decreased from 33.4% ± 5.8 
at -21 d to 18.0% ± 2.2 at +1 d, rebounding to 28.1% ± 4.6 by +21 d. The percentage of 
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CD4+ T-cells from control animals remained relatively constant during the periparturient 
period until an increase was noted at +14 d.  
There was no overall effect of infection group on the percent of CD8+ T-cells from 8 
d control PBMC; however, an increase in CD8+ T-cells was observed at parturition for all 
cows (Fig. 5).  Interestingly, clinical cows had a brief increase (P < 0.01) in CD8+ T-cells 
from 15.7% ± 0.7 at +7 d to 31.6% ±5.1 at +14 d.  No effect of parturition or infection group 
was observed on the CD8+ population in 8 d infected PBMCs (data not shown). There was no 
effect of infection group on the CD4:CD8 ratio in either control or infected 8 d PBMC; 
however, a significant decrease (P < 0.01) in CD4:CD8 ratio was observed for control and 
clinically infected cows as parturition approached (data not shown).  
There was no overall effect of infection group on percent of γδ-TCR+ or B-cells from 
control or 8 d infected PBMCs (data not shown).  However, a significant (P < 0.04) DRTC 
effect was noted on +1 d with clinical cows having higher numbers of B-cells in 8 d control 
PBMC (70.8% ± 7.6) compared with subclinical (56.7% ± 4.7) and control (45.8% ± 4.6).  
Clinical cows had a greater (P < 0.05) percentage of CD14+ cells in 8 d control PBMC 
(39.1% ±2.7) compared with subclinical cows (31.5% ±1.4), with a tendency for higher 
numbers of monocyte-derived macrophages compared with the control cows (P < 0.10).  
Parturition did not affect the percentage of CD14+ cells in 8 d control PBMC (Fig. 6).  There 
was no overall effect of infection group or parturition on CD14+ cells from 8 d infected 
PBMCs (data not shown). 
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3.3 CD5 expression on mononuclear cell populations after fresh isolation or 8 d of culture 
Overall, in fresh PBMCs, clinical cows expressed lower (P < 0.01) percentages of 
CD4+/CD5bright T-cells and CD8+/CD5bright T-cells compared with the control cows and 
tended to have lower expression of these subpopulations than the subclinical cows (P < 0.10) 
(Fig. 7A/B).  There was no overall effect of periparturient period.  However, there was a 
significant increase (P < 0.01) in expression of CD4+/CD5bright T-cells for control cows 
between -14 d (46.82%) and the day of calving (79.2%).  This same pattern was observed for 
CD8+/CD5bright T-cells. Control cows also expressed a higher (P < 0.05) percentage of 
γδTCR+/CD5bright T-cells in fresh PBMC compared with the subclinically infected cows (Fig. 
7C).  Although parturition did not affect the percentage of γδTCR+/CD5bright T-cells, infected 
cows did have decreased expression in the postpartum period from +1 d through +21 d.  
Parturition did not affect the percentage of B-cell/CD5bright cells, but there was a strong trend 
towards lower expression for both subclinical (P < 0.11) and clinical (P < 0.13) cows 
compared with control cows (Fig. 7D). 
In contrast, clinical cows expressed a greater percentage of CD4+ cells/CD5dim cells 
compared with control (21.6% ± 4.8 vs. 40.44% ± 5.5; P <0.05).  There was no overall effect 
of parturition, but the percentage of cells from subclinical cows increased from -7 d to +21 d 
(P <0.05) and decreased in control cows from -14 d to +1 (P <0.05) (Fig. 8A).  The 
percentage of CD8+ cells/CD5dim cells was greater in clinical cows (P < 0.01) and tended to 
be greater in subclinical cows (P <0.06) compared with the control cows (Fig. 8B).  For 
clinical cows, the percentage rapidly increased from -7 d to +14 d (P < 0.01).  During the 
postpartum period, subclinical and clinical cows expressed a greater percentage of γδ 
cells/CD5dim compared with the control cows (P < 0.05) (Fig. 8C).  Overall, clinical cows 
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expressed a greater percentage of B-cell/CD5dim cells compared with the control cows (P < 
0.05) (Fig. 8D).   
There was no overall effect of infection or parturition on CD4+/CD5bright T-cells in 8d 
control (Table 3) or infected (Table 4) PBMCs, although there was an infection group x 
DRTC effect (P < 0.09).  There was an overall effect of parturition (P < 0.07) (Table 3) with 
overall percentages of CD8+/CD5bright T-cells decreasing from -21 d to +28 d (P < 0.05).  In 8 
d infected PBMCs, there was an overall DRTC effect (P < 0.01) and an infection group x 
DRTC effect (P < 0.01).  In the control cows, the percentage of γδ/CD5bright T-cells cells 
declined from 39.8% ± 5.8 at -21 d to 9.2% ± 2.9 by +7 d (P < 0.01).   The percentage then 
rapidly increased to +21 d.  A DRTC effect was observed in 8 d infected PBMC as the 
percentage of B-cell/CD5bright cells increased in the prepartum period from -14 d to +1 d (P < 
0.01) for subclinically infected cows, whereas an increase in B-cell/CD5bright cells was also 
observed from +7d to +21 d postpartum in control cows (P < 0.05).   
  
4. DISCUSSION 
 
Infections caused by MAP have an overwhelming impact on the health of the dairy 
cow and ultimately on the dairy industry. Limited research has focused on changes in 
populations of peripheral blood mononuclear cells in dairy cows naturally infected with MAP 
during the periparturient period.  The populations of B and T lymphocytes subsets in the 
peripheral blood have a direct impact on the ability of the animal to respond to new and 
existing infections. There are two distinct lineages of T-cells based upon the T-cell receptor, 
αβ TCR and γδ TCR, with commitment to a lineage occurring early in T-cell development 
(MacDonald et al., 2001).  T-cells committing to the α:β TCR lineage will further develop 
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into either a CD4+ or CD8+ phenotype.  CD4+ T-cells, also known as T-helper cells, play an 
active role in initiating both the humoral and cell-mediated immune responses.  In 
mycobacterial infections, CD4+ T-cells are recognized as the primary producer of IFN-γ, a 
key proinflammatory cytokine required for activation of macrophages and subsequent 
clearance of infection (Stuehr and Marletta, 1987; Flynn et al., 1993).   
 The percentage of CD4+ T-cells in PBMCs from healthy adult dairy cattle is 
approximately 25-35%.  Previous studies offer contrasting results for the effects of 
parturition on the number of circulating CD4+ T-cells.  Studies with dairy cows have 
supported an increase (Van Kampen et al., 1999), decrease (Kimura et al., 1999), or no 
change (Harp et al., 2004) in the percentage of CD4+ T-cells at parturition.  In the current 
study, the number of CD4+ T-cells in the peripheral blood averaged 21.6% ± 2.1, 24.3% ± 
1.3, and 25.7% ± 2.4 for control, subclinical, and clinical cows, respectively, with no 
differences noted between the infection groups.  No effect of MAP infection on percentages 
of CD4+ T-cells is in agreement with a previous study that did not observe differences in 
CD4+ T-cell percentages in fresh PBMCs isolated from healthy and MAP-infected 
periparturient cows (Harp et al., 2004).  However, these results are in contrast to one study 
that reported a decrease in CD4+ T-cells in peripheral blood and the ileum of clinically 
infected cows compared with their subclinically infected counterparts (Koets et al., 2002).   
A loss of CD4+ T-cells likely contributes to the progression of granulomatous enteritis noted 
in the clinical stage of disease.  Interestingly, stimulation of 8 d PBMCs with MAP resulted 
in an increase in the percentage of CD4+ T-cells during the prepartum period for subclinical 
cows with a decrease noted for clinical cows.  These data would suggest that CD4+ T-cells 
from subclinically infected cows are able to proliferate in response to antigen during periods 
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of physiologic stress, whereas clinically infected cows may be compromised in their ability 
to respond.   
CD8+, or cytotoxic T-cells are important for their ability to recognize viral and 
bacterial antigens and to target T-cells displaying these antigens for apoptosis (Kagi et al., 
1994). Similar to CD4+ T-cells, CD8+ T-cells also secrete pro-inflammatory cytokines, IFN-γ 
and TNF-α, making them equally important in controlling infection (Fong and Mosmann, 
1990; Berg et al., 2002).  Studies depleting mice of their CD8+ T-cell populations by using 
anti-CD8 antibodies have demonstrated a protective role for CD8+ cells in M. tuberculosis 
(Muller et al., 1987).  In the current study, the percentage of CD8+ T-cells ranged from 10-
22% which is equivalent to published values for adult dairy cows (Harp et al., 1991; Meglia 
et al., 2005).  An interactive effect of infection group and day relative to calving was 
observed with subclinically infected cows expressing 2-fold higher percentages of CD8+ cells 
in the postpartum period. Similar studies with healthy cows have reported a decline in CD8+ 
T-cell percentages at parturition (Kimura et al., 1999; VanKampen et al., 1999).  This is in 
contrast to two studies reported by Harp et al. (1991 and 2004) that suggest that CD8+ T-cells 
in peripheral blood are not influenced by parturition.  In Harp’s study, the percentage of 
CD8+ T-cells was 9% at calving and 12% at +21d.  In contrast to our data, other groups also 
have reported no differences in percentages of CD8+ T-cells between healthy, subclinical, 
and clinical cows (Koets et al., 2002).  However, these observations were not made during 
the periparturient period.  Cytotoxic killing of CD4+ cells by γδ T cells has been reported in 
infections caused by MAP (Chiodini and Davis, 1992).  However, the ability of γδ T cells to 
exert this effect is limited when CD8+ cells are present because of the inactivation of this 
group by a subset of CD8+ T-cells (Chiodini and Davis, 1993).  In our study, the increase in 
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both CD8+ and γδ T cells observed during the postpartum period may be an example of the 
dynamic regulation that exists among the T-cell subsets.  Another explanation for the 
increase in CD8+ T-cells in the subclinically infected animals may be that this T cell 
subpopulation is highly activated as a result of the cytokine microenvironment associated 
with the initial stages of MAP-infection and that this response provides an early defense 
system against the invading bacteria (Lertmemongkolchai et al., 2001; Yajima et al., 2002).  
The CD4 to CD8 T-cell ratio is often used as an indicator of immune status.  For 
example, in HIV-infected populations, a diminished CD4:CD8 ratio may be used to 
accurately predict the occurrence of an AIDS-related complication (Pirzada et al., 2006).  In 
advanced mycobacterial infections, there is a reduction in the number of CD4+ T-cells that is 
associated closely with a loss of Th1-mediated immune function.  A decrease in the number 
of CD4+ T-cells, resulting in diminished CD4:CD8 ratio is observed in cases of pulmonary 
tuberculosis (Pilheu et al., 1997; Uppal et al., 2004).  One mechanism that may account for 
the fewer CD4+ T cells is an increase in cellular apoptosis such as was observed in BALB/c 
mice infected intraperitoneally with M. tuberculosis (Das et al., 1999). When compared with 
subclinical cows, clinical cows have diminished CD4:CD8 ratios in the peripheral blood, 
with little variation in the percentage of CD8+ T-cells (Chiodini and Davis, 1992; Koets et 
al., 2002).  On the first sampling day of the current study (d -21), the CD4 to CD8 ratios were 
significantly lower for infected cows compared with controls (1.9 vs 4.0).  This follows the 
aforementioned paradigm for MAP infection.  However, the periparturient period triggered 
differences in the peripheral blood CD4 to CD8 T-cell ratios between cows in different stages 
of infection. Subclinically infected cows had lesser CD4 to CD8 ratios, whereas the clinically 
infected cows had higher CD4:CD8 ratios during the immediate postpartum period. The 
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CD4:CD8 ratio does not seem to be influenced by parturition in healthy dairy cows, with 
ratios averaging 3:1 (Van Kampen and Mallard 1997; Kimura et al., 1999). However, during 
the first 90 d in lactation, the ratio has been reported to decline to 1.81 (Park et al., 1992).  
Values in our study averaged 2.7 ± 0.6, 1.9 ± 0.4, and 3.9 ± 0.7 for control, subclinical, and 
clinical cows, respectively, throughout the periparturient period.   These results suggest there 
was an interaction between the effects of MAP infection and the dynamic events occurring 
during the periparturient period.  Although a decrease in the CD4 to CD8 ratio is indicative 
of immunosupression, recent information on the role of CD8 cells in the host response to 
mycobacterial infections suggests this population may provide additional protection by 
augmenting the innate immune response through secretion of IFN-γ (Berg et al., 2002). 
γδ T-cells seem to initiate immune responses and may regulate host inflammatory 
response to infection although their specific roles in host immunity are still relatively 
undefined.  The percentage of γδ T-cells is greatest in the calf (40%) and gradually declines 
to approximately 5% of adult PBMCs (Hein and MacKay, 1991).  In fresh PBMCs, clinically 
infected cows had a much lower percentage of γδ T-cells compared with subclinically 
infected and control cows.  This response is in agreement with a study reporting that the 
population of γδ T-cells from freshly isolated PBMCs was much greater in control cows 
(21.8%) compared with cows clinically infected with MAP (7.3%) (Koets et al., 2002).  In 
the current study, an increase in γδ T-cells was noted as parturition approached, with further 
increases noted throughout the postpartum period for subclinically infected cows.  Typical 
observations for dairy cows during the periparturient period include either declining numbers 
of γδ T-cells (Van Kampen and Mallard, 1997; Kimura et al., 1999) or no change in the 
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percentage of γδ T-cells (Park et al., 1992; Harp et al., 2004; Meglia et al., 2005).  Kimura et 
al. (1999) reported a decline in γδ T-cells from 7.3% on -13 d to 5.4% on +5 d.  These values 
are similar to values obtained for control and subclinically infected cows in our study, but are 
higher than the average values in this study for clinically infected cows (1.66%).  The exact 
function of γδ T cells remains to be found, although there is evidence to suggest that these 
cells play a significant role in the innate immune response to initial mycobacterial infection.  
Early infection with M.  tuberculosis results in increased numbers of activated γδ T cells that 
are capable of producing the proinflammatory cytokine, IFN-γ (Tsukagucki et al., 1995).  
Furthermore, stimulation of bovine γδ T cells with mycobacterial products resulted in 
expansion and production of IFN- γ (Vesosky et al., 2004).  The lower percentage of γδ T 
cells observed in the clinically infected cows in our study may be an attempt to limit the 
severe inflammation and tissue damage caused by an abundance of proinflammatory 
cytokines in the subclinical stage of Johne’s disease.   
In the current study, the percentage of B-cells across infection groups ranged from 
28-35%.  Neither infection status of the cows nor parturition had an effect on the overall 
percentages of B-cells. Similar to the T lymphocytes, the literature gives a contrasting view 
of B-cell percentages in healthy cows over the periparturient period.  Some studies indicate 
that the percentage of B-cells in peripheral blood throughout the periparturient period 
remains constant at 25% (Park et al., 1992; Harp et al., 2004) while others indicate increasing 
(Meglia et al., 2005) and decreasing (Van Kampen and Mallard, 1997) percentages during 
the postpartum period.  In the advanced stages of Johne’s disease, antibody production by B-
cells does little to protect the host from the progressive MAP-infection.  Waters et al. (1999) 
reported that population percentages of B-cells in peripheral blood were similar between 
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subclinically infected and control cows but were greater in clinically infected cows.  This 
same study concluded that B cells from clinically infected, but not subclinically infected, 
Johne’s cows fail to proliferate in response to antigen stimulation and that antigen response 
in the peripheral blood of these cows is absent.  In our study, the increase in percentage of B 
cells from -14 d to +7 d in freshly isolated PBMCs for clinically infected cows is an 
indication of activated humoral response around the time of calving.  In our study, clinically 
infected cows had a lower percentage of B cells prepartum and at calving compared with 
subclinical and control cows.  The fact that this value returned to a normal level by +7 d may 
be an indication of activated humoral response in clinically infected cows during the 
postpartum period. 
CD5 is expressed on all bovine T-cells and a subset of B-cells (Delpelchin et al., 
1989; Naessens and Williams, 1992).  In T-cells, CD5 is a regulating component of TCR-
signal transduction during the double-positive stage of lineage commitment (Tarakhovsky et 
al., 1995).  In healthy dairy cows, a subset of B-cells is CD5+ and is associated with the B-
cell receptor (Cantor et al., 2001).  We have identified previously two subpopulations of 
CD5+ cells (CD5bright and CD5dim) in the bovine that are modified by paratuberculosis 
infection.  Both CD5 bright and dim populations were examined as a percentage of marker 
positive lymphocyte subsets.  For CD4+, CD8+, and B-cell subsets, clinical cows expressed 
the lowest percentage of CD5bright cells and the greatest percentage of CD5dim cells compared 
with the control cows.  It is significant that clinical cows expressed a greater percentage of 
CD5dim B-cells (21.8% ± 3.6 in control cows vs. 33.4% ± 4.2 in clinical cows) because these 
cells are capable of producing the Th2 cytokine, IL-10 (Gieni et al., 1997).  It has been 
identified that the IL-10 produced by CD5+ B-cells acts directly on macrophages to decrease 
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IL-12 secretion (Sun et al., 2005).  The transition from the subclinical to the clinical stage of 
Johne’s disease is characterized by a switch from Th1- to Th2–mediated immune responses.  
The ability of MAP to modulate the expression of IL-10 is critical in the pathogenesis of 
Johne’s disease.  Interleukin-10 is capable of down-regulating macrophage and natural killer 
cell function, lowering the overall ability of T cells to proliferate, and suppressing cell-
mediated immunity.  Previous work has shown that proliferation of CD5+ B-cells is inhibited 
by IL-12 and enhanced by IL-5, another Th2 cytokine (Vogel et al., 1996).  On the basis of 
our data, we hypothesize that the increased percentages of CD5+dim B-cells by clinical 
Johne’s cows directly inhibits cell-mediated immune responses by altering the cytokine 
microenvironment in favor of a Th2 response. 
The results from this study contribute to the limited available information that focuses 
on the impact periparturient immunosuppression may have on the ability of the host to 
respond to progressing MAP infection.  Stress induced by parturition has a major impact on 
the number of T- and B-cells in the peripheral blood.  Our data clearly supports an interaction 
of parturition and infection status on these lymphocyte subsets.  This interaction is best 
illustrated by the upregulation of CD4+ in clinically infected cows and an increase in CD8+ in 
subclinically infected cows at parturition.  In these animals, these lymphocyte subsets are 
responding to the bacteria in an attempt to contain and limit the MAP-infection.  Altering 
changes in lymphocyte immune responses may be one mechanism to assist the infected dairy 
cow in attempting to manage the highly stressful periparturient period. 
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CONCLUSIONS 
Results of this study indicate that in dairy cows the percentages of both lymphocyte 
subsets and mononuclear cells are modulated by natural infection with MAP and by the 
periparturient period.  In addition, these factors are capable of influencing expression of the 
activation marker, CD5, on T cell subpopulations and B cells.  The data presented are 
important because they highlight changes in the immune response of infected cattle at 
parturition that may be an attempt to limit the progression of Johne’s disease during the 
highly stressful time of parturition. 
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Table 1. Primary antibodies1 
Antigen                 MAb clone              Isotype              Working MAb          Specificity 
                                                                                        Concentration2 
                                                                                            (μg/mL) 
CD4                      GC50A1                    IgM                          14                T-Helper cell 
CD5                      B29a                          IgG2a                         7              Activation Marker 
CD8                      BAQ111A                 IgM                          14                 T-cytotoxic/ 
                                                                                                                      suppressor cell 
CD14                    CAM36A                   IgG1                         14                 Monocytes/   
                                              Macrophages 
N12                      CACT61A                  IgM                          14                 γδ-cell receptor 
B lymphocyte       BAQ155A                  IgG1                          7                  Total B cell 
1 VMRD Inc. (Pullman, WA) 
2 Diluted in PBS with 1% fetal calf serum and 0.04% sodium azide
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Table 2. CD4:CD8 ratios across the periparturient period for freshly cultured peripheral blood mononuclear cells isolated from 
healthy cows, subclinical, and clinical cows naturally infected with MAP. 
                                                                      Days Relative to Calving_____________________              
Infection Status        -21             -14            -7            +1            +7            +14            +21            +28  
Control                 4.03±0.7a      3.32±1.1    2.41±1.0   2.03±0.6a   2.58±1.0a    2.21±0.2a     1.11±0.6     2.34±0.4 
Subclinical           1.93±0.4b      2.18±0.4    2.42±0.5   1.78±0.4a   1.61±0.6a    1.22±0.2a     1.52±0.4     1.45±0.4 
Clinical                 1.97±1.8ab     3.43±1.4    3.20±1.3   6.08±1.3b   4.78±1.5b    5.49±0.1b     2.98±0.9     2.52±1.1 
Subscripts indicate differences between infection groups within a given time point (P < 0.05). 
Infection group, P <0.03 
DRTC, P <0.11 
Infection group X DRTC, P <0.05 
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Table 3. Percentage of CD5bright cells in CD4, CD8, γδ T-cell, and B-cell populations after 8 days in culture.  Cells were PBMCs 
isolated from healthy, subclinical, and clinical dairy cows naturally infected with MAP. 
          
 Infection Status -21 -14 -7 +1 +7 +14 +21 +28 
CD4+ Control 53.03±10.4 45.82±10.9 60.76±8.8a 39.84±7.6 40.00±9.1 31.30±7.0 47.60±3.1 24.52±5.3 
 Subclinical 34.07±6.3 38.76±6.0 35.23±6.7b 40.52±6.0 47.63±9.3 36.88±8.4 47.78±6.7 41.98±5.7 
 Clinical 57.45±33.8 47.70±17.1 33.30±12.4ab 50.50±16.39 39.90±10.4 29.40±0.6 58.40±17.1 33.60±22.1 
          
CD8+1 Control 34.11±15.5 29.16±7.9 45.52±10.1 41.02±12.4 29.10±10.3 27..66±7.2 40.82±6.9 26.12±5.6 
 Subclinical 32.00±5.3 30.06±6.2 31.52±5.3 31.32±6.6 42.37±9.9 21.89±4.9 36.13±7.4 21.63±4.7 
 Clinical 49.96±19.6 34.37±8.7 47.73±14.8 55.70±16.1 32.63±10.4 15.90±0.4 27.03±7.1 16.65±4.2 
          
γδ TCR2 Control 33.78±10.1 47.20±10.9 56.82±12.5a 21.97±5.6ab 33.05±8.1 46.78±9.9a 52.60±11.9a 37.03±1.4 
 Subclinical 16.77±3.7 27.24±6.8 23.74±6.1b 12.69±3.2a 13.98±3.1 14.24±3.4b 22.71±5.7b 15.39±2.2 
 Clinical 27.23±15.5 27.55±8.9 30.94±9.3b 35.77±12.7b 23.03±6.8 16.74±11.8ab 21.45±9.3b 23.30±7.0 
          
B-cells4 Control 39.20±10.4 25.30±3.6 49.80±6.9a 37.82±5.0 37.20±7.9 33.98±8.9 33.57±7.8 24.64±4.8 
 Subclinical 28.01±4.2 24.16±5.4 24.64±4.0b 29.38±3.8 40.11±6.3 30.90±5.9 36.64±8.6 31.33±7.0 
 Clinical 54.15±21.6 32.88±12.9 37.38±13.9b 16.17±7.3 28.21±11.8 17.20±1.8 37.30±10.2 27.50±8.0 
Superscripts indicate differences between infection groups within a given time point (P < 0.05). 
1
 Day relative to calving effect: P < 0.07 
2
 Infection group: P < 0.01 
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Cell Type Infection Status -21 -14 -7 +1 +7 +14 +21 +28 
CD4+1 Control 32.30±9.7ab 18.22±7.6 24.70±7.4 30.12±13.4 16.12±5.7a 23.91±8.3ab 41.46±10.7 23.40±9.2 
 Subclinical 16.42±4.2a 29.77±4.9 30.60±5.8 40.85±8.2 46.3±6.0b 42.03±6.5a 42.06±5.9 39.34±4.8 
 Clinical 54.00±21.0b 34.0±10.5 28.38±11.5 21.31±6.1 34.10±6.9ab 12.45±4.9b 39.53±16.5 31.78±26.3 
          
CD8+2 Control 8.96±0.4a 10.63±2.2 15.68±4.9 13.44±3.6a 17.17±5.5a 27.47±11.4 44.92±9.1 16.57±3.7 
 Subclinical 15.70±1.8a 22.22±4.9 20.59±4.3 30.66±7.1ab 28.89±6.0ab 34.74±6.4 34.88±6.3 34.48±1.0 
 Clinical 32.23±4.8b 24.92±8.2 20.48±4.9 25.47±3.1b 43.33±13.2b 17.12±6.3 28.67±4.9 8.09±2.6 
          
γδ TCR3 Control 39.77±5.8a 19.42±2.4 21.73±3.4 19.31±4.4 9.23±2.9a 26.18±3.8a 39.72±5.1a 14.01±5.9 
 Subclinical 13.74±2.2b 29.29±4.9 20.19±2.7 11.75±3.5 9.11±1.8a 11.12±1.7b 22.29±4.8b 23.44±5.1 
 Clinical 21.30±6.4b 22.22±8.7 23.60±10.9 22.61±8.3 24.13±5.0b 12.06±1.2ab 25.17±5.2ab 13.25±2.9 
          
B-cells4 Control 19.43±8.1 9.32±4.3 11.96±3.9 18.47±7.7ab 11.04±2.3 21.66±5.4 29.41±8.0ab 25.26±4.5 
 Subclinical 20.01±4.5 11.98±2.8 16.87±3.7 24.06±4.6a 24.01±2.6 24.41±2.6 24.27±4.3a 25.36±2.8 
 Clinical 23.60±10.6 14.37±7.0 15.15±3.9 7.67±2.59b 14.80±5.4 9.97±2.8 18.70±4.8b 15.0± ― 
Table 4. Percentage of CD5dim cells in CD4, CD8, γδ T-cell, and B-cell populations after 8 days in culture. Cells were PBMCs 
isolated from healthy, subclinical, and clinical dairy cows naturally infected with MAP. 
Superscripts indicate differences between infection groups within a given time point (P < 0.05). 
 
1
 Infection group x day relative to calving effect: P < 0.09 
2
 Day relative to calving effect: P < 0.003; Infection group x day relative to calving effect: P < 0.02 
3 Day relative to calving effect: P < 0.01; Infection group x day relative to calving effect: P < 0.004 
4 Day relative to calving effect: P < 0.09 
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Figure 1. Percentage of positive mononuclear cells from fresh PBMCs isolated from control 
(♦), subclinical (■), and clinical (▲) periparturient dairy cows.  A) CD4+ T-cells. There was 
a day relative to calving (DRTC) (P <0.05) and interaction of infection group and DRTC (P 
< 0.01).  B) CD8+ T-cells. Subclinical cows expressed a greater percentage compared with 
the control and clinical cows (P < 0.05).  There was a DRTC and interaction of infection 
group and DRTC effect (P < 0.01).  C) γδ T-cells. Clinical cows expressed a lower 
percentage compared with control (P < 0.06) and subclinical (P < 0.01) cows.  Data are least 
square means ± SEM.  Significant differences between infection groups on a given day are 
represented by asterisks (P < 0.05).   
 
Figure 2. Percentage of positive mononuclear cells from fresh PBMCs isolated from control 
(♦), subclinical (■), and clinical (▲) periparturient dairy cows.  A) B-cells  B) CD14+ cells. 
There was a tendency for interaction of infection group and day relative to calving (P < 
0.12).  Data are least square means ± SEM.  Significant differences between infection groups 
on a given day are represented by asterisks (P < 0.05).   
 
Figure 3.  Percentage of mononuclear from 8 d infected PBMCs isolated from control (♦), 
subclinical (■), and clinical (▲) periparturient dairy cows.  There was an interaction of 
infection group and day relative to calving (P < 0.10).  There was a DRTC effect for clinical 
cows (P < 0.05).  Data are least square means ± SEM.  Significant differences between 
infection groups on a given day are represented by asterisks (P < 0.05).   
 
Figure 4. Percentage of positive CD4+ T-cells from 8 d PBMCs isolated from control (♦), 
subclinical (■), and clinical (▲) periparturient dairy cows.  A) Control cells. There was a 
trend for an interaction between infection group and DRTC (P < 0.09). B) Infected cells. 
There was an interaction between infection group and DRTC (P < 0.01).  Data are least 
square means ± SEM.  Significant differences between infection groups on a given day are 
represented by asterisks (P < 0.05).   
 
Figure 5. Percentage of positive CD8 T-cells from 8 d control PBMCs isolated from control 
(♦), subclinical (■), and clinical (▲) periparturient dairy cows.  There was a day relative to 
calving effect (P < 0.05). Data are least square means ± SEM.  Significant differences 
between infection groups on a given day are represented by asterisks (P < 0.05).   
 
Figure 6. Percentage of positive CD14 cells from 8 d control PBMCs isolated from control 
(♦), subclinical (■), and clinical (▲) periparturient dairy cows.  Clinical cows expressed a 
greater percentage compared with subclinical cows (P < 0.05).  Data are least square means ± 
SEM.  Significant differences between infection groups on a given day are represented by 
asterisks (P < 0.05).   
 
Figure 7. Percentage of CD5bright T-cells within lymphocyte subsets from fresh PBMCs 
isolated from control (♦), subclinical (■), and clinical (▲) periparturient dairy cows. A) 
 
 
 130
 
 
CD4+ T-cells. Clinical cows expressed a smaller percentage compared with control cows (P 
< 0.01). B) CD8+ T-cells. Clinical cows expressed a smaller percentage compared with 
control cows (P < 0.05).  There was a tendency for a DRTC effect (P < 0.08). C) γδ T-cells. 
Subclinical cows expressed a lower percentage than the control cows (P < 0.05). D) B-cells. 
Data are least square means ± SEM.  Significant differences between infection groups on a 
given day are represented by asterisks (P < 0.05).   
 
Figure 8.  Percentage of CD5dim T-cells within lymphocyte subsets from fresh PBMCs 
isolated from control (♦), subclinical (■), and clinical (▲) periparturient dairy cows. A) 
CD4+ T-cells. Clinical cows expressed a greater percentage compared with control cows (P 
<0.05).  B) CD8+ T-cells. Clinical cows expressed a greater percentage compared with 
controls (P <0.01) and subclinical (P <0.06) cows.  C) γδ T-cells. During postpartum period, 
subclinical and clinical cows had greater percentage compared with controls (P < 0.05). D) 
B-cells. Clinical cows had greater percentage compared with controls (P < 0.05). Data are 
least square means ± SEM.  Significant differences between infection groups on a given day 
are represented by asterisks (P < 0.05). 
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Figure 2. 
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Figure 3. 
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Figure 4. 
A. 
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Figure 5. 
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Figure 6. 
 
 
0
10
20
30
40
50
60
70
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
C
D
14
 P
os
iti
ve
 C
el
ls
 (%
) *
C
D
14
 P
os
iti
ve
 C
el
ls
 (%
)
♦ Control      ■ Subclinical      ▲ Clinical 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 137
 
 
0
20
40
60
80
100
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
C
D
4+
/C
D
5b
ri
gh
t  C
el
ls
 (%
)
**** *
C
D
4+
/C
D
5b
ri
gh
t  C
el
ls
 (%
)
♦ Control      ■ Subclinical      ▲ Clinical Figure 7.  
A. 
 
 
 
 
 
 
 
 
 
 
B. 
0
10
20
30
40
50
60
70
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
C
D
8+
/C
D
5b
ri
gh
t  C
el
ls
 (%
)
** * ** *
C
D
8+
/C
D
5b
ri
gh
t  C
el
ls
 (%
) 
 
 
 
 
 
 
 
 
 
 
C. 
0
20
40
60
80
100
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
γδ−
TC
R
/C
D
5b
ri
gh
t  C
el
ls
 (%
)
** **
γδ−
TC
R
/C
D
5b
ri
gh
t  C
el
ls
 (%
) 
 
 
 
 
 
 
 
 
 
D. 
0
10
20
30
40
50
60
70
80
-28 -21 -14 -7 0 7 14 21 28 35
B
-c
el
l/C
D
5b
ri
gh
t  C
el
ls
 (%
) ****
Days Relative to Calving
B
-c
el
l/C
D
5b
ri
gh
t  C
el
ls
 (%
) 
 
 
 
 
 
 
 138
 
 
0
10
20
30
40
50
60
70
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
C
D
4+
/C
D
5d
im
 C
el
ls
 (%
)
*
* *
*
C
D
4+
/C
D
5d
im
 C
el
ls
 (%
)
♦ Control      ■ Subclinical      ▲ Clinical Figure 8. 
A.  
 
 
 
 
 
 
 
 
 
 
B. 
0
10
20
30
40
50
60
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
C
D
8+
/C
D
5d
im
 C
el
ls
 (%
)
*
* *
C
D
8+
/C
D
5d
im
 C
el
ls
 (%
) 
 
 
 
 
 
 
 
 
 
C. 
0
10
20
30
40
50
60
70
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
B
-c
el
l/C
D
5d
im
 C
el
ls
 (%
)
0
10
20
30
40
50
60
70
-28 -21 -14 -7 0 7 14 21 28 35
Days Relative to Calving
γδ
-T
C
R
/C
D
5d
im
 C
el
ls
 (%
) 
* *
γδ
-T
C
R
/C
D
5d
im
 C
el
ls
 (%
)  
 
 
 
 
 
 
 
 
 
D. 
 
 
 
 
 
 
 
 
 139
 
 
CHAPTER FOUR 
 
OSTEOPONTIN EXPRESSION IN PERIPARTURIENT DAIRY COWS 
NATURALLY INFECTED WITH MYCOBACTERIUM AVIUM SUBSP. 
PARAUBERCULOSIS 
 
A paper to be submitted to Infection and Immunity 
 
E.L. Karcher1,3, D. Bayles2, J.P. Bannantine2, D.C. Beitz1, J.R. Stabel2,4 
 
 
ABSTRACT 
Osteopontin (Opn), a highly acidic glycoprotein, is an important mediator of the cell-
mediated immune response and is an enhancer of the host immune response against 
mycobacterial infections.  Infections caused by the intracellular bacteria, Mycobacterium 
avium subsp. paratuberculosis (MAP), have a devastating impact on the dairy industry.  We 
sought to characterize Opn at both the level of gene and protein expression in periparturient 
dairy cows naturally infected with MAP.  Peripheral blood mononuclear cells (PBMCs) were 
isolated from control, subclinical, and clinical periparturient dairy cows naturally infected 
with MAP beginning 3 wks pre- to 5 wks post-calving and incubated with or without 
concanavalin A (ConA) or a whole-cell sonicate of MAP (MPS).  Real-time PCR was 
performed to evaluate expression of Opn and classical Th1 and Th2 cytokines.  Results 
demonstrated greater Opn expression in nonstimulated PBMCs isolated from subclinical 
cows compared with control and clinical cows.  For clinical cows, there was a strong 
1Department of Animal Science, Iowa State University, Ames, IA  50010. 
2USDA-ARS, National Animal Disease Center, Ames, IA  50010. 
3Primary Researcher and author. 
4Author for correspondence. 
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correlation between Opn expression and expression of the Th1 cytokines, IFN-γ and IL-1α 
for non stimulated PBMCs, and IFN-γ and IL-12 for PBMCs stimulated with MPS.  
Expression of TNF-α was greater in clinical cows than in cows of the other groups.  In 
support of a Th1/Th2 dichotomy, NS, ConA, and MPS-stimulated PBMCs from subclinically 
infected cows secreted more IFN-γ and MPS-stimulated PBMCs from clinically infected 
cows secreted more IL-4 compared with those of the other groups.  Immunoblot analysis of 
PBMCs detected four Opn proteins at 60, 52, 34, and 27 kDa.  There was an interaction of 
infection group and parturition.  Protein abundance increased at calving for subclinical and 
control cows. This is the first study to evaluate the role of Opn on the immune response of 
dairy cows naturally infected with MAP.  Results of this study suggest Opn may be a key 
regulator against MAP infection. 
 
Key Words: Osteopontin, Periparturient, Mycobacterium avium subsp. paratuberculosis 
 
 
 
INTRODUCTION 
  The causative agent of Johne’s disease (JD) in ruminant animals is Mycobacterium 
avium subsp. paratuberculosis (MAP).  Dairy cows generally are infected as neonates by the 
ingestion of feed or water contaminated with the organism.  Once they are infected animals 
may remain in the subclinical or asymptomatic stage of the disease until a period of stress, 
such as parturition, occurs.  Advancement to the clinical stage of the disease is characterized 
by fecal shedding of the bacteria, severe weight loss, and intermittent diarrhea.  There are no 
known cures for JD and often the animal will succumb to the infection. 
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 Osteopontin (Opn) is a highly acidic glycoprotein that is produced by both immune 
and non-immune cells, such as osteoclasts, smooth muscle cells, and epithelial cells 
(Denhardt and Guo, 1993).  The primary immune sources of Opn are activated macrophages 
(Atkins et al, 1998), activated T cells (Ashkar et al., 2000), and dendritic cells (Kawamura et 
al. 2005).  Osteopontin also is secreted from activated, but not resting, natural killer cells 
(Pollack et al., 1994), and it is an important mediator of the cell-mediated, or Th1, immune 
response. Osteopontin induces T cell chemotaxis and costimulates T cell proliferation 
(O’Regan et al., 2000). Stimulating murine macrophages with Opn resulted in the production 
of proinflammatory cytokines, IL-12 and TNF-α (Weber et al., 2002).  In addition, when 
human gut-derived T-cells were stimulated with bovine Opn and CD3 antibody, there was a 
dose-dependent increase in the secretion of interferon gamma (IFN-γ) and tumor necrosis 
factor (TNF)-α (Agnholt et al., 2007). In addition to its effects on T-cells, Opn stimulates 
IgM and IgG production from B-cells (Lampe et al., 1991).   
 The role of Opn in mycobacterial infection is of interest because of its reported ability 
to upregulate and promote Th1 cytokines.  When Opn knock-out mice were challenged with 
M. bovis Bacillus Calmette-Guerin, they had more severe infection, heavier bacterial loads, 
and greater granuloma burdens compared with the wild-type mice (Nau et al., 1999).  
Infecting human alveolar macrophages with M. tuberculosis caused an upregulation of Opn 
expression (Nau et al., 1997).  Furthermore, a positive correlation has been noted between the 
amount of Opn in tissues and disease severity in patients with mycobacterial infections (Nau 
et al., 2000).  Patients suffering from nontuberculous mycobacterial infections with high Opn 
protein concentrations in the lymph nodes recovered faster than did those patients with lower 
Opn concentrations (Nau et al., 2000).  
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 The ability of Opn to promote a Th1 immune response and increase resistance to 
mycobacterial infections identified it as a cytokine of interest in the study of MAP infection 
in cattle.  An effective Th1 response to MAP infection is critical for controlling the initial 
stages of the disease.  Subclinical JD cows produce greater amounts of IFN-γ and TNF-α 
than do clinical cows (Stabel, 2000).  The transition from the subclinical to clinical stage of 
disease coincides with a shift from Th1 to Th2-mediated host responses.  Production of Th2 
cytokines supports a humoral immune response by stimulating the proliferation of B 
lymphocytes and inhibiting Th1 cytokines.  Both IL-10 and TGF-β are upregulated in clinical 
MAP-infected cows (Khalifeh and Stabel, 2004b).   
 To date, there are no reports in the literature of Opn expression in dairy cows infected 
with MAP.  Based on this observation, and the critical role of Opn in controlling other 
mycobacterial infections, the objective of this study was to characterize Opn at both the level 
of gene and protein expression in periparturient dairy cows naturally infected with MAP.  In 
addition, the expression and secretion of other key Th1 and Th2 cytokines was performed 
during this time period and correlated with Opn results.   
 
MATERIALS AND METHODS 
Animals 
 Twenty-five multiparous Holstein cows were grouped according to infection status.  
These 3 groups consisted of 8 noninfected healthy cows, 10 cows naturally infected with 
MAP, but asymptomatic, and 7 naturally infected cows with clinical JD.  The stage of 
infection was determined by fecal shedding of MAP, IFN-γ secretion, and specific antibody 
response to MAP.  Infection was monitored by bacteriologic culture for the fecal shedding of 
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MAP by standard methods (Stabel, 1997).  By definition, clinical animals were shedding 
more than 100 CFU/tube (BBL™ Herrold’s Egg Yolk Agar Slants with mycobactin J, 
amphotericin, nalidixic acid, and vancomycin; Becton, Dickinson and Co., Sparks, MD) and 
presented with weight loss and intermittent diarrhea. Subclinically infected cows were 
shedding less than 10 CFU/tube and were asymptomatic. The noninfected control cows were 
characterized by repeated negative fecal cultures performed quarterly over a 3- to 5-yr period 
and had been purchased from herds with no recent history of Johne’s disease. In addition, 
these animals were negative on any serologic assays (i.e., production of antibody specific for 
MAP and IFN- ) performed during that period. All procedures performed on the animals 
were approved by the Institutional Animal Care and Use Committee (National Animal 
Disease Center [NADC], Ames, IA). 
 
Blood Collection, Culture Conditions, and Sample Collection 
Blood was collected from the jugular vein in 2x acid-citrate-dextrose (ACD; 1:10).  
For each animal, blood was collected at -21, -14, -7, +1, +7, +14, +21, +28, and +35 days 
relative to calving (DRTC).  Peripheral blood mononuclear cells (PBMCs) were isolated 
from the buffy coat fractions of peripheral blood.  PBMCs were resuspended in RPMI-1640 
(Gibco, Grand Island, NY) with 10% fetal calf serum (Atlanta Biologics, Atlanta, GA), 100 
U of penicillin G sodium per mL100 μg of streptomycin sulfate per mL, 0.25 μg of 
amphotericin B per mL, and 2 mM L-glutamine (Gibco, Grand Island, NY).  Cells were 
cultured at 1.4 x 106/mL in 48-well flat-bottomed plates (Corning, Corning, NY) with either 
medium alone (nonstimulated, NS), with concanavalin A (ConA; 10 μg/mL) or with MAP 
whole cell sonicate (MPS;10 μg/mL) added to designated wells.  Plates were incubated for 24 
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h at 39°C in 5% CO2 in a humidified atmosphere.  After 24 h, plates were centrifuged at 400 
x g for 5 min.  Supernatants were removed without disturbing the cells in culture and stored 
at -20°C prior to cytokine measurement. 
 
Bacteria 
M. avium subsp. paratuberculosis strain K-10 (NADC) was grown in Middlebrook 
7H9 broth (pH 6.0) supplemented with mycobactin J (2 mg/L; Allied Monitor, Fayette, MO) 
and oleic acid-albumin-dextrose complex (Becton Dickinson Microbiology, San Jose, CA).  
The bacteria were harvested, washed 3 times with PBS (137 mM sodium chloride, 10 mM 
phosphate, 2.7 mM potassium chloride; pH 7.4), and sonicated on ice for 10 min.  After 
incubating at RT for 10 min, the bacteria was sonicated for an additional 10 min and then 
centrifuged at 2500 x g for 20 min.  Supernantant was removed and absorbance was read at 
540 nm.  Bacterial stocks (109/mL) were frozen in PBS at -80°C until used in the 
experiments.   
 
RNA Extraction and RT-PCR 
Peripheral blood mononuclear cells from each of the sampling time points were 
resuspended in RPMI 1640 (Gibco, Grand Island, NY) containing 10% fetal calf serum.  
PBMCs from each cow at each sampling time point were split into two aliquots: one aliquot 
that was cultured with medium alone (NS) and one that was stimulated with MPS (10 
μg/mL).  Cells were cultured in 75-cm2 flasks at a concentration of 1 x 107 PBMCs per flask 
at 39°C in 5% CO2 in a humidified atmosphere for 24 h.  RNA was extracted from NS and 
MPS-stimulated PBMCs by using the standard protocol for Trizol Reagent (Invitrogen Life 
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Technologies Corp., Carlsbad, CA).  All RNA samples were purified by using the RNeasy® 
Mini Kit Protocol for RNA Cleanup (Qiagen, Valencia, CA).  Samples were treated with 
TURBO DNA-free (Ambion, Austin, TX).  The quantity of total RNA was determined by 
UV spectrophotometry.  RNA samples were frozen at -80°C until converted to cDNA. 
Real time RT-PCR was performed by using an Applied Biosystems 7500 DNA 
sequence detection system (Perkin-Elmer Corp., Foster City, CA).  Total RNA extracted 
from both NS and MPS-stimulated cells was converted to first strand cDNA.  Briefly, 2 µg of 
total RNA was added to 12-µL reaction mixture consisting of 10 mM oligo(dT)12-18 primer 
(Invitrogen, Carlsbad, CA) and RNase-free water.  The reaction mixture was incubated at 
70°C for 5 min and then chilled quickly on ice to 20°C.  To the reaction mixture, 4 µL of 5x 
First Strand Buffer (Invitrogen, Carlsbad, CA), 2 µL of 10 mM dNTP Mix (Invitrogen, 
Carlsbad, CA), 1 µL of 0.1 M dithiothreitol (Invitrogen, Carlsbad CA), and 2 U 
SuperScript™ RNase H-Reverse Transcriptase (Invitrogen, Carlsbad CA) were added for a 
total volume of 20 µL.  The reaction mixture was incubated at 42°C for 1 h, heated to 70°C 
for 15 min, and then cooled to 37°C.  Two units of DNase-free RNase H (Invitrogen, 
Carlsbad, CA) were added to the mixture that then was incubated at 37°C for 20 min to 
remove the original RNA template.  The RNase H was inactivated by heating the reaction 
mixture at 70°C for 10 min.  All cDNA samples were stored at -80°C until RT-PCR analyses 
were performed. 
For RT-PCR analysis, SYBR Green PCR master mixture (Perkin-Elmer Corp., Foster 
City, CA), template cDNA, and gene-specific primers for Opn, IFN-γ, TNF-α, IL-1α, IL-
12p35, IL-4, IL-10, and β-actin were combined in a 20-µL reaction mixture.  Primer 
sequences are listed in Table 1.  All reactions were performed in triplicate.  The β-actin gene 
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was used as the control (for calculation of dCt).  RT-PCR data were analyzed by using the 
2−(dd )Ct  method as described previously (Livak and Schmittgen, 2001).  The +1 dCt value for 
each cow was used as the reference expression point. 
 
Measurement of IFN-γ, IL-10, TGF-β, and IL-4 production in cell culture supernatants by 
ELISA. 
Bovine IFN-γ was measured by using the Bovigam test kit (CSL Veterinary 
Laboratories, Parkville, Victoria, Australia) as described by the manufacturer.  The minimal 
sample concentration of IFN-γ that could be detected by using the kit was 0.39 ng/mL.  
Bovine IL-10 was quantified by coating MaxiSorp microtiter plates (Nunc, Rochester, 
N.Y.) with mouse anti-bovine IL-10 in coating buffer (15 mM sodium carbonate, 34 mM 
sodium bicarbonate, pH 9.6) (100 µL per well at 2 µg/mL) (MCA2110, Serotec, Raleigh, 
NC) overnight at RT.  Plates were washed 5 times with PBS containing 1% Tween 80 
(washing buffer).  The samples and serial 2-fold dilutions of bovine IL-10 standard (0.3125-
20 ng/mL) (generous gift from Dr. Jayne Hope, Compton, UK) were added to duplicate wells 
and incubated at RT for 1 h.  Plates then were washed 5 times with washing buffer before 
incubating with the detection antibody, mouse anti-bovine IL-10:biotin (MCA2111B, 
Serotec, Raleigh, NC).  Plates were washed 5 times with washing buffer, 100 µL of avidin-
HRP conjugate (diluted 1:800) (PharMingen, San Diego, CA) were added to each well, and 
the plates were incubated for 45 min at RT.  After another wash cycle, plates were incubated 
with substrate solution (40 mM ABTS [2, 2’-azino-di-ethylbenzthiozoline-6-sulfonic acid] in 
citrate buffer (50 mM, pH 4.0) and H2O2 (30% solution as 1:30 dilution).  Color development 
was quantified after 30 min by measuring absorbance at 405 nm with a Wallac Victor 1420 
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multilabel counter ELISA plate reader (Perkin-Elmer, Gaithersburg, MD).  The minimal 
sample concentration of IL-10 that could be detected by using the kit was 0.3125 units. 
Bovine TGF-β was quantified by using the Quantikine® Human TGF-β1 
Immunoassay kit as described by the manufacturer and by using standards supplied (R&D 
Systems, Inc, Minneapolis, MN).  Previous studies have utilized anti-bovine TGF-β1 
antibodies to detect bovine TGF-β activity (Ginjala and Pakkanen, 1998; Khalifeh and 
Stabel, 2004a).  Significant concentrations of latent TGF-β1 are found in bovine cell culture 
supernatants.  Latent TGF-β was activated by the addition of 1 N HCl followed by 10 min of 
incubation.  The samples were neutralized by the addition of 1.2 N NaOH/0.5 M HEPES.   
The concentration determined by the standard curve was multiplied by the dilution factor 1.4 
to account for the activation procedure.  Because of the high cost of the kit and large number 
of samples in this study, only NS and MPS-stimulated cell culture supernatants were 
evaluated at -21, -14, -7, +1, +7,+14, and +21 DRTC for this assay.  The minimal sample 
concentration of TGF-β that could be detected by using the kit was 31.2 pg/mL.  Bovine IL-4 
was measured by using Bovine IL-4 Screen Set as described by the manufacturer and using 
standards supplied (Endogen, Rockford, IL).  
 
Protein Extraction and Immunoblots 
     Peripheral blood mononuclear cells were isolated from whole blood and stored at –
80°C freezer until protein extraction.  At time of extraction, PBMC cell pellet was thawed on 
ice and 1 mL of protein extraction buffer (Tris·EDTA (pH, 8.0), 50 mM KCl, 1 mg of 
Protease Inhibitor Cocktail/mL (Sigma, St. Louis, MO)) was added. The sample then was 
sonicated at 25W for 30 s with a Tekmar sonic disturber (Lorton, Va.) and incubated on ice 
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for 10 min.  Sample then was centrifuged at 2500 x g for 20 min at 4°C and supernatant 
transferred to 1.5 mL microcentrifuge tube.  Protein was quantified by using the BCA Protein 
Assay Reagent Kit (Pierce, Rockford, IL). 
     Protein samples were incubated at 95°C for 5 min and separated (16 µg of protein per 
lane) by 4-20% SDS polyacrylamide gel electrophoresis (Laemmli, 1970). The separated 
proteins were electrotransferred to 0.45-µm pure nitrocellulose membrane.  For analysis of 
Opn and β-actin proteins, the membrane was blocked by overnight incubation in PBS plus 
2% bovine serum albumin (BSA) and 0.1% Tween 20 (PBS-BSA). The membrane then was 
incubated at RT for 2 h in PBS-BSA containing a polyclonal anti-mouse Opn (1:2500 
dilution; Cosmo Bio Co., LTD, Tokyo) antibody.  After three washes in PBS plus 0.1% 
Tween 20, blots were incubated for 1.5 h in protein A-peroxidase (1:20,000 dilution; Pierce 
Biotechnology Inc., Rockford, IL).  The blots again were washed 3x as described above and 
were developed for chemiluminescence by using Supersignal detection reagents (Pierce 
Biotechnology Inc., Rockford, IL).  The membranes were blotted gently, wrapped in plastic 
wrap, and exposed to x-ray film (Kodak X-Omat AR, Rochester, NY).  Membranes then 
were stripped by incubating in Restore Western Blot Blocking Stripping Buffer (Pierce 
Biotechnology, Rockford, IL) for 15 min at RT and then washing 3 x for 5 min each in 
PBST.  To insure the membrane had been stripped completely, the membrane was exposed to 
x-ray film (Kodak X-Omat AR, Rochester, NY).  Membranes then were blocked by 
overnight incubation in PBS plus 2% PBS-BSA and the following day re-probed for β-actin 
(1:2500 dilution; Imgenex, San Diego, CA). 
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Determination of Molecular Size and Relative Protein Abundance 
Digital images of the autoradiographic film from the immunoblots were scanned, and 
scanning densitometry was performed with the Kodak Digital Science 1-D Image Analysis 
Software (Eastman Kodak Co., Rochester, NY).  Relative molecular weights of Opn and β-
actin protein were calculated by regressing the distance of migration of the protein through 
the gel, against the relative molecular weights of known markers ranging from 20.9 to 101 
kDa (Prestained SDS-PAGE Standards, low range; BioRad, San Diego, CA). 
 
Statistical Analysis 
RT-PCR data were analyzed by using the 2-(ddCt) method as previously described 
(Livak and Schmittgen, 2001).  β-actin was used as the reference gene, and the dCt value at 
+1 d for each animal was used as the reference expression point.  Outliers were determined 
by the SAS/STAT PROC RobustReg software.  To evaluate the appropriateness of β-actin as 
a reference gene, the 2-(dCt) method was used as previously described (Schmittgen and 
Zakrajsek, 2000).  This test indicated that β-actin would serve as a suitable reference for both 
healthy and MAP-infected animals. 
Several 2-factor repeated measures analyses of variance were performed (one for 
each stimulation level-gene combination) comparing fold expression of the treatments 
through time. The model accounted for infection group, parturition, and the interaction of 
infection group and parturition.  Levene’s homogeneity of variance test was performed on 
data to determine transformation necessity.  All analyses were performed on transformed 
data where necessary, but raw data means are presented for ease of interpretation.  If a 
significant F-test value from the ANOVA was obtained at P ≤ 0.05, differences of least 
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squares means were used as the pairwise multiple comparison test for determining day or 
infection group x day differences. Means differed if P < 0.05 and tended to differ if 0.05 ≤ P 
≤ 0.15.  Analyses were performed by using PROC MIXED in SAS
®
 PC Windows Version 
9.1.3 software.  Pearson correlation coefficients were obtained by using the PROC CORR 
procedure of SAS. 
 
RESULTS 
Osteopontin Gene Expression 
 Overall, expression of Opn from NS PBMCs was greater (P < 0.05) in subclinically 
infected animals compared with control and clinical cows (Fig. 1A).  There was also a 
significant interaction of infection group and parturition (P < 0.01).   For the subclinical 
cows, Opn expression increased during the postpartum period and was significantly greater 
(P < 0.05) at +14, +28, and +35 d compared with +1 d.  Osteopontin expression in NS 
PBMCs was reduced 7.7-fold between -21 and +1 d (P <0.001) in control cows and 6.9-fold 
between -7 d and +1 d (P <0.01) in clinical cows. 
 When PBMCs were stimulated with MPS, there was an overall effect of infection 
group, with control cows expressing more Opn than subclinical (P < 0.001) and clinical (P < 
0.05) cows (Fig. 1B).  For subclinical cows, expression increased (P < 0.001) at calving and 
then declined during the postpartum period.  In contrast, a decline (P < 0.03) in Opn 
expression by MPS-stimulated PBMCs was observed for clinically infected cows as calving 
approached followed by an increase during the postpartum period. 
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Effect of Infection Status on Gene Expression 
 Overall, expression of the Th1 cytokines, IFN-γ, IL-12, IL-1α, for both NS and MPS-
stimulated PBMCs, was not affected by infection status of the cows.  The expression of TNF-
α by NS PBMCs was increased significanly in clinical cows (6.39 ± 1.2) compared with 
control (2.19 ± 1.0; P < 0.02) and subclinical cows (1.86 ± .9; P < 0.001) (Fig. 2A).  There 
was no effect of infection on TNF-α from MPS-stimulated PBMCs (Fig. 2B).  NS PBMCs 
from control cows tended (P < 0.10) to express more IL-1α compared with those from 
infected cows (Fig. 2C). In contrast, after stimulation with MPS there was a tendency (P < 
0.13) for PBMCs isolated from subclinical cows to express more IL-1α compared with those 
from control cows (Fig. 2D). 
 There was a lack of an overall effect of infection on the expression of Th2 cytokines, 
IL-4 and IL-10.  However, MPS-stimulated PBMCs from control cows expressed more IL-4 
than those from subclinical cows (P < 0.05) and tended to express more than those from 
clinical cows (P < 0.09) (Fig. 3A).  The expression of IL-10 from NS PBMCs tended to be 
greater (P < 0.10) for control cows compared with that of clinical cows (Fig 3B) whereas, 
MPS-stimulated PBMCs from subclinical cows expressed more (P < 0.05) IL-10 compared 
with those from clinical cows (Fig. 3C). 
 
Effect of Parturition on Gene Expression 
 There was no effect of parturition on expression of IL-12 or IL-1α for NS and MPS 
PBMCs.  There was an overall effect of parturition (P < 0.01) on the expression of IFN-γ 
from NS PBMCs (Fig. 4).  Expression by clinical cows declined (P < 0.01) from -7 d to +21 
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d with a brief rebound by +28 d (P <0.01).  Interferon expression by subclinical cows 
decreased (P < 0.06) from -7 d to +1 d.  There was also a significant effect of parturition (P < 
0.01) on expression of TNF-α by NS PBMCs (Fig. 2A).  Control cows experienced a decline 
(P < 0.05) in TNF-α expression during the last week of the prepartum period. Expression of 
TNF-α for NS PBMCs from clinical cows declined (P < 0.001) from -21 d to +21 d, with a 
rapid increase (P < 0.001) at +28 d.  Similarly, expression of TNF-α by MPS-stimulated 
PBMCs declined (P < 0.04) in clinical cows from -14 d to +1 d (Fig. 2B). 
 There was no overall effect of parturition on the expression of IL-4 or IL-10 by NS or 
MPS-stimulated PBMCs.  However, expression of IL-10 by NS PBMCs isolated from 
control cows declined (P < 0.02) from -21 d to +1 d and then increased (P < 0.02) to +35 d 
(Fig. 3B). 
 
Measurement of IFN-γ, IL-10, IL-4, and TGF-β production in cell culture supernatants by 
ELISA 
 Production of IFN-γ by NS (Fig. 5A) and ConA-stimulated (Fig. 5B) PBMCs tended 
to be greater (P < 0.08) in subclinical cows compared with the control cows.  Secretion by 
subclinical cows increased (P < 0.05) from -21 d to +7 d.  Production of IFN-γ by MPS-
stimulated PBMCs, was greater (P < 0.01) in subclinical cows compared with control cows 
and tended to be greater (P < 0.11) than clinical cows (Fig. 5C).  In subclinical cows, 
secretion increased (P < 0.002) from -7 d (1.24 ng/mL ±0.4) to +7 d postpartum (4.2 ng/mL 
± 2.2). 
 Interleukin-10 secretion by NS PBMCs was not affected by infection group or 
parturition (Fig. 6A).  However, subclinical cow secretion of IL-10 increased (P < 0.01) from 
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-21 d to +1 d and then declined (P < 0.02) to +7 d.  Secretion also increased (P < 0.04) for 
control cows from -14 d to +7 d returning to precalving levels in the postpartum period.  
When stimulated with ConA, secretion was greater (P < 0.003) in subclinical cows compared 
with controls and tended to be greater (P < 0.09) than that of clinical cows (Fig. 6B).  A 
significant effect of parturition (P < 0.03) also was observed.  Secretion of IL-10 in 
subclinical cows steadily increased (P < 0.0001) from -21 d (0.72 U± 0.2) to +35 d (3.87 U± 
0.9).  Production of IL-10 by MPS-stimulated PBMCs was greater (P < 0.04) in subclinical 
cows compared with controls (Fig. 6C).  There was also an effect of parturition with IL-10 
secretion from control (P < 0.04), subclinical (P < 0.001), and clinical (P < 0.05) cows 
increasing from -21 d to +14 d.   
 Interleukin-4 secretion by NS PBMCs tended to be greater (P < 0.11) in clinical cows 
compared with controls (Fig. 7A).  There was an infection by parturition interaction on IL-4 
secretion by PBMCs (P < 0.01).  Secretion by clinical cows increased (P < 0.03) from -21 d 
to +1 d.  When cells were stimulated with ConA, an interaction of infection group and 
parturition was observed (P < 0.03) (Fig. 7B).  Interleukin-4 secretion by MPS-stimulated 
PBMCs was greater in clinical cows compared with control (P < 0.004) and subclinical cows 
(P < 0.04) (Fig. 7C).  Secretion of IL-4 by clinical cows increased (P < 0.02) from -21 d to 
+7 d and control cow secretion increased (P < 0.04) from -14 d to +7 d. 
 Secretion of TGF-β by NS PBMCs was not affected by infection group (Fig. 8A), 
however, there was an affect of parturition (P < 0.01) and an overall infection group x  
parturition interaction (P < 0.03).  There was a tendency (P < 0.15) for subclinical (1793.2 ± 
35.3) and clinical (1795.7 ± 42.9) cows to have increased secretion compared with controls 
(1708.8 ± 38.8).  Secretion of TGF-β by PBMCs from subclinical cows increased (P < 
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0.0001) from +1 d to +21 d (1639.2 ± 73.8 vs. 1921.9 ± 75.2).  Secretion by PBMCS from 
clinical cows rapidly declined (P < 0.01) from -21 d to +1 d and then increased (P < 0.04) 
from +1 d to +21 d (P < 0.04).  Stimulation of PBMCs with ConA did not result in an overall 
effect of infection group or parturition on TGF-β secretion (Fig. 8B).   However, secretion 
from subclinical cows increased (P < 0.05) from -7 d to +1 d and then declined until +7 d.  
Secretion from clinical cows declined (P < 0.05) from -14 d to +14 d (1795.9 ± 99.3 vs. 
1590.4 ± 51.6).  Secretion of TGF-β by MPS-stimulated PBMCs was not affected by 
infection group or parturition (Fig. 8C). 
 
Osteopontin Protein Analysis 
 The immunoblotting procedure detected Opn protein bands at 24, 37, 50, and 62-kDa  
in the PBMC lysates of all animals (Fig. 9A).  Purified bovine milk Opn was used as a 
standard and is identified as a single band at 60 kDa.  The densities of the 24, 37, and 62-kDa 
proteins varied extensively between cows over the periparturient period and the variation did 
not seem to be related to infection group.  Densitometry software was unable to consistently 
detect these three proteins.  The 50-kDa protein was consistently the most intense of the four 
detected isomers.   Therefore, to determine the relative abundance of Opn total protein, the 
50-kDa band was analyzed.  Sample dates were grouped into precalving (-21 d, -14 d, and -7 
d), calving, and postcalving (+7 d, +14 d, +21 d, and +28 d).  Analysis of total Opn protein 
abundance by immunoblotting revealed an interaction of infection group and parturition (P < 
0.01) (Fig. 9B).  The protein abundance in PBMCs from control cows increased throughout 
the sampling period (P < 0.02).  PBMCs isolated from subclinical cows had an increase in 
protein abundance at calving and then declined during the postpartum period (P < 0.06). 
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DISCUSSION 
Osteopontin, also identified as early T cell activator-1, is a highly acidic glycoprotein 
that is produced by a number of cells in the immune system. Within the immune system, Opn 
is produced by activated macrophages (Atkins et al., 1998), activated CD4+ T-cells (Ashkar 
et al., 2000), and dendritic cells (Kawamura et al., 2005).  The ability of Opn to upregulate 
and promote pro-inflammatory cytokines in response to intracellular bacterial infections 
made it an interesting candidate to evaluate in MAP-infected dairy cows.  
Many calves will become infected with MAP during the first six months of life 
(Sweeney, 1996) through the fecal-oral route.  Once infected, the cow often remains in the 
subclinical, or asymptomatic, stage of the disease until a period of heightened stress occurs.  
The subclinical stage of paratuberculosis is characterized by a Th1- or cell-mediated immune 
response.  In the current study, there was an increase in Opn expression in subclinical cows 
compared with expression in control and clinical cows.  This result is important because an 
increase in Opn expression supports the Th1 host response typically observed in subclinically 
infected dairy cows.  Osteopontin enhances the production of other Th1 cytokines, including 
IL-12 and TNF-α (Ashkar et al., 2000; Weber et al., 2002).  IL-12 regulates the balance of 
Th1 and Th2 cells by promoting the differentiation of naïve T cells to Th1 cells.  
Surprisingly, IL-12 expression was not affected by either MAP infection or parturition in this 
study.  Previous reports have demonstrated that subclinical JD cows have greater expression 
and secretion of IFN-γ, another Th1 cytokine, compared with that of clinical cows (Stabel, 
2000; Khalifeh and Stabel, 2004).  Although IFN-γ expression was not affected by infection 
status in the present study, consistent with the literature subclinical cows secreted greater 
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quantities of IFN-γ compared with control and clinical cows.  Along with IFN-γ, TNF-α is 
involved in the early stages of mycobacterial infections by controlling bacterial proliferation 
(Appelberg, 1994).  Interestingly, in this study NS PBMCs from clinical cows expressed 
more TNF-α then the controls or subclinical animals.   
The importance of the relationship between Opn and the Th1 cytokines was further 
emphasized when assessing the Pearson correlation data.  Interesringly, significant 
correlations were observed only for the clinically infected cows.  In MPS-stimulated PBMCs 
isolated from clinical cows, the Pearson correlation coefficient for Opn and IFN-γ expression 
was 0.76 (P < 0.0001) and 0.50 for Opn and IL-12 expression (P < 0.004), whereas, in the 
NS PBMCs from clinical cows, the coefficient for Opn and IFN-γ expression was 0.53 (P < 
0.0003) and for Opn and IL-1α expression was 0.52 (P < 0.001).  The correlations presented 
here are important because they support a positive relationship between Opn and key Th1 
cytokines in MAP-infected cattle. 
Typically in MAP infection, as the disease progresses from a subclinical to a clinical 
stage there is a transition from the Th1 to Th2 immune response.  This transition has been 
documented by the upregulation of IL-10 and TGF-β in ileal tissues from clinical JD cows 
(Khalifeh and Stabel, 2004).  In addition, Coussens et al. (2004) reported decreased 
expression of IL-4 from PBMCs isolated from subclinical JD cows compared with clinical 
and control cows.  In the present study, the secretion of IL-4 by NS and MPS-stimulated 
PBMCs was greater in clinical cows compared with the control and subclinical cows.  This 
finding is consistent with the transition from a Th1 to Th2 response occurring in clinical JD 
cows.  TGF-β and Th2 cytokines work synergistically to inhibit the secretion of IFN-γ and 
the activation of macrophages.  However, Opn is capable of inhibiting the expression of Th2 
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cytokines.  Mice deficient in Opn expression had increased IL-10 production and decreased 
macrophage function (Ashkar et al., 2000).  In the current study, TGF-β secretion for both 
subclinical and clinical dairy cows rapidly increased at calving and continued to increase 
until +21 d.  This increase at calving in subclinical cows mirrored a decline in Opn 
expression.  This is the first study to report an interaction of the Th3 cytokine, TGF-β and 
Opn in dairy cattle.   
Published reports indicate that the expression and secretion of IFN-γ begins to decline 
as parturition approaches (Ishikawa et al., 1994; Shafer-Weaver et al., 1999). The decline in 
Opn as parturition approached further supports the classification of Opn as a Th1 cytokine.  
In late gestation, there is a shift in the CD4+ T-cell population supporting a Th2 response in 
healthy dairy cows (Shafer-Weaver et al., 1999).  In the present study, IL-10 secretion from 
all groups, regardless of infection status, increased during the last week of gestation.  
Furthermore, clinical cows showed increased expression of IL-4 from -21 d to +7 d post-
calving.  Together, these results support a Th2 response during the immediate prepartum and 
postpartum period.   
Despite a lack of studies evaluating the role of Opn in MAP infection, there are an 
extensive number of human and murine studies documenting interactions of other 
mycobacterial infections and Opn.  When Opn knock-out mice were challenged with 107 
CFU of M. bovis Bacillus Calmette-Guerin, the mutant mice had more severe infection, 
heavier bacterial loads, and greater granuloma burdens compared with the controls (Nau et 
al., 1999).  Another study utilizing Opn knock-out mice demonstrated a 95% and 90% 
decrease in IL-12 and IFN-γ secretion, respectively, compared with the wild-type controls 
(Ashkar et al., 2000).  These knock-out studies present convincing data that establish the 
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importance of Opn involvement in the immediate host immune response to mycobacterial 
challenges.  
This is the first study to report protein expression of Opn in PBMCs isolated from 
Holstein dairy cows.  We identified four isomers of the Opn protein at 24, 37, 50, and 62 
kDa.  The 50 kDa protein was dominant for all animals, but there was extensive cow-to-cow 
variation in the 24, 37, and 62 kDa isomers.  Multiple isomers of the Opn protein are not 
uncommon in tissues.  Three Opn isomers at 60, 40, and 22 kDa were identified in the 
testicular parenchyma of the bull reproductive tract (Erikson et al., 2007) and using an 
antibody to bovine milk Opn, Kimmins et al. (2004) identified Opn proteins at 70, 45, 34, 
and 24 kDa in cyclic bovine endometrium. It has been suggested that the lower molecular 
weight isomers (20-25 kDa) are part of the COOH-terminal portion of Opn (Zhang et al., 
1990).  The active form of Opn in bovine PBMCs is unknown, however, a 45 kDa Opn 
protein was detected in human monocyte/macrophages after treatment of cells with IFN-γ 
and LPS (Li et al., 2003). There is a subset of T-cells that secrete a 40 kDa Opn protein that 
is capable of activating B cells to produce immunoglobulins (Leibson et al., 1981).  
Osteopontin protein abundance by PBMCs from control cows increased throughout the 
sampling period.  Subclinical cows had an increase in Opn abundance at calving and then a 
decline in the postpartum period.  An increase in Opn at calving was not consistent with a 
decline in Th1 cytokines as parturition approached. 
 
CONCLUSIONS 
 This study presents the first known data examining Opn gene and protein expression 
in periparturient dairy cows naturally infected with MAP.  Results of this study indicate that 
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in dairy cows expression of Opn is modulated by natural infection with MAP and by the 
periparturient period.  Furthermore, the present study demonstrates for the first time the 
presence of Opn protein expression in PBMCs of healthy and MAP-infected dairy cows.  Our 
data suggest that Opn may be a key regulator in MAP infection. 
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Table 1. Primers used for RT-PCR of bovine cytokines 
Gene             Primer1      Sequence 
β-actin            F                CGCCATGGATGATGATATTGC 
β-actin            R                AAGCCGGCCTTGCACAT 
IFN-γ             F                 TGGAGGACTTCAAAAAGCTGATT 
IFN-γ             R                 TTTATGGCTTTGCGCTGGAT 
IL-1α              F                 TTGGTGCACATGGCAAGTG 
IL-1α              R                GCACAGTCAAGGCTATTTTTCCA 
IL-4            F                GCCACACGTGCTTGAACAAA        
IL-4                R                TGCTTGCCAAGCTGTTGAGA 
IL-10              F                GCCTTGTCGGAAATGATCCA 
IL-10              R                TCAGGCCCGTGGTTCTCA 
IL-12p35        F                CTTTCTTCAAATGCAGCATTGG 
IL-12p35        R                GGGTCTGGGTGATACAACGAA 
Opn                F                 ACAGCCAGGACGTCAACTCT 
Opn                R                GTGAGACTCGTCGGAATGGT 
TNF-α            F                 TCTACCAGGGAGGAGTCTTCCA                     
TNF-α            R                GTCCGGCAGGTTGATCTCA 
                1F, forward; R, reverse.  
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Figure 1. Osteopontin gene expression by peripheral blood mononuclear cells isolated from 
whole blood of control (♦), subclinical (■), and clinical (▲) periparturient dairy cows 
naturally infected with Mycobacterium avium subsp. paratuberculosis. A) NS PBMCs. 
(Infection group, P < 0.05; Infection group x Parturition, P < 0.05).  B) MPS PBMCs. 
(Infection group, P < 0.05).  Significant differences within an infection group on a given day 
relative to +1 d are represented by asterisks (P < 0.05).  
 
Figure 2.  Expression of Th1 cytokines by peripheral blood mononuclear cells isolated from 
whole blood of control (♦), subclinical (■), and clinical (▲) periparturient dairy cows 
naturally infected with Mycobacterium avium subsp. paratuberculosis. A) TNF-α NS 
PBMCs. (Infection group, P < 0.05; Parturition, P < 0.05).  B) TNF-α MPS PBMCs.  C) IL-
1α NS PBMCs.  D) IL-1α MPS PBMCs. Significant differences within an infection group on 
a given day relative to +1 d are represented by asterisks (P < 0.05). 
 
Figure 3. Expression of Th2 cytokines by peripheral blood mononuclear cells isolated from 
whole blood of control (♦), subclinical (■), and clinical (▲) periparturient dairy cows 
naturally infected with Mycobacterium avium subsp. paratuberculosis. A) IL-4 MPS 
PBMCs.   B) IL-10 NS PBMCs.  C) IL-10 MPS PBMCs. Significant differences within an 
infection group on a given day relative to +1 d are represented by asterisks (P < 0.05). 
 
Figure 4. Interferon gamma gene expression by no stim peripheral blood mononuclear cells 
isolated from whole blood of control (♦), subclinical (■), and clinical (▲) periparturient 
dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis.  
(Parturition, P < 0.01) Significant differences within an infection group on a given day 
relative to +1 d are represented by asterisks (P < 0.05). 
 
Figure 5. Interferon gamma secretion from peripheral blood mononuclear cells isolated from 
control (♦), subclinical (■), and clinical (▲) periparturient dairy cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis. Cells were incubated in RPMI for 24 hours. 
A) NS PBMCs.  B) ConA PBMCs.  C) MPS PBMCs.  Significant differences between 
infection groups on a given day represented by asterisks (P < 0.05).  
 
Figure 6. IL-10 secretion from peripheral blood mononuclear cells isolated from control (♦), 
subclinical (■), and clinical (▲) periparturient dairy cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis. Cells were incubated in RPMI for 24 hours. 
A) NS PBMCs. B) ConA PBMCs. Parturition, P < 0.003. C) MPS PBMCs. Parturition, P < 
0.002. Significant differences between infection groups on a given day represented by 
asterisks (P < 0.05).  
 
Figure 7. IL-4 secretion from peripheral blood mononuclear cells isolated from control (♦), 
subclinical (■), and clinical (▲) periparturient dairy cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis. Cells were incubated in RPMI for 24 hours. 
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A) NS PBMCs. (Infection group and Parturition interaction, P < 0.01)  B) ConA PBMCs. 
(Infection group and Parturition interaction, P < 0.03)  C) MPS PBMCs. (Infection group, P 
< 0.05; Parturition effect, P < 0.0002). Significant differences between infection groups on a 
given day represented by asterisks (P < 0.05). 
 
Figure 8. TGF-β secretion from peripheral blood mononuclear cells isolated from control 
(♦), subclinical (■), and clinical (▲) periparturient dairy cows naturally infected with 
Mycobacterium avium subsp. paratuberculosis. Cells were incubated in RPMI for 24 hours. 
A) NS PBMCs. (Parturition, P < 0.01; Infection group and Parturition interaction, P < 0.03) 
B) ConA PBMCs. C) MPS PBMCs. Significant differences between infection groups on a 
given day represented by asterisks (P < 0.05). 
 
Figure 9. Osteopontin protein expression in PBMCs from peripheral blood mononuclear 
cells isolated from whole blood of control (♦), subclinical (■), and clinical (▲) periparturient 
dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis. A) 
Detection of Osteopontin protein using Western Blot Analysis.  Picture is of a representative 
blot from one subclinically MAP-infected periparturient dairy cow across the sampling time 
period. B) Densitometric analysis of protein relative abundance compared with calving.  
(Infection group and Parturition interaction, P <0.01).  
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Figure 4. 
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Figure 5 
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Figure 6 
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Figure 7 
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Figure 8 
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Figure 9 
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CHAPTER FIVE 
 
OSTEOPONTIN IMMUNOREACTIVITY IN THE ILEUM AND ILEOCECAL 
LYMPH NODE OF DAIRY COWS NATURALLY INFECTED WITH 
MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS 
 
A short communication to be submitted to Veterinary Immunology and Immunopathology 
 
E.L. Karcher1,4, C.S. Johnson2, D.C. Beitz1, J.R. Stabel3,5 
 
 
ABSTRACT 
Osteopontin (Opn), a highly acidic glycoprotein, promotes cellular adhesion and recruitment 
and has been shown to be upregulated in the granulomas of mycobacterial infections.  
Johne’s disease, caused by Mycobacterium avium subsp. paratuberculosis (MAP), is 
associated with granulomatous enteritis.  The objective of this experiment was to identify 
Opn in the ileum and ileocecal (IC) lymph node of dairy cows naturally infected with MAP 
and to compare the frequency and intensity of staining between noninfected healthy controls, 
subclinical and clinical cows.  Sections from these three groups were selected from a tissue 
archive.  Immunohistochemical analysis was used to determine the location and expression 
of Opn.  The frequency and intensity of staining were also reported. Confirmation of acid-
fast bacilli in the tissue sections was achieved by the Ziehl-Neelsen method.  Within the ileal 
tissue, macrophages, lymphocytes, and plasma cells stained positive for Opn.  Clinical cows 
expressed Opn at a greater frequency in the lamina propria.  Control and subclinical cows 
1Department of Animal Science, Iowa State University, Ames, IA  50010. 
2Department of Veterinary Pathology, Iowa State University, Ames, IA 50010. 
3USDA-ARS, National Animal Disease Center, Ames, IA  50010. 
4Primary Researcher and author. 
5Author for correspondence. 
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did not have areas of granulomatous inflammation, but cells staining for Opn were equally 
intense for the three groups.  Osteopontin expression in the IC node was not affected by 
MAP infection.  Results of this study confirm for the first time the expression of Opn in the 
ileum and IC node of MAP-infected cattle. 
 
1. INTRODUCTION 
 Mycobacterium avium subsp. paratuberculosis (MAP), the causative agent of Johne’s 
disease, is currently a major economic and welfare issue for dairy producers in the United 
States.  Once infected, animals may remain in the subclinical, or asymptomatic, stage of the 
disease for several years.  The formation of granulomas at the site of MAP infection is 
critical for the early control of the infection.  In subclinical cows, the lesions are 
predominantly located in the ileal lamina propria and are composed of lymphocytes, plasma 
cells, and macrophages.  As the disease progresses to the clinical stage, animals present with 
severe weight loss, intermittent diarrhea, and thickening of the intestinal wall.  Lesions in 
clinical cows, consisting primarily of macrophages, are found in the lamina propria, 
submucosa, and the lymphoid follicles of the Peyer’s Patches. 
 Osteopontin (Opn) is a highly acidic glycoprotein that is produced by activated 
macrophages (Atkins et al., 1998), activated T-cells (Ashkar et al., 2000), and dendritic cells 
(Kawamura et al., 2005).  The role of Opn in mycobacterial infections is of interest based on 
its reported ability to promote the production of Th1 cytokines and to enhance host resistance 
against mycobacteria (Nau et al., 1999; Weber et al., 2002).  Stimulating macrophages with 
Opn resulted in the production of the proinflammatory cytokines, IL-12 and TNF-α (Weber 
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et al., 2002).  The Th1 cytokines, TNF-α and IFN-γ are essential for the production of the 
protective granulomas in MAP-infected cows (Roach et al., 2002).   
 Although Opn is constitutively expressed, it is unregulated in inflamed tissues, such 
as granulomas (Nau et al., 1997).  Macrophages interact with Opn through the CD44 receptor 
and engagement induces chemotaxis and chemoattractant activity (Weber et al., 2002).  This 
interaction is important for the formation of granulomas, as the interaction facilitates the 
movement of macrophages and lymphocytes from peripheral blood to the tissue.    
 The objective of this study was to identify Opn in the ileum and ileocecal lymph node 
(ICN) of dairy cows naturally infected with MAP.  This is the first study to report Opn 
localization in the intestinal tract of MAP-infected cows and differences in Opn expression at 
the site of infection. 
 
2. MATERIALS AND METHODS 
2.1 Samples 
 The study was designed as a retrospective study in which sections were selected from 
an archive of tissue samples from previously characterized control, subclinical, and clinical 
dairy cows.  Standard procedure in our laboratory mandates a complete necropsy after death 
including tissue collection for histological and immunohistochemical examination.  Ileum 
and ileocecal lymph node (ICN) are two tissues routinely collected.  While in the herd, 
animals were routinely evaluated on a quarterly basis to determine infection status, which 
was monitored by culturing the feces for MAP using standard culture methods (Stabel, 1997).  
By definition, clinical animals were shedding more than 100 CFU/tube of medium and 
presented with weight loss and intermittent diarrhea.  The noninfected control cows were 
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characterized by repeated negative fecal cultures performed quarterly over a 3- to 5- year 
period. In addition, the animals were negative on serologic assays (i.e., production of 
antibody specific for MAP and IFN- ) performed during that period.  The number of ileal 
sections included samples from 4 controls, 4 subclinical, and 3 clinical cows.  The total 
number of ICN sections included 5 control, 5 subclinical, and 5 clinical cows.  Samples of 
tissues from all cows were fixed in neutral-buffered 10% zinc-formalin, processed routinely, 
and embedded in paraffin. 
 
2.2 Immunohistochemistry 
Sections were deparaffinized in xylene and rehydrated by an ethanol series (100%, 
95%, 70%, distilled water).  An antigen retrieval step was performed by boiling slides in 
citrate buffer (10 μM citric acid, pH 6; Mallinckrodt, Hazelwood, MO) plus 0.05% Tween 20 
(Sigma, St. Louis, MO) for 20 min and then incubated at RT for an additional 20 min.  Slides 
were washed in 0.1% saponin (Sigma, St. Louis, MO)-PBS solution for 5 min.  Endogenous 
peroxidases were quenched for 30 min by placing the slides in a 3% hydrogen peroxide 
(Fisher Scientific, Pittsburgh, PA) solution prepared with 0.1% saponin-PBS.  Slides were 
washed for 5 min in 0.1% saponin-PBS before blocking for 30 min in 10% normal goat 
serum (KPL, Gaithersburg, MD).  Rabbit anti-bovine Opn (generously supplied by Dr. Gary 
Killian; Pennsylvania State University, Almquist Research Centre, University Park, PA) was 
added to each slide (1:25, diluted in tris/PBS/BSA) and allowed to incubate overnight at 4°C 
in a humidified chamber.  A slide with normal rabbit serum served as a no primary antibody 
control for each tissue type.  The following day, slides were washed in 0.1% saponin-PBS for 
5 min and incubated at RT for 30 min with biotinylated goat anti-rabbit IgG (KPL, 
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Gaithersburg, MD).  Following a 5 min wash, slides were treated with streptavidin-
horseradish peroxidase (KPL, Gaithersburg, MD) for 30 min.  Slides were washed in 0.1% 
saponin-PBS and incubated in DAB-nickel substrate solution (Vector Laboratories, 
Burlingame, CA) for 20 min.  Washed (3 x 5min) slides were stained with Harris 
Hematoxylin (Newcomer Supplies, Middleton, WI).  Slides were then washed (3 x 5 min) in 
water, treated with blueing water (ammonium hydroxide) for 1 min, and then washed an 
additional 3x (1 min/wash).  Slides then were dehydrated by an ethanol series (water, 95%, 
100%) and xylene, coverslipped with Permount (Fisher Scientific, Pittsburgh, PA), and 
evaluated for the presence of Opn by light microscopy at 40x magnification. 
 
2.3 Scoring of Immunohistochemistry 
 For evaluation of Opn in ileal tissue, 10 random fields of the lamina propria were 
scored for the frequency and intensity of cellular Opn immunoreactivity.  For evaluation of 
the ICN, 10 random fields of the paracortex were scored.  The frequency of cell staining was 
scored on a scale of 0-3 (0= 0%, 1= <25%, 2=25-75%, and 3= >75%.  The intensity of the 
cell staining also was scored on a scale from 0-3 (0= negative, 1= mild intensity, 2= 
moderate intensity, and 3= intense).  
 
2.4 Ziehl-Neelsen Staining 
 Sections from the ileum and ICN were cut at 4-6 μm and stained with Ziehl-Neelsen 
(ZN) by conventional methods.  Ten random fields of the lamina propria or the paracortex 
were scored for ileal tissue and IC node, respectively.  Slides were scored on a scale of 0-3 
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(0= no acid-fast bacilli, 1= small number of bacilli, 2= moderate number of bacilli, 3= large 
number of bacilli).  All slides were read at 40x magnification. 
 
2.5 Statistical Analysis 
 The data was analyzed using the PROC Mixed analysis of SAS (PROC MIXED in 
SAS PC Windows Version 9.1.3 software).  The model included infection group and 
frequency of cellular staining or intensity of staining.  The values reported are means and 
standard errors with significance set at P < 0.05. 
 
3. RESULTS AND DISCUSSION 
 We present here the first reported data on the localization of Opn in the ileum and 
ICN of dairy cows naturally infected with MAP.  Infections caused by MAP, the causative 
agent of Johne’s disease, are estimated to cost the US dairy industry upwards of $250 million 
annually (Ott et al., 1999).  MAP is a weakly gram-positive, acid-fast bacillus.  Calves most 
likely become infected with MAP during the first six-months of life (Sweeney et al., 1996).  
Once infected, cows generally remain in the subclinical, or asymptomatic, stage of the 
disease for several years until the disease progresses to the clinical state.  The disease is 
associated with chronic granulomatous enteritis.  
 Osteopontin plays an early role in initiating the innate immune response to 
mycobacterial infections by promoting cellular adhesion and recruitment of inflammatory 
cells from the peripheral blood, increasing the number of activated macrophages, and 
eliciting a Th1 cytokine response.  It is produced by activated macrophages (Atkins et al., 
1998), activated T-cells (Ashkar et al., 2000), and dendritic cells (Kawamura et al., 2005).  In 
 
 
 180
 
 
the current study, macrophages, lymphocytes, and plasma cells in the ileal tissues of all 
animals stained positive for Opn.  This result is in contrast to that in the ICN, in which only 
lymphocytes stained positive for the subclinical and control groups.  Both lymphocytes and 
macrophages, however, stained positive for Opn in the ICN from clinically infected animals.  
In all cell types, Opn stained within the cytoplasm.  Despite reports of Opn expression by 
enterocytes and smooth muscle cells, there was no staining of these cell types in either the 
ileum or ICN. 
 Progression of MAP-infection to the clinical stage of the disease is characterized by 
increases in the granulomatous lesions in the lamina propria of the ileum. Macrophages 
become the predominate immune cell in the lesion and there is a dramatic increase in the 
bacterial load (Hostetter et al., 2005).  This result is consistent with those of the current study 
in which clinical cows had poorly demarcated areas of severe granulomatous inflammation.  
These intestinal lesions were composed predominantly of macrophages immunoreactive for 
Opn (Fig. 1A).  Diffusely, the lamina propria in clinical cows was expanded by an abundant 
number of macrophages.  Additionally, the submucosa of clinical cows was multifocally 
infiltrated and expanded by linear aggregates of macrophages.  The staining of the 
macrophages appeared granular within the cytoplasm of the cell. Clinical cows had a greater 
percentage of cells staining positive for Opn compared with control cows (P < 0.01) (Table 
1).  Although Opn is expressed constitutively, it is upregulated in inflamed tissues such as 
granulomas (Nau et al., 1997).  Osteopontin interacts with the CD44 receptor on 
macrophages to induce chemotaxis and chemoattractant activity (Weber et al., 2002).  It also 
induces T-cell chemotaxis and costimulates T-cell proliferation (O’Regan et al., 1999).  The 
ability of Opn to recruit macrophages to sites of inflammation was illustrated when rats that 
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were injected with recombinant Opn had a 225% increase in the number of macrophages at 
the injection site compared with the controls (Giachelli et al., 1998).  Despite differences in 
the frequency of staining, there were no differences observed in the intensity of the stained 
cells (Table 1).  Staining by ZN method demonstrated acid-fast bacilli within the cytoplasm 
of macrophages in the lamina propria of the clinical Johne’s cows only (Table 2).   
 In contrast to the ileum sections, differences in the frequency of cells staining positive 
for Opn were not observed in the ICN between the different infection groups (Table 2).  For 
both subclinical and control animals, only the lymphocytes were positive for Opn.  However, 
in the clinical animals, both lymphocytes and macrophages were positive (Fig. 1B).  Staining 
by ZN method demonstrated acid-fast bacilli in the paracortex of clinical cows only.  Control 
and subclinical cows were negative for acid-fast bacilli. 
 In conclusion, the results of this study show for the first time the presence of Opn in 
ileal and ICN tissue sections from healthy dairy cows and cows naturally infected with MAP.  
We also showed that Opn was upregulated in the areas of granulomatous inflammation in the 
ileum of clinical cows. Results presented here are important because they support a role for 
Opn in the regulation of MAP infection. 
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Table 1. Frequency and staining intensity scores of osteopontin immunoreactivity in the ileum1 and ileocecal2 lymph node from 
dairy cows naturally infected with Mycobacterium avium subsp. paratuberculosis. 
Ileum 
Infection Group                 Frequency of Cellular Staining3               Staining Intensity4   Cell Types 
Control        1.43 ± 0.4a                                                                    1.93 ± 0.3                                   Lymphocytes 
                        Plasma Cells 
                        Macrophages 
Subclinical                                               2.25 ± 0.2ab                                                                 2.04 ± 0.3                                   Lymphocytes 
                                                                                                                                                                                  Plasma Cells      
                                   Macrophages     
Clinical                                                    2.93 ± 0.03b                                                 1.57 ± 0.03                                 Macrophages 
 
 
IC Lymph Node 
Infection Group                Frequency of Cellular Staining               Staining Intensity   Cell Types 
Control                                                     1.42 ± 0.6                                              1.00 ± 0.5                                   Lymphocytes              
Subclinical                                               2.25 ± 0.4                                              1.27 ± 0.3                                   Lymphocytes 
Clinical                                                    1.77 ± 0.4                                              0.64 ± 0.1                      Lymphocytes/Macrophages 
110 random fields of lamina propria scored. 
210 random fields of paracortex scored. 
3Frequency Score: 0= no cells, 1= <25%, 2= 25-75%, 3= >75% 
4Staining Intensity: 0= negative, 1= mild, 2= moderate, 3= intense 
a-bDifferent superscripts indicate differences (P < 0.05). 
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Table 2. Acid Fast Scoring for ileum1 and ileocecal2 lymph node from dairy cows naturally 
infected with Mycobacterium avium subsp. paratuberculosis. 
Ileum 
Infection Group                  Score3
Control                                   0a
Subclinical                             0a
Clinical                             2.73 ± 0.2b 
 
IC Lymph Node 
Infection Group                  Score 
Control                                   0a
Subclinical                             0a
Clinical                              1.97 ± 0.6b
110 random fields of lamina propria scored. 
210 random fields of paracortex scored. 
3Score: 0=no acid-fast bacilli, 1= small number, 2= moderate number, 3=large number 
a-bDifferent superscripts indicate differences (P < 0.05). 
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List of Figures 
 
Figure 1. Staining of ileum and Ileocecal lymph node from control, subclinical, and clinical 
MAP-infected cow after DAB staining using a polyclonal antibody to Opn. A) The lamina 
propria contains rare to small numbers of macrophages, lymphocytes, and plasma cells.  The 
arrow highlights intense Opn immunoreactivity in individual lymphocytes. B) The paracortex 
contains multifocal small aggregates of lymphocytes that are immunoreactive for Opn.  C) 
The lamina propria contains small numbers of irregular clusters of macrophages, 
lymphocytes, and plasma cells. The arrow highlights a focus of moderately intense Opn 
immunoreactivity.  D) The paracortex contains multifocal aggregates of lymphocytes that are 
immunoreactive for Opn.  E) The lamina propria is expanded and the intestinal crypts are 
separated by poorly demarcated sheets of macrophages. The arrow highlights a focus of 
granular Opn immunoreactivity. F) The paracortex is infiltrated by a poorly defined 
aggregate of macrophages (arrow) that lacks the granular Opn immunoreactivity seen in the 
ileum. Note (arrow) the intensely immunoreactive lymphoyctes at the periphery of 
granulomatous inflammation. (x40) Bar, 50μm. 
 
Figure 2. Section of ileal tissue (A) and IC node (B) from clinical MAP-infected cow stained 
for acid-fast bacilli using the Ziehl-Neelsen method. (x40) Bar, 50μm. 
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CHAPTER SIX 
 
 
 
SUMMARY AND CONCLUSIONS 
  
 
Mycobacterium avium subsp. paratuberculosis (MAP), the causative agent of Johne’s 
disease (JD), is estimated to infect more than 22% of US dairy herds and cost the industry 
$250 million annually. One major period of stress for dairy cows is the periparturient period, 
and field observations suggest that MAP-infected cows may advance to the clinical stage of 
the disease during the early post-partum period. Research on what prompts the progression of 
disease during this time period is lacking. Therefore, the studies presented in this dissertation 
were guided by the primary goal to gain a better understanding of the host immune response 
to MAP during the periparturient period.   A better understanding of the interaction of these 
two factors may provide valuable information to the dairy industry.  Preventing the incidence 
of JD is not only an issue of animal welfare but will be economically beneficial to the 
industry. 
Chapter 2 characterized cytokine gene expression and secretion in periparturient dairy 
cows naturally infected with MAP.  Upon ingestion of the bacteria, animals remain in the 
subclinical, or asymptomatic, stage of the disease for several years.  The subclinical stage of 
the disease is highlighted by a Th1, or cell-mediated, immune response.  As the disease 
progresses to the clinical stage, there is a transition from the Th1 to Th2, or antibody- 
mediated immune response.  In this study, we examined the Th1 cytokines, IFN-γ, TNF-α, 
and IL-12, the Th2 cytokines, IL-4 and IL-10, and the Th3 cytokine, TGF-β.  Despite 
published reports in the literature describing the Th1/Th2 paradigm in mycobacterial 
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infections, the results of this study did not support an effect of MAP-infection on cytokine 
gene expression.  One major downfall was the small number of clinical cows and the 
inability to analyze cytokine gene expression for this group.  Expression could not be 
determined for the clinical cows because due to sampling error, there was only one sample at 
the reference expression point (+1 day).  However, there were effects of parturition on gene 
expression for control and subclinical cows.  Expression of IFN-γ, IL-4, and IL-10 were 
affected by the periparturient period.  We were able to evaluate the secretion of IFN-γ, IL-10, 
and TGF-β for control, subclinical, and clinical cows.  The overall effect of MAP-infection 
or parturition on cytokine secretion was minimal.  Despite the problem of sample size for 
evaluation of clinical cow gene expression, this study is important because it contributes to a 
small body of literature examining cytokine gene expression and secretion in periparturient 
dairy cows with JD.  Future studies are required with larger sample sizes to insure sufficient 
numbers for statistical analysis.  Furthermore, during the four-week postpartum period, we 
did not observe any of the subclinical cows progressing to the clinical stages of the disease.  
Therefore, it may be important to evaluate early postpartum animals as they progress into 
lactation. 
 The objective of the research presented in chapter 3 was to determine the percentages 
of CD4+, CD8+, and γδ T-cells, B-cells, and monocytes in the peripheral blood of dairy cows 
naturally infected with MAP during the periparturient period as compared with healthy 
control cows.  In addition, cell populations were delineated further by staining for CD5, a 
marker for T- and B-cell activation.  Parturition has a major impact on the number of T- and 
B-cells, both components of the adaptive immune system, and the number of 
monocyte/macrophages, effectors of the innate immune system, in the peripheral blood of 
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healthy dairy cows.  Previous research has described the increased incidence of infectious 
diseases and declining lymphocyte function during the periparturient period.  There are 
conflicting reports in the literature describing population changes in CD4+, CD8+, γδ T-cells, 
and B-cells at parturition.  It has been reported that B-cells do little to protect the host during 
the clinical stage of MAP-infection.  In this study, fluorescent antibody labeling of 
lymphocyte subsets and monocytes and flow cytometry was utilized to determine the 
percentages of specific cell types from three weeks post-partum through four weeks post-
partum.  Results indicate that in dairy cows the percentages of both lymphocyte subsets and 
mononuclear cells are modulated by natural infection with MAP and by the periparturient 
period.  In addition, these factors are capable of influencing expression of the activation 
marker, CD5, on T-cell subpopulations and B-cells.  Clinical animals consistently had greater 
percentages of CD5dim lymphocyte subsets compared with control and subclinical cows.  The 
data presented in this chapter are important because they highlight changes in the immune 
response of infected cattle during the highly stressful time of parturition.  Future research 
should seek to further characterize the changes in CD5 observed between infected groups. 
 Osteopontin (Opn), a highly acidic glycoprotein, was examined in chapter 4 because 
of its known ability to enhance the Th1 response and to increase host resistance to 
Mycobacterial infections. The objective of this study was to evaluate Opn gene and protein 
expression in dairy cows naturally infected with MAP during the periparturient period as 
compared with healthy controls.  In addition, Th1 and Th2 cytokines were evaluated for 
expression and secretion.  On the basis of problems presented in chapter 2 with the small 
number of clinical cows, this study contained seven clinically infected animals.  Results 
revealed that Opn expression and protein abundance in PBMCs isolated from periparturient 
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cows are modulated by both MAP-infection status and parturition.  As hypothesized, 
nonstimulated PBMCs from subclinically infected cows expressed more Opn than did the 
control or clinically infected  cows.  Osteopontin protein was identified in PBMCs at 60, 52, 
34, and 27 kDa and was shown to be present at a high intensity in the areas of granulomas 
formation in clinical cows.  This study is extremely important because it presents the first 
known data investigating Opn gene and protein expression in MAP-infected cows.  Further 
research is required to understand what role Opn may be playing in the progression of JD. 
 Finally, as a follow-up to the previous study, Opn was further explored in chapter 5.  
The objective of this short communication was to identify Opn in the ileum and IC node of 
dairy cows naturally infected with MAP and to compare the frequency and intensity of 
staining between the different infection groups.  In contrast to the findings in chapter 4 that 
focused on Opn in the peripheral blood, this chapter highlighted Opn localization at the site 
of MAP infection.  Immunohistochemical analysis revealed that, within the ileum, 
macrophages, lymphocytes, and plasma cells stained positive for Opn.  Osteopontin was 
upregulated in areas of granulomatous inflammation.  Ziehl-Neelsen staining for acid-fast 
bacilli supported increased bacteria in the areas of inflammation.  Although Opn was 
expressed constitutively in the ileocecal lymph node, there were no differences in expression 
between the infection groups.  The results presented in this chapter are the first reported 
localization of Opn in the ileum and ileocecal lymph node of MAP-infected dairy cows.  
Additional research is needed to distinguish which subsets of lymphocytes are producing 
Opn (CD4+, CD8+, or γδ T-cells). 
 Taken together, data in this dissertation suggest that critical changes during the 
periparturient period that may alter the ability of the host immune system to respond to MAP.  
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Future research will be required to gain a better understanding of these critical changes.  A 
study following MAP-infected cows through lactation would be beneficial to further evaluate 
cytokine profiles and progression of JD.  In addition, the Th1 cytokine, IL-18, should be 
examined.  IL-18 has been shown to enhance the production of other Th1 cytokines and 
enhance the maturation of T-cells.  Furthermore, IL-18 has been reported to improve host 
resistance to other mycobacterial infections. 
 
 
 
